data_1tvm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tvm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 56' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.487 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.606 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 52' ' ' PRO . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.735 HG22 ' HA ' ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.471 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 73' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.488 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.573 HG13 HD13 ' A' ' 73' ' ' ILE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.616 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.484 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 92' ' ' MET . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.487 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 107' ' ' ILE . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD13 ' CG2' ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.824 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' A' ' 73' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.6 0.238 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.554 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.718 ' HB3' HG13 ' A' ' 51' ' ' ILE . 3.0 t60 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' A' ' 49' ' ' HIS . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 22' ' ' ARG . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.595 ' HB ' HD11 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.759 HG22 ' HB3' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.405 ' HB ' HD12 ' A' ' 88' ' ' LEU . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.536 ' O ' HG23 ' A' ' 73' ' ' ILE . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.759 ' HB3' HG22 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.428 HG22 ' C ' ' A' ' 88' ' ' LEU . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.487 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.538 HD13 ' HA2' ' A' ' 97' ' ' GLY . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 94' ' ' PHE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.652 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HG ' HD22 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 2.5 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.572 0.225 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.646 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.756 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.854 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 57' ' ' GLN . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 55' ' ' LEU . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.52 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.488 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.495 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.563 HD21 HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.624 ' HB ' HD11 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.621 ' HA ' HG22 ' A' ' 26' ' ' VAL . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.854 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.716 HG22 ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB3' HG22 ' A' ' 73' ' ' ILE . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.567 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.631 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.631 HG21 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.534 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.618 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.602 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.602 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.603 0.24 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.784 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.617 HH11 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.784 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.564 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.475 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 94' ' ' PHE . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 106' ' ' LYS . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 111' ' ' LEU . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.563 0.22 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.635 ' HB ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.778 0.323 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.402 ' HG3' ' HA ' ' A' ' 34' ' ' THR . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.678 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.463 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 22' ' ' ARG . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.494 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.458 ' CD1' HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.446 ' CE ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.446 HG12 ' CE ' ' A' ' 67' ' ' MET . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.413 ' N ' HG13 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 90' ' ' HIS . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.512 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.727 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.482 ' HD2' ' O ' ' A' ' 75' ' ' THR . 7.2 m170 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.567 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.511 ' CD1' HD23 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.687 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.687 HD11 ' HA2' ' A' ' 97' ' ' GLY . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.678 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.441 ' HA ' HD22 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 105' ' ' ASN . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.436 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 111' ' ' LEU . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.921 0.391 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.603 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 55' ' ' LEU . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.538 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 22' ' ' ARG . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.671 ' O ' ' HB3' ' A' ' 67' ' ' MET . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.671 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 HD13 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.586 ' HB2' HG12 ' A' ' 24' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.639 HG13 ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.58 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CG2' HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.668 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' HG11 ' A' ' 95' ' ' VAL . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.559 HG21 ' CE1' ' A' ' 94' ' ' PHE . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.668 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.79 HG13 HD13 ' A' ' 111' ' ' LEU . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 107' ' ' ILE . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.736 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 95' ' ' VAL . 2.2 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.499 HD12 HD13 ' A' ' 55' ' ' LEU . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.407 ' SG ' HG13 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 10.7 m170 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 42' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.616 HG13 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.601 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.316 0 CA-C-O 120.612 0.007 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.555 HG21 ' CD1' ' A' ' 88' ' ' LEU . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.624 HD22 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.534 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.611 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 96' ' ' SER . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.611 ' CD1' ' HG2' ' A' ' 93' ' ' PRO . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.607 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.579 ' HA ' HD23 ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 105' ' ' ASN . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.484 ' N ' HD11 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 70' ' ' VAL . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.637 HD13 HG12 ' A' ' 56' ' ' ILE . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 57' ' ' GLN . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.679 0.276 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.412 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 51' ' ' ILE . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 22' ' ' ARG . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG13 ' A' ' 26' ' ' VAL . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.603 HG23 HD11 ' A' ' 25' ' ' ILE . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.669 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 88' ' ' LEU . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.411 ' HD1' ' HB2' ' A' ' 92' ' ' MET . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.539 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.432 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.604 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.497 HD13 ' HG2' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.425 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.552 0.215 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.712 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 25' ' ' ILE . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.656 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 67' ' ' MET . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.509 HG12 HG23 ' A' ' 73' ' ' ILE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.725 ' HA ' HG21 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.569 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 100' ' ' ILE . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG23 ' HA2' ' A' ' 97' ' ' GLY . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.703 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HA ' HD23 ' A' ' 111' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' A' ' 111' ' ' LEU . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.567 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 57' ' ' GLN . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.551 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.602 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 22' ' ' ARG . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.548 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 24' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 86' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' CG1' HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 1.4 t60 -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.58 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.506 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 95' ' ' VAL . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 98' ' ' VAL . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.687 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.633 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' N ' HG21 ' A' ' 107' ' ' ILE . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 7.4 mm-40 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' CG ' ' A' ' 71' ' ' HIS . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' CD ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' O ' HG21 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.607 HG13 ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG21 HD21 ' A' ' 55' ' ' LEU . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.451 HG21 ' CG1' ' A' ' 95' ' ' VAL . 5.3 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.695 ' HD1' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' CD ' ' A' ' 23' ' ' LYS . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG21 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.725 HG21 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.607 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.588 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' SD ' ' A' ' 67' ' ' MET . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.867 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.409 ' OG1' HD11 ' A' ' 88' ' ' LEU . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.867 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.431 ' N ' HG22 ' A' ' 89' ' ' VAL . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.522 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.451 ' CG1' HG21 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.419 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 4.8 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.066 0.46 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 72' ' ' LEU . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 57' ' ' GLN . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' HE21 ' A' ' 104' ' ' GLN . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.51 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.776 HG23 ' HA ' ' A' ' 25' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.521 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 24' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.194 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.5 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.416 ' O ' HG21 ' A' ' 95' ' ' VAL . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.69 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.524 ' N ' HG22 ' A' ' 107' ' ' ILE . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 2.0 ttpm? . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 111.26 0.096 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 25' ' ' ILE . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 59' ' ' ARG . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' MET . 7.8 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.753 0.311 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 38' ' ' ALA . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.478 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 49' ' ' HIS . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 22' ' ' ARG . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.649 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.718 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 90' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD13 HD12 ' A' ' 73' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.536 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 92' ' ' MET . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.438 ' CE2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 95' ' ' VAL . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.543 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.543 HD13 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 HD22 ' CE2' ' A' ' 94' ' ' PHE . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.549 ' HA ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' HG13 ' A' ' 107' ' ' ILE . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.754 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 HG21 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' H ' HD11 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.605 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.536 ' HB ' HD23 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HB3' HG12 ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 22' ' ' ARG . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.647 ' O ' HD11 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 60' ' ' VAL . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.678 HG21 HG12 ' A' ' 25' ' ' ILE . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 23' ' ' LYS . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.445 ' HA ' HD21 ' A' ' 72' ' ' LEU . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.674 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.761 HG21 HD22 ' A' ' 88' ' ' LEU . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.515 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CG ' HD12 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 99' ' ' GLY . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' N ' HG11 ' A' ' 98' ' ' VAL . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 108' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.577 0.227 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.686 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.704 0.288 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 52' ' ' PRO . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.686 HG23 ' HA ' ' A' ' 25' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.775 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.635 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' HG22 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.673 ' CG ' HD12 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.442 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.6 t60 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.76 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.673 HD12 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.76 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.511 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.64 ' O ' HD11 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 95' ' ' VAL . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' O ' ' A' ' 94' ' ' PHE . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB3' HD23 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.621 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.746 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.621 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.445 0.164 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 70' ' ' VAL . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 104' ' ' GLN . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.609 ' HB2' HD11 ' A' ' 51' ' ' ILE . 33.7 m80 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 49' ' ' HIS . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 52' ' ' PRO . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.506 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 63' ' ' ILE . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 59' ' ' ARG . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.515 ' HA ' HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 73' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.461 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.699 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.703 ' HE1' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.703 HG21 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.738 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.47 ' HA ' HD22 ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 105' ' ' ASN . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.838 0.351 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.641 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HE2' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.838 HG12 HD12 ' A' ' 72' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.741 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 HD13 ' A' ' 108' ' ' LEU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 HD12 HG23 ' A' ' 51' ' ' ILE . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 53' ' ' VAL . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' CD1' ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.741 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 67' ' ' MET . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 55.4 t60 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.838 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.586 ' HB ' ' CB ' ' A' ' 88' ' ' LEU . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 HG13 HD12 ' A' ' 73' ' ' ILE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.586 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.579 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 95' ' ' VAL . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 2.9 tp60 -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 103' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.736 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.821 0.343 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.706 ' HA ' HG23 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 25' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.545 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 67' ' ' MET . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.652 HG22 ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.438 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.6 ' CG1' HG21 ' A' ' 73' ' ' ILE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.652 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 93' ' ' PRO . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.558 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.587 HG13 HG21 ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.55 HG22 ' CE1' ' A' ' 94' ' ' PHE . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.564 ' HA ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 105' ' ' ASN . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.424 ' N ' HD11 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 111' ' ' LEU . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.518 HE21 HD13 ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.827 0.346 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.689 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.671 0.272 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.797 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.425 HD23 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.604 HG21 ' HA ' ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 56' ' ' ILE . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.589 HG21 ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 63' ' ' ILE . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.515 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.52 ' CD1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' THR . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 104' ' ' GLN . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.751 0.31 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 56' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.431 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 HD21 HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.406 HG21 ' NH2' ' A' ' 22' ' ' ARG . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.71 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG13 ' HD3' ' A' ' 22' ' ' ARG . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.566 HG21 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 67' ' ' MET . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 25' ' ' ILE . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 16.9 m-70 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.207 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.597 ' CG1' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.457 ' O ' HG21 ' A' ' 73' ' ' ILE . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HA ' HG21 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.554 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 97' ' ' GLY . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.594 ' HG ' HG21 ' A' ' 107' ' ' ILE . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.594 HG21 ' HG ' ' A' ' 103' ' ' LEU . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.418 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.603 0.24 . . . . 0.0 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.59 24.16 0.1 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.374 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.99 68.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.285 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m 51.43 97.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.237 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -174.34 160.2 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.79 102.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.429 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.474 ' HB2' ' CD2' ' A' ' 11' ' ' HIS . 8.7 m170 -96.74 120.73 37.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.417 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -84.45 -28.97 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -61.41 -61.22 2.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.216 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.08 138.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 111.286 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 7' ' ' HIS . 34.8 m80 -96.9 55.49 1.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -60.22 90.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.86 160.89 18.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.68 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -113.9 116.55 29.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.28 148.97 37.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.7 81.98 1.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -100.64 33.09 2.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.467 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 34.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.834 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . -144.46 -76.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.172 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.21 -67.8 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -164.44 -65.56 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.613 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 56' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.53 -56.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.59 -108.18 0.33 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.53 -105.32 2.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.19 104.69 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' THR . 1.4 t -132.29 38.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' A' ' 37' ' ' MET . . . 77.17 -33.94 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.487 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -64.25 -47.94 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.606 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 52' ' ' PRO . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.735 HG22 ' HA ' ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.471 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 73' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.488 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -80.38 69.43 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.22 84.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 11.7 tpt85 -151.6 -60.24 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 p -66.86 170.4 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.292 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -100.29 -23.04 14.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.711 ' HG3' ' HG ' ' A' ' 88' ' ' LEU . 2.6 tmm_? 57.34 33.37 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.695 0.283 . . . . 0.0 111.149 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.6 t -121.57 11.42 10.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.511 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.413 ' CE1' HG21 ' A' ' 86' ' ' ILE . 23.0 p90 -110.19 112.38 24.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.034 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.37 -110.26 3.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.357 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.573 HG13 HD13 ' A' ' 73' ' ' ILE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.711 ' HG ' ' HG3' ' A' ' 81' ' ' ARG . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.484 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 92' ' ' MET . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.487 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 107' ' ' ILE . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD13 ' CG2' ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.874 0.368 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.85 -16.44 6.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.589 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.97 -26.08 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.635 0.255 . . . . 0.0 111.248 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -120.7 159.99 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.79 86.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -113.47 78.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -177.56 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 176.96 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -127.89 148.85 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.193 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -21.45 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.37 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -92.33 140.97 29.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -59.22 154.87 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 92.75 3.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.7 89.29 2.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp 59.06 71.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -145.07 -53.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.35 27.6 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.53 93.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.9 -78.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.72 -175.97 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.824 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -132.38 -55.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' A' ' 73' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.56 165.25 20.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.57 62.63 1.15 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.802 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.63 73.93 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.381 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HB2' ' HG1' ' A' ' 34' ' ' THR . . . -82.03 -76.34 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 111.575 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t 75.84 -21.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.103 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.55 -40.2 2.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.771 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.407 ' HG1' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -86.5 -6.43 58.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.075 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.554 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD22 ' HG ' ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.479 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.718 ' HB3' HG13 ' A' ' 51' ' ' ILE . 3.0 t60 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' A' ' 49' ' ' HIS . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 22' ' ' ARG . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.595 ' HB ' HD11 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.759 HG22 ' HB3' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.405 ' HB ' HD12 ' A' ' 88' ' ' LEU . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.2 p -98.66 79.5 2.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.89 -23.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.141 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.9 53.09 1.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.099 0.476 . . . . 0.0 111.355 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.51 42.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.542 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 7.5 p-10 -99.03 -20.39 16.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -16.34 56.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -127.11 1.91 6.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.355 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.604 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 1.8 m-30 -91.48 -44.94 8.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.12 -71.13 0.48 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.536 ' O ' HG23 ' A' ' 73' ' ' ILE . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.759 ' HB3' HG22 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG22 ' C ' ' A' ' 88' ' ' LEU . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.487 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.538 HD13 ' HA2' ' A' ' 97' ' ' GLY . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 94' ' ' PHE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.652 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HG ' HD22 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 2.5 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.712 0.292 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.54 138.26 2.42 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.562 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -116.15 29.35 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -127.9 176.67 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -158.52 89.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.4 61.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.92 48.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.988 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 86.24 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -106.99 107.47 18.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.256 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -133.43 -17.19 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.366 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.68 144.46 23.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -110.43 -22.84 11.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.49 119.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.8 41.13 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.83 -77.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.56 106.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.86 0.362 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -111.9 90.69 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -114.55 23.54 12.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.88 -73.64 0.85 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.73 162.46 13.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.656 0.265 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp -144.71 -82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.646 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.756 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.854 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 57' ' ' GLN . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -161.82 156.57 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.33 -146.06 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 94.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.383 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB2' ' OG1' ' A' ' 34' ' ' THR . . . -73.53 -66.08 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.0 111.418 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 70.9 t 75.35 -43.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.4 64.23 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.93 0.395 . . . . 0.0 110.957 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 31' ' ' ALA . 13.3 p -154.44 -40.23 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.896 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 55' ' ' LEU . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.52 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.488 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.495 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.563 HD21 HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.624 ' HB ' HD11 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.621 ' HA ' HG22 ' A' ' 26' ' ' VAL . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.854 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.756 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.716 HG22 ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 2.7 m -95.2 80.25 3.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 76' ' ' THR . . . 178.76 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.692 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.507 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.31 51.14 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.741 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' PHE . 23.9 m -74.91 47.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.392 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.563 ' HB2' ' CD2' ' A' ' 88' ' ' LEU . 11.4 t0 -101.9 -20.81 14.71 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -14.83 54.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.32 10.89 7.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.221 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 3.2 m-85 -106.24 -43.92 4.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.811 0.339 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.82 -68.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB3' HG22 ' A' ' 73' ' ' ILE . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.427 ' NE2' ' HD2' ' A' ' 78' ' ' ARG . 50.9 m170 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.567 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.631 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.631 HG21 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.534 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.602 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.602 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.16 123.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -149.89 -168.45 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -137.12 172.99 12.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -66.32 -59.45 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.7 ' HD1' ' N ' ' A' ' 7' ' ' HIS . 1.8 t-80 64.0 140.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.7 ' N ' ' HD1' ' A' ' 6' ' ' HIS . 7.7 t-160 -134.59 113.52 11.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.05 9.95 1.72 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.268 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.441 ' HD1' ' HD2' ' A' ' 11' ' ' HIS . 38.3 t-80 -92.02 82.35 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -63.96 134.97 56.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.441 ' HD2' ' HD1' ' A' ' 9' ' ' HIS . 0.2 OUTLIER -119.23 80.01 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.09 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -110.74 -20.69 12.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.38 74.48 0.15 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.802 0.334 . . . . 0.0 110.988 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.75 141.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.2 26.97 5.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.826 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -122.51 41.8 3.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.82 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -114.34 157.47 22.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -124.45 -42.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.41 111.45 1.12 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.985 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -178.14 -62.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.3 -50.99 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.784 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.12 -55.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.81 -6.39 33.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.842 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.99 -145.23 0.12 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.83 -168.31 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.785 0.326 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t 48.77 70.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.368 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 69.26 50.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.49 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -133.55 -54.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.858 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.678 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.617 HH11 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.784 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.47 62.04 0.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.29 143.28 20.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -72.59 78.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.493 ' CG2' HD11 ' A' ' 88' ' ' LEU . 27.3 m -84.74 -171.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.225 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 32.4 m-20 -98.24 -13.85 20.6 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER 33.67 47.0 0.14 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -2.94 5.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.241 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -80.45 102.71 9.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.15 -103.0 1.41 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.3 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.564 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 94' ' ' PHE . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 106' ' ' LYS . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 111' ' ' LEU . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.78 53.24 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.964 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -114.88 148.1 39.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 111.165 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.4 m -118.93 104.13 10.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -159.58 147.38 17.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.41 -16.09 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.793 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.3 m80 59.83 -82.77 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.653 0.263 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.1 -171.27 2.0 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -76.0 178.33 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -59.8 -75.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.33 35.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.814 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -118.64 -37.76 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 66.8 35.84 4.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.83 145.48 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -107.61 -12.8 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -102.02 87.82 3.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.801 0.334 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.91 151.24 36.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -84.88 52.33 2.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.94 3.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.512 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.92 177.77 1.03 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.786 0.327 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -165.1 -77.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.602 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.635 ' HB ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.48 161.42 41.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.13 87.39 1.55 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.323 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.74 174.95 13.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.518 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' C ' HG22 ' A' ' 32' ' ' VAL . . . 179.25 79.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 ' C ' ' A' ' 31' ' ' ALA . 11.4 t -141.04 -42.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 37' ' ' MET . . . -140.78 -42.18 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.163 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -64.36 -57.57 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.678 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.463 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 22' ' ' ARG . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.494 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 ' CD1' HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.446 ' CE ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.446 HG12 ' CE ' ' A' ' 67' ' ' MET . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.413 ' N ' HG13 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 90' ' ' HIS . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.61 70.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.79 147.91 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 60.49 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -62.88 -178.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.996 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -94.73 -22.56 18.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.05 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 42.87 40.17 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.9 p -126.0 2.82 7.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.015 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.492 ' CE2' HG23 ' A' ' 86' ' ' ILE . 28.7 p90 -94.09 99.8 12.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.902 0.382 . . . . 0.0 111.034 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.29 -119.4 5.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.512 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.727 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' HD2' ' O ' ' A' ' 75' ' ' THR . 7.2 m170 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.567 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.511 ' CD1' HD23 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.687 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.687 HD11 ' HA2' ' A' ' 97' ' ' GLY . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.678 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.441 ' HA ' HD22 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 105' ' ' ASN . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.436 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 111' ' ' LEU . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.42 -85.22 0.12 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.36 142.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.8 t -165.23 -15.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m170 60.62 -178.76 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 175.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -59.01 88.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 -171.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.46 134.93 54.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 48.56 84.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -79.46 -172.82 3.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.63 -167.69 1.32 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 65.43 102.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.945 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -77.47 -76.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.82 75.65 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.115 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.84 6.25 2.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 17' ' ' PHE . 0.6 OUTLIER 61.14 22.69 12.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.248 . . . . 0.0 110.943 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -87.34 14.83 7.23 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.253 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.17 62.15 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -163.53 165.73 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.86 -52.48 1.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.603 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 55' ' ' LEU . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.87 156.32 22.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.71 123.7 7.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -157.27 51.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.82 -78.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t 46.99 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.98 49.78 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.973 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -142.62 -49.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.538 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 22' ' ' ARG . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.671 ' O ' ' HB3' ' A' ' 67' ' ' MET . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.671 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 HD13 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.586 ' HB2' HG12 ' A' ' 24' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.639 HG13 ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -129.07 45.84 2.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.01 1.03 13.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.647 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.6 64.16 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 ' CG2' HD11 ' A' ' 88' ' ' LEU . 21.0 m -85.59 -169.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 81' ' ' ARG . 20.3 p-10 -96.9 -20.74 17.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.341 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.543 ' HA ' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER 40.9 40.55 1.02 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.485 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.07 10.11 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 13.1 p90 -95.61 113.03 24.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.749 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.29 -110.2 3.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.58 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.639 ' CG2' HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 81' ' ' ARG . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.668 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' HG11 ' A' ' 95' ' ' VAL . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.559 HG21 ' CE1' ' A' ' 94' ' ' PHE . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.668 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.79 HG13 HD13 ' A' ' 111' ' ' LEU . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 107' ' ' ILE . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.659 0.266 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.49 -147.86 16.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.243 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.98 154.13 36.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.31 19.62 5.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -72.97 158.25 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' C ' ' HD1' ' A' ' 7' ' ' HIS . 51.4 m80 -145.07 -78.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.516 ' N ' ' HD1' ' A' ' 7' ' ' HIS . 0.2 OUTLIER -104.54 72.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -145.59 22.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.002 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' HD1' ' C ' ' A' ' 9' ' ' HIS . 4.1 t-80 -151.9 -44.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -102.56 -169.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 112.17 4.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.38 174.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.84 -75.82 0.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.88 45.11 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.261 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.16 138.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.768 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.69 60.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.023 0.44 . . . . 0.0 111.099 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.74 17.9 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -122.57 112.41 17.97 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.91 -119.46 13.57 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 p -162.15 -34.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.7 0.286 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.49 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.736 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.05 -173.26 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.33 12.68 19.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.11 -34.64 4.74 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.64 106.67 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 3.5 t -60.09 168.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.831 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . 82.18 -34.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.883 0.473 . . . . 0.0 111.425 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 95' ' ' VAL . 2.2 m -70.67 -44.63 66.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.499 HD12 HD13 ' A' ' 55' ' ' LEU . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.407 ' SG ' HG13 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 10.7 m170 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 42' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.616 HG13 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.601 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.16 69.93 7.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.96 -69.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.825 ' HG2' ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER 68.99 39.75 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.048 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.522 HG23 ' HG2' ' A' ' 81' ' ' ARG . 7.1 p -66.42 85.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.12 -5.05 24.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.6 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' HG2' HG23 ' A' ' 79' ' ' VAL . 7.0 ptp180 -41.68 -31.75 0.32 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.624 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.6 36.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -110.49 38.81 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.183 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.5 -91.57 0.06 OUTLIER Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.555 HG21 ' CD1' ' A' ' 88' ' ' LEU . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.825 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 78' ' ' ARG . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.534 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.611 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 96' ' ' SER . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.611 ' CD1' ' HG2' ' A' ' 93' ' ' PRO . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.607 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.579 ' HA ' HD23 ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 105' ' ' ASN . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.484 ' N ' HD11 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.432 HD23 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.579 0.228 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.66 154.72 30.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 t -111.28 -26.79 8.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.02 163.05 2.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.73 112.74 13.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.738 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 48.19 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.92 111.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.83 78.32 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -96.78 43.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 26.97 10.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -117.46 128.39 54.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.964 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.22 28.87 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -97.11 177.98 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.722 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -67.11 -89.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.14 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER 178.05 50.47 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.828 0.347 . . . . 0.0 110.601 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -93.51 82.24 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -160.33 40.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -69.19 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.03 -99.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.334 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.97 -56.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -78.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 70' ' ' VAL . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.637 HD13 HG12 ' A' ' 56' ' ' ILE . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 57' ' ' GLN . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m 55.92 -168.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' CG2' ' A' ' 34' ' ' THR . . . -164.95 -115.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.011 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.32 -69.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 21.24 7.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.472 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t 60.65 15.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.185 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -146.57 13.71 1.21 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.697 0.284 . . . . 0.0 111.438 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HA3' ' A' ' 29' ' ' GLY . 9.0 t -78.05 -17.64 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.996 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.412 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 51' ' ' ILE . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 22' ' ' ARG . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG13 ' A' ' 26' ' ' VAL . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.603 HG23 HD11 ' A' ' 25' ' ' ILE . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.669 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p -93.2 73.09 4.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.66 175.28 2.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.65 52.52 1.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.9 m -77.03 27.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 1.58 56.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -33.31 74.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 110.467 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 49.24 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.669 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -110.51 46.26 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.646 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.43 -90.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.351 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 88' ' ' LEU . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.411 ' HD1' ' HB2' ' A' ' 92' ' ' MET . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.539 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.432 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.604 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.497 HD13 ' HG2' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.425 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.643 0.258 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.53 -86.66 0.42 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 t -172.69 -170.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t 62.12 92.99 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.585 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.91 145.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.535 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 9.0 m-70 -95.52 -10.38 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 62.24 93.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.131 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.495 ' HA ' ' HD1' ' A' ' 11' ' ' HIS . 8.9 m80 -102.23 -71.37 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.774 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.43 -74.08 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.039 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.43 ' C ' ' HD1' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -127.97 39.48 3.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.747 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.495 ' HD1' ' HA ' ' A' ' 8' ' ' HIS . 0.8 OUTLIER -86.86 77.04 9.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 13' ' ' GLU . 2.0 p-80 -162.41 -65.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' A' ' 12' ' ' HIS . 4.9 mt-10 63.48 -71.41 0.06 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.502 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' HIS . 19.5 t30 -161.57 129.69 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -170.93 62.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 0.0 110.75 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 62.79 67.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.85 14.04 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -97.03 87.72 4.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.886 ' HA2' ' HB3' ' A' ' 52' ' ' PRO . . . -165.75 39.29 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.228 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -91.49 88.31 6.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.286 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt -145.36 -76.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.017 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.712 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 25' ' ' ILE . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 51.33 -169.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.92 10.09 1.41 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.974 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 83.14 123.06 0.83 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.16 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 -160.96 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 t 56.9 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.307 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 46.92 55.19 8.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 30' ' ' GLY . 50.0 m -153.17 -47.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.656 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.886 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 67' ' ' MET . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.656 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -102.71 62.24 0.83 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.11 135.52 22.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -68.04 70.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.967 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG23 HD22 ' A' ' 88' ' ' LEU . 26.9 m -73.99 -177.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.992 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -102.14 -22.18 14.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' HG3' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER 48.19 49.02 18.12 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.177 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.4 p -131.57 -1.54 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 86' ' ' ILE . 33.9 p90 -92.91 97.4 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.18 -115.8 4.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.348 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.552 HG22 ' CE2' ' A' ' 83' ' ' PHE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.725 ' HA ' HG21 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.569 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 100' ' ' ILE . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG23 ' HA2' ' A' ' 97' ' ' GLY . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.703 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.71 ' HA ' HD23 ' A' ' 111' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' A' ' 111' ' ' LEU . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.92 0.391 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.86 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -54.58 42.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 111.094 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.2 120.89 40.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.12 -65.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.839 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -116.84 89.78 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 81.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 12' ' ' HIS . 60.7 m80 -60.16 160.4 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -101.99 70.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.247 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.519 ' HD2' ' H ' ' A' ' 11' ' ' HIS . 2.2 t-160 61.58 159.33 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.747 0.308 . . . . 0.0 110.707 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' H ' ' HD2' ' A' ' 10' ' ' HIS . 34.8 m170 63.7 30.43 14.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 0.0 110.125 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.716 ' HD1' ' H ' ' A' ' 12' ' ' HIS . 0.6 OUTLIER -105.34 -179.28 3.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.935 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.58 100.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.66 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -145.57 -72.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.28 163.01 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -84.46 88.01 7.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.97 -56.63 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.48 45.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.32 -88.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -61.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -157.98 -75.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.567 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.507 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 57' ' ' GLN . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.41 -64.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.3 137.65 8.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.285 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.02 -53.87 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.69 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 67.75 80.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 26.8 m -124.64 75.31 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.861 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . 75.99 -28.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.517 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 32' ' ' VAL . 51.1 p -66.84 -44.17 81.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.551 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.602 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 22' ' ' ARG . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.548 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 24' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 86' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' CG1' HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 1.4 t60 -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p -102.32 66.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.15 142.5 25.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.074 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 66.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.452 HG23 HD13 ' A' ' 88' ' ' LEU . 6.9 m -70.88 -176.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 26.6 p30 -102.01 -15.91 16.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.688 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 3.4 ppt_? 35.66 43.91 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 111.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.2 t -128.72 2.0 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.358 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 24.7 p90 -97.86 101.74 13.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.02 -130.53 9.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.408 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.58 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 95' ' ' VAL . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 98' ' ' VAL . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.687 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.633 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' N ' HG21 ' A' ' 107' ' ' ILE . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 7.4 mm-40 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.842 0.353 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.94 56.98 0.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.475 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.73 178.24 5.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 p -168.77 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.27 163.2 31.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -165.24 155.4 13.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.8 78.29 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.591 ' HD1' ' N ' ' A' ' 9' ' ' HIS . 1.6 t-80 -121.93 135.64 54.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.591 ' N ' ' HD1' ' A' ' 8' ' ' HIS . 1.2 t-160 -57.94 167.78 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.85 -69.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.92 76.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -112.83 -10.12 13.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.23 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.29 140.66 16.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.03 128.65 36.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.74 171.01 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -143.29 -25.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.362 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -87.55 -59.97 2.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 111.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 73.38 45.63 0.25 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.85 73.81 0.25 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.613 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 p -156.18 101.65 2.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -63.61 -105.29 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.467 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' CG ' ' A' ' 71' ' ' HIS . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' CD ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' O ' HG21 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.607 HG13 ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG21 HD21 ' A' ' 55' ' ' LEU . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -126.65 176.29 7.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.24 73.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.332 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.03 -115.23 0.57 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB1' ' HG1' ' A' ' 34' ' ' THR . . . -70.86 126.54 29.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.33 -45.12 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' MET . . . -54.46 -25.37 24.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.464 ' HG1' ' HB1' ' A' ' 31' ' ' ALA . 5.3 m -68.89 -56.29 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.695 ' HD1' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' CD ' ' A' ' 23' ' ' LYS . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG21 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.725 HG21 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.607 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.588 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' SD ' ' A' ' 67' ' ' MET . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.867 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.409 ' OG1' HD11 ' A' ' 88' ' ' LEU . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.87 70.06 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.26 175.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -117.13 80.21 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 t -99.06 24.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' HB3' ' NH2' ' A' ' 81' ' ' ARG . 34.9 t0 -78.04 -1.11 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -99.83 32.24 2.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.637 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 t -142.9 -42.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.098 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.51 ' CD2' HD13 ' A' ' 86' ' ' ILE . 15.0 m-85 -81.48 -37.46 27.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.322 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.53 -39.79 2.68 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.74 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.867 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.431 ' N ' HG22 ' A' ' 89' ' ' VAL . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.522 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' CG1' HG21 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.419 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.711 0.291 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.39 -33.91 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.185 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.09 74.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.969 0.414 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -136.78 -25.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.69 102.97 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.782 0.325 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 60.92 97.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.93 -167.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.403 ' HD1' ' HA ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 68.97 75.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.756 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -92.09 174.08 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -167.9 -179.51 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.698 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.39 103.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -95.84 20.55 9.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' HIS . 11.6 pt-20 39.24 -166.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.899 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.98 44.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.93 0.395 . . . . 0.0 110.785 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.82 172.86 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.59 23.26 9.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -164.12 145.39 8.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -148.76 56.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.15 132.53 9.65 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.343 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 16.7 t -61.31 -61.1 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 20' ' ' SER . 4.8 mttt -171.66 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.607 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 72' ' ' LEU . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HA ' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 57' ' ' GLN . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -178.62 172.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.29 105.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.211 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA3' ' OG1' ' A' ' 34' ' ' THR . . . -127.91 -63.3 0.13 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.829 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.29 14.13 7.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.649 0.261 . . . . 0.0 111.161 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -69.37 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.21 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.19 53.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 111.219 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.523 ' OG1' ' HA3' ' A' ' 30' ' ' GLY . 32.3 p -145.09 -36.05 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.254 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' HE21 ' A' ' 104' ' ' GLN . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.51 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.776 HG23 ' HA ' ' A' ' 25' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.521 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.603 HD13 HG12 ' A' ' 24' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.17 75.27 6.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.17 -178.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.019 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.31 62.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.82 23.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.362 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -88.43 -0.3 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.276 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.79 -4.62 46.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -123.62 -24.81 4.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.219 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.43 ' HB2' HG21 ' A' ' 86' ' ' ILE . 8.3 m-85 -76.14 -45.72 32.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.259 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.01 0.52 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.581 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.5 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.416 ' O ' HG21 ' A' ' 95' ' ' VAL . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.69 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.524 ' N ' HG22 ' A' ' 107' ' ' ILE . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HE2' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.92 108.71 0.27 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.564 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -63.96 128.74 37.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 111.02 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -132.31 -67.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.45 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.413 ' HD1' ' HA ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -148.28 -28.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.303 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -164.67 97.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.84 -178.74 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.01 154.01 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.609 ' HD1' ' H ' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -113.57 146.15 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.065 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -170.35 1.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -158.05 53.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -104.31 -179.89 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.41 151.76 46.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -123.59 151.78 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.03 92.63 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.966 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -78.68 179.59 7.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.979 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -141.93 -77.8 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -177.35 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.718 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.99 -64.1 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.4 73.52 0.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.634 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 2.0 ttpm? -149.66 -88.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.26 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 25' ' ' ILE . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 59' ' ' ARG . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m 48.58 -166.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.75 9.52 46.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.422 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.67 88.07 1.93 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.283 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.846 ' HA ' ' HB2' ' A' ' 35' ' ' SER . . . -116.02 42.22 2.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.643 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.45 -40.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.635 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.18 -36.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.29 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' MET . 7.8 m -85.09 -20.22 30.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.176 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.846 ' HB2' ' HA ' ' A' ' 31' ' ' ALA . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 38' ' ' ALA . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.478 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 49' ' ' HIS . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 22' ' ' ARG . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.649 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.544 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.718 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.412 HG23 ' CE1' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -129.81 51.12 2.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -105.44 -106.2 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 14.4 mmm-85 -157.15 40.3 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 81' ' ' ARG . 3.2 t -67.74 168.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -99.09 -22.32 15.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.693 0.282 . . . . 0.0 111.367 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.484 ' HG3' ' CD1' ' A' ' 88' ' ' LEU . 6.0 ttt-85 57.42 37.32 27.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.942 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.58 15.92 7.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.559 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 27.7 p90 -110.07 109.11 19.54 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.0 -115.82 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.44 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.581 HD13 HD12 ' A' ' 73' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.536 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 92' ' ' MET . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.438 ' CE2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 95' ' ' VAL . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.543 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.543 HD13 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 HD22 ' CE2' ' A' ' 94' ' ' PHE . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.549 ' HA ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.506 ' N ' HG13 ' A' ' 107' ' ' ILE . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.52 -10.0 0.42 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.196 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.409 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 3.1 m -136.94 158.0 45.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.954 0.377 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 68.02 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.409 ' CE1' ' HB2' ' A' ' 3' ' ' SER . 1.5 p-80 -129.78 44.35 2.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 -79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 18.36 8.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -147.8 170.64 17.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -123.71 169.01 11.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HD1' ' HA ' ' A' ' 10' ' ' HIS . 0.0 OUTLIER 66.14 -178.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.407 ' HD1' ' HA ' ' A' ' 11' ' ' HIS . 0.0 OUTLIER 68.71 -67.22 0.21 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.072 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.22 76.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.705 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 -166.24 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp 58.92 55.27 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.81 -8.8 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.724 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 17' ' ' PHE . 1.9 m-85 -110.59 30.1 7.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 58.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.51 175.34 53.2 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.0 p -114.84 -177.48 3.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.93 0.395 . . . . 0.0 110.561 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -147.75 -76.87 0.17 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.661 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.754 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 HG21 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' H ' HD11 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m -70.59 126.6 30.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.63 -12.94 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.976 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.27 -76.94 0.77 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.428 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 34' ' ' THR . . . -93.94 163.79 13.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.0 111.051 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.33 13.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.3 0.09 8.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.361 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 31' ' ' ALA . 9.7 t -97.47 35.25 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.605 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.536 ' HB ' HD23 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HB3' HG12 ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 22' ' ' ARG . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.647 ' O ' HD11 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 60' ' ' VAL . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.678 HG21 HG12 ' A' ' 25' ' ' ILE . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.666 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 23' ' ' LYS . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.445 ' HA ' HD21 ' A' ' 72' ' ' LEU . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.674 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -88.13 73.28 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.49 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.721 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 9.6 ptm180 45.75 41.28 7.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.885 0.374 . . . . 0.0 111.229 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.2 m -66.35 66.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 15.3 t0 -100.3 -21.34 15.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -55.6 -35.04 65.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.15 4.46 16.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.371 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -92.8 -49.79 5.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.2 -78.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.29 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.761 HG21 HD22 ' A' ' 88' ' ' LEU . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.761 HD22 HG21 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.515 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CG ' HD12 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 HG11 ' HB1' ' A' ' 31' ' ' ALA . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 99' ' ' GLY . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' N ' HG11 ' A' ' 98' ' ' VAL . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 108' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.718 0.294 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.46 0.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.32 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -71.38 124.68 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.636 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.16 85.59 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -67.97 -168.78 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.039 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.9 38.98 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -62.37 176.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -94.43 -70.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.006 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 10' ' ' HIS . 0.3 OUTLIER 60.26 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 9' ' ' HIS . 9.9 m-70 -111.98 178.26 4.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -56.78 -42.37 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.988 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 64.0 177.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.91 67.64 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -68.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt 62.08 134.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 122.73 18.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -176.05 156.54 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -113.35 -58.46 2.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.49 -61.96 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -176.32 140.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt -131.53 -73.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.686 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m -147.92 178.49 8.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.86 90.75 1.18 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.786 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.33 -132.04 32.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.745 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.98 104.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.72 -69.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.86 49.23 1.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.401 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.1 m -158.67 -38.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 52' ' ' PRO . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.686 HG23 ' HA ' ' A' ' 25' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.775 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.635 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.505 ' HB ' ' HD3' ' A' ' 78' ' ' ARG . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' HG22 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CD2' ' A' ' 83' ' ' PHE . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.673 ' CG ' HD12 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.6 t60 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.59 72.67 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.64 95.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' HD3' ' HB ' ' A' ' 60' ' ' VAL . 6.5 tpm_? -120.71 -44.47 2.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.45 -172.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.03 -24.35 13.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.797 0.332 . . . . 0.0 111.219 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -91.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 84' ' ' GLY . 32.3 m -160.4 105.73 1.49 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.006 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 86' ' ' ILE . 32.6 p90 -71.89 42.91 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.685 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 82' ' ' SER . . . 140.77 -107.46 0.52 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.739 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.76 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.673 HD12 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.76 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.511 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.64 ' O ' HD11 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 95' ' ' VAL . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' O ' ' A' ' 94' ' ' PHE . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB3' HD23 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.621 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.746 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.621 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.789 0.328 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.05 138.17 9.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.29 134.14 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -108.63 -68.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 42.4 m170 59.06 80.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 6.3 m170 -168.09 116.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.64 38.6 1.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.22 140.39 49.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -175.22 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.3 176.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.51 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -108.02 -178.03 3.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.806 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.78 113.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 63.38 47.48 3.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HA ' HE22 ' A' ' 18' ' ' GLN . 0.2 OUTLIER 61.92 146.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -138.24 -100.53 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' LEU . 61.5 m-85 -163.72 82.17 0.44 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.67 0.272 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 43.5 m-85 67.71 71.74 0.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.186 0.517 . . . . 0.0 110.881 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.51 ' HG3' ' HD2' ' A' ' 11' ' ' HIS . 2.0 pt20 -105.69 -9.87 17.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.17 123.96 0.7 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.037 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.12 115.47 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 0.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -137.35 -81.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 70' ' ' VAL . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -73.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.81 66.87 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.35 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.612 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.31 164.54 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.327 . . . . 0.0 111.155 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -73.81 -9.24 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.384 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.11 25.08 3.0 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.184 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m -142.58 -63.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 104' ' ' GLN . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.609 ' HB2' HD11 ' A' ' 51' ' ' ILE . 33.7 m80 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 49' ' ' HIS . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 52' ' ' PRO . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.506 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 63' ' ' ILE . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 59' ' ' ARG . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.515 ' HA ' HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 73' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.461 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.699 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -126.66 48.79 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . -110.07 0.25 18.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.805 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.69 ' HA ' ' HE1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER 76.43 62.2 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.017 0.436 . . . . 0.0 111.288 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -83.84 -174.44 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 4.7 m-20 -98.76 -22.28 15.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.586 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.672 ' CB ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 43.75 40.83 3.29 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.833 0.349 . . . . 0.0 111.552 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.4 m -130.81 5.43 4.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.22 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 86' ' ' ILE . 25.7 p90 -96.22 114.24 25.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.71 -119.22 8.91 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.672 HD11 ' CB ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.69 ' HE1' ' HA ' ' A' ' 78' ' ' ARG . 6.3 m-70 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.703 ' HE1' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.703 HG21 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.738 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.47 ' HA ' HD22 ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 105' ' ' ASN . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.86 -137.54 13.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -133.1 -45.29 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.919 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.49 -175.26 0.19 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.092 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.451 ' HD2' ' H ' ' A' ' 6' ' ' HIS . 1.4 t-160 -171.32 154.39 3.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.858 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.451 ' H ' ' HD2' ' A' ' 5' ' ' HIS . 3.9 t60 62.69 47.7 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -125.25 -46.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -176.33 132.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 2.7 m170 -104.76 126.47 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 59.81 111.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -72.14 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 24.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 61.72 -175.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.075 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -93.73 -34.7 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.052 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.64 115.4 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -121.31 76.28 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.3 96.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.58 154.89 11.86 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.373 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m 72.58 172.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.755 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -160.18 -81.52 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.641 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HE2' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.838 HG12 HD12 ' A' ' 72' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.741 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t -137.58 155.3 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.61 -58.46 13.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.98 -175.93 39.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.46 80.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.99 146.35 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.023 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 39.55 34.64 0.15 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m -142.99 -43.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.759 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD12 HD13 ' A' ' 108' ' ' LEU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 HD12 HG23 ' A' ' 51' ' ' ILE . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 53' ' ' VAL . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' CD1' ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.741 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 67' ' ' MET . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 55.4 t60 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.838 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.586 ' HB ' ' CB ' ' A' ' 88' ' ' LEU . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 72.03 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' CA ' ' HD2' ' A' ' 90' ' ' HIS . . . 45.09 -137.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 76.54 -54.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.71 177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.015 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.73 -19.94 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.448 ' HG2' HD11 ' A' ' 88' ' ' LEU . 2.6 mtm180 50.53 34.77 10.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.353 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.19 26.52 2.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.611 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -96.67 28.08 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.762 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.35 -110.9 0.67 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.927 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.611 HD12 ' HE2' ' A' ' 83' ' ' PHE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.586 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.412 ' HD2' ' CA ' ' A' ' 77' ' ' ALA . 9.1 m80 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.579 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 95' ' ' VAL . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 2.9 tp60 -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 103' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.736 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.736 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.37 39.95 0.6 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -117.15 179.13 4.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.9 96.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m80 54.48 33.09 18.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 5.8 t-80 63.42 -174.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.523 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 69.4 m-70 -56.18 152.98 9.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -41.35 83.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.073 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -175.11 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -115.43 -173.59 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -118.27 125.04 49.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.032 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -80.57 -77.81 0.19 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -174.65 121.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.02 107.93 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 59.03 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -76.34 45.37 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 53.12 94.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.212 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.95 112.76 25.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 32.22 47.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.73 80.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 110.727 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -139.19 -74.96 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.706 ' HA ' HG23 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -135.8 177.65 7.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.8 62.21 0.59 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.508 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.99 -72.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 66.64 76.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.01 -45.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.61 -37.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -72.25 -22.96 61.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.262 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.485 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 25' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.728 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.545 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 67' ' ' MET . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.652 HG22 ' HA ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.438 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.56 62.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.54 137.93 14.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 82.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.01 -175.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.39 -22.59 18.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.778 0.323 . . . . 0.0 111.105 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.514 ' HG3' HD13 ' A' ' 88' ' ' LEU . 1.5 ttt-85 49.28 45.76 23.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -132.85 2.5 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.358 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.716 ' CE2' HG23 ' A' ' 86' ' ' ILE . 19.0 p90 -94.79 98.37 10.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.997 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.27 -117.98 4.8 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.568 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.716 HG23 ' CE2' ' A' ' 83' ' ' PHE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.652 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 93' ' ' PRO . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.558 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.587 HG13 HG21 ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.55 HG22 ' CE1' ' A' ' 94' ' ' PHE . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.564 ' HA ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 105' ' ' ASN . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.424 ' N ' HD11 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 111' ' ' LEU . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.518 HE21 HD13 ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.7 46.02 3.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.88 56.16 7.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.13 172.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.81 25.72 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 84.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.53 150.84 22.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 178.97 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.673 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m170 58.41 -168.06 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.756 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -70.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.469 ' ND1' ' H ' ' A' ' 12' ' ' HIS . 1.1 t-80 -157.83 -160.88 0.96 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.525 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.469 ' H ' ' ND1' ' A' ' 11' ' ' HIS . 54.9 t60 -157.53 154.82 29.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.309 . . . . 0.0 110.268 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 168.42 26.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.706 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -144.28 128.76 18.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.033 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.89 75.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.655 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -115.41 -9.25 12.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.076 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 151.26 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.823 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 58.16 76.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.8 -77.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.64 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -133.09 131.52 40.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.797 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? -137.19 -75.26 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.689 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -81.59 0.62 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.57 41.21 0.19 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.903 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.76 40.91 4.54 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.96 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.08 74.99 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.05 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.163 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.53 40.59 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.249 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -167.16 -36.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.017 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.45 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.797 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.425 HD23 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.604 HG21 ' HA ' ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 56' ' ' ILE . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.589 HG21 ' HB ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 63' ' ' ILE . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.443 HG21 HG11 ' A' ' 79' ' ' VAL . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.25 72.81 3.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . 52.77 -154.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.129 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 34.6 mtt180 74.56 -53.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.461 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 88' ' ' LEU . 2.9 p -59.29 170.55 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -22.7 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 53.1 36.47 22.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.189 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 m -133.15 14.1 4.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.416 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' CZ ' HG22 ' A' ' 86' ' ' ILE . 38.5 p90 -105.57 115.83 30.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.5 -119.04 6.42 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.517 ' CD2' ' HA ' ' A' ' 77' ' ' ALA . 36.0 m80 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.515 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.52 ' CD1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' THR . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 104' ' ' GLN . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.93 74.24 0.78 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.606 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -78.46 57.63 2.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.01 35.87 20.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -132.35 26.34 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.549 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -126.59 70.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.991 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 7' ' ' HIS . 2.3 p80 -148.74 -58.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -172.32 20.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.345 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 55.59 -84.15 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.459 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' NE2' ' HG2' ' A' ' 13' ' ' GLU . 0.6 OUTLIER 177.19 155.06 0.27 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.782 0.325 . . . . 0.0 110.92 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -146.56 -31.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.46 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -132.68 128.15 36.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' HG2' ' NE2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -126.34 60.73 1.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 110.872 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 53.78 93.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.32 118.39 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.3 t80 62.99 138.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 99.51 4.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.13 87.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.05 -167.05 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.73 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.413 ' C ' ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -113.79 148.49 36.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.309 . . . . 0.0 110.962 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.71 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -139.47 -74.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 56' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.51 124.35 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.29 102.04 0.97 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.158 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.31 -49.13 0.88 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 51.22 82.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.113 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 34' ' ' THR . 27.8 m -147.49 110.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 72.9 -38.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.389 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 32' ' ' VAL . 43.1 p -79.55 -13.13 59.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.946 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.431 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD21 HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.406 HG21 ' NH2' ' A' ' 22' ' ' ARG . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.71 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG13 ' HD3' ' A' ' 22' ' ' ARG . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.566 HG21 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 83' ' ' PHE . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 25' ' ' ILE . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 16.9 m-70 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p -87.2 74.61 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.36 175.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.06 53.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 110.423 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 5.8 t -75.85 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -91.43 2.1 56.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.941 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.9 ttp85 -62.36 -34.21 76.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.155 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.0 m -160.84 45.53 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.887 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -110.65 48.7 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.69 -90.43 0.04 OUTLIER Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.802 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.597 ' CG1' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.457 ' O ' HG21 ' A' ' 73' ' ' ILE . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HA ' HG21 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.554 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 100' ' ' ILE . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 97' ' ' GLY . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.594 ' HG ' HG21 ' A' ' 107' ' ' ILE . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.594 HG21 ' HG ' ' A' ' 103' ' ' LEU . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.414 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.736 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.83 HG21 HG12 ' A' ' 63' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 55' ' ' LEU . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.688 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.622 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 108' ' ' LEU . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 53' ' ' VAL . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 26' ' ' VAL . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.78 HG23 HG23 ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.83 HG12 HG21 ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.683 HG11 HG13 ' A' ' 25' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.502 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 63' ' ' ILE . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 27' ' ' ALA . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.487 HG21 ' SG ' ' A' ' 28' ' ' CYS . 43.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.561 HG13 HD13 ' A' ' 73' ' ' ILE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HG2' HD22 ' A' ' 103' ' ' LEU . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.649 ' CE1' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.594 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.649 HG23 ' CE1' ' A' ' 94' ' ' PHE . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.692 HD22 ' HG2' ' A' ' 93' ' ' PRO . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 45' ' ' LEU . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.764 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.908 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.6 0.238 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.724 ' HB3' HG13 ' A' ' 51' ' ' ILE . 6.4 t-80 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.855 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 51' ' ' ILE . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG21 ' A' ' 42' ' ' ILE . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.832 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.908 ' HB ' HD12 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG11 ' CG2' ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HG12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 1.028 HG12 HG21 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.893 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.507 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' HE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' GLY . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.668 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 6.8 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.572 0.225 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' OE2' HD13 ' A' ' 100' ' ' ILE . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.51 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 60' ' ' VAL . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 23' ' ' LYS . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 23' ' ' LYS . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.668 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.509 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.774 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 1.023 ' HG2' HD22 ' A' ' 103' ' ' LEU . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.843 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.603 0.24 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG2' ' CG ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 42' ' ' ILE . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 55' ' ' LEU . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD13 HG21 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.49 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 86' ' ' ILE . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.787 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 22' ' ' ARG . 52.7 t-80 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.864 HD13 HG23 ' A' ' 86' ' ' ILE . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 27' ' ' ALA . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.584 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' MET . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD11 ' HA2' ' A' ' 97' ' ' GLY . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.484 ' HA ' HG22 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.67 ' HA ' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 107' ' ' ILE . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 107' ' ' ILE . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.563 0.22 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.653 HD12 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.775 HG13 ' HG2' ' A' ' 57' ' ' GLN . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.778 0.323 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 34' ' ' THR . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 53' ' ' VAL . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.775 ' HG2' HG13 ' A' ' 26' ' ' VAL . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.877 HG21 HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.543 ' HE3' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 25' ' ' ILE . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.877 HD13 HG21 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.794 HD12 HG12 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.628 HG23 ' SG ' ' A' ' 74' ' ' CYS . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD1' HD22 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' GLY . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 98' ' ' VAL . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.793 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' HD21 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 111' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 109' ' ' THR . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 107' ' ' ILE . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.921 0.391 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.667 ' O ' HG13 ' A' ' 70' ' ' VAL . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.719 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 95' ' ' VAL . 16.2 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 51' ' ' ILE . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 57' ' ' GLN . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 55' ' ' LEU . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' VAL . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.726 HG22 HG21 ' A' ' 25' ' ' ILE . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 73' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.91 HG13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.91 HG23 HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 90' ' ' HIS . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.415 ' N ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.516 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 34' ' ' THR . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.408 HD13 ' OE2' ' A' ' 41' ' ' GLU . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.722 ' HA ' HG22 ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.816 ' HG2' HG23 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.634 HG23 HG13 ' A' ' 95' ' ' VAL . 2.2 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' A' ' 38' ' ' ALA . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' HG11 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 2.2 m-70 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD12 ' HB ' ' A' ' 24' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.562 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.801 HG11 HG22 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.62 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.801 HG22 HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.316 0 CA-C-O 120.612 0.007 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 88' ' ' LEU . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.627 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 108' ' ' LEU . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 56' ' ' ILE . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.589 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.889 HD12 ' OH ' ' A' ' 66' ' ' TYR . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' VAL . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.679 0.276 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 53' ' ' VAL . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' A' ' 49' ' ' HIS . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 54' ' ' GLU . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 60' ' ' VAL . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG12 HG21 ' A' ' 25' ' ' ILE . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.889 ' OH ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 23' ' ' LYS . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 73' ' ' ILE . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 74' ' ' CYS . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' HD22 ' A' ' 103' ' ' LEU . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.585 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG23 ' CE1' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 93' ' ' PRO . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.87 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.87 HD12 ' O ' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.552 0.215 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.836 HG22 ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.971 HD13 HD11 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.625 HD12 HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.973 ' HB2' HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' VAL . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.67 HG21 HD12 ' A' ' 73' ' ' ILE . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.836 ' HB2' HG22 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 73' ' ' ILE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 91' ' ' GLY . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.75 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' CD ' HD22 ' A' ' 45' ' ' LEU . 4.5 tp60 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' HD12 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 45' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.971 HD11 HD13 ' A' ' 51' ' ' ILE . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HB3' ' CB ' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.559 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.039 HD12 HG23 ' A' ' 63' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 56' ' ' ILE . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.097 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.616 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 54' ' ' GLU . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 25' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.824 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 59' ' ' ARG . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.824 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.039 HG23 HD12 ' A' ' 25' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.55 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.863 HG21 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.097 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.728 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.64 HD23 HG23 ' A' ' 86' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 91' ' ' GLY . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.422 HD13 ' OE1' ' A' ' 41' ' ' GLU . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.657 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 10.3 mm100 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' HG13 ' A' ' 53' ' ' VAL . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.603 HG23 HG13 ' A' ' 95' ' ' VAL . 5.3 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 94' ' ' PHE . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.737 HG13 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.548 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' A' ' 25' ' ' ILE . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.537 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.921 HG22 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.897 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 75' ' ' THR . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 103' ' ' LEU . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.603 HG13 HG23 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.627 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD11 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.748 HD21 ' CD2' ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 4.8 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.066 0.46 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 56' ' ' ILE . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.784 ' CD1' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 55' ' ' LEU . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.53 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 42' ' ' ILE . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 25' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 67' ' ' MET . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 73' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.194 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.527 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.764 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.764 HD11 ' HA2' ' A' ' 97' ' ' GLY . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.693 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 45' ' ' LEU . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 111.26 0.096 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.829 ' HB3' HD11 ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.911 HG21 HG12 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.658 HG21 HG13 ' A' ' 95' ' ' VAL . 7.8 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.753 0.311 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 55' ' ' LEU . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 108' ' ' LEU . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 53' ' ' VAL . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 51' ' ' ILE . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 42' ' ' ILE . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.568 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 75' ' ' THR . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.911 HG12 HG21 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 90' ' ' HIS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HB2' HD13 ' A' ' 103' ' ' LEU . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 34' ' ' THR . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.623 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.623 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 106' ' ' LYS . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 93' ' ' PRO . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' HA ' HG12 ' A' ' 107' ' ' ILE . 1.2 tt0 -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 109' ' ' THR . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 102' ' ' ALA . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 45' ' ' LEU . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' ASN . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.759 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' H ' HD12 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.615 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' SER . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 51' ' ' ILE . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' ILE . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 73' ' ' ILE . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.775 HD13 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.674 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.582 ' CG ' HD13 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 91' ' ' GLY . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HA ' HD12 ' A' ' 111' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.971 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.577 0.227 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.889 ' HD3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.816 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.638 HG13 HG11 ' A' ' 70' ' ' VAL . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 95' ' ' VAL . 99.1 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.704 0.288 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.532 HD11 ' CZ ' ' A' ' 94' ' ' PHE . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HB2' HD11 ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.658 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.889 HG22 ' HD3' ' A' ' 22' ' ' ARG . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 24' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.718 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.718 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.651 ' CG ' HD11 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.646 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-80 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' ALA . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.781 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.651 HD11 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.781 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 90' ' ' HIS . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' N ' HG12 ' A' ' 89' ' ' VAL . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 34' ' ' THR . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.655 ' H ' HD11 ' A' ' 100' ' ' ILE . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.655 HD11 ' H ' ' A' ' 97' ' ' GLY . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.557 ' NE2' HD13 ' A' ' 45' ' ' LEU . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.721 ' HA ' HD21 ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.651 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 108' ' ' LEU . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.445 0.164 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 56' ' ' ILE . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.717 HG23 HG21 ' A' ' 25' ' ' ILE . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 25' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.683 ' C ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.715 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 27' ' ' ALA . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.51 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' HG13 ' A' ' 73' ' ' ILE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.706 ' HE1' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.462 ' OG ' HG12 ' A' ' 98' ' ' VAL . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.462 HG12 ' OG ' ' A' ' 96' ' ' SER . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.706 HG23 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 106' ' ' LYS . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.783 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.654 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 109' ' ' THR . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.503 ' N ' HD12 ' A' ' 108' ' ' LEU . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.838 0.351 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.607 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 55' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.751 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 41' ' ' GLU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.751 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 HG23 ' A' ' 73' ' ' ILE . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.506 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 57.7 t-80 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.657 HG23 HD13 ' A' ' 63' ' ' ILE . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.901 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG13 HD13 ' A' ' 73' ' ' ILE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.605 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 91' ' ' GLY . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.879 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.879 HD11 ' HA2' ' A' ' 97' ' ' GLY . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.704 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.903 HG22 ' CD1' ' A' ' 111' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.742 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' CD1' HG22 ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.821 0.343 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 70' ' ' VAL . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.834 HD13 HG12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' VAL . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.485 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.644 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HG3' ' OE1' ' A' ' 47' ' ' GLN . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.432 ' SG ' HG21 ' A' ' 53' ' ' VAL . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HG3' ' A' ' 43' ' ' LYS . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.502 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 42' ' ' ILE . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 24' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 25' ' ' ILE . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 25' ' ' ILE . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.689 ' HA ' HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.73 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.586 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.808 HD12 ' N ' ' A' ' 109' ' ' THR . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.808 ' N ' HD12 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.827 0.346 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 63' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 57' ' ' GLN . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.671 0.272 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 108' ' ' LEU . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.471 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.774 ' CG2' HG22 ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 60' ' ' VAL . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.933 HG21 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.603 ' N ' HD12 ' A' ' 73' ' ' ILE . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.495 HG22 HD13 ' A' ' 88' ' ' LEU . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.933 HG12 HG21 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.801 ' CA ' HG23 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.562 ' CG ' HD13 ' A' ' 103' ' ' LEU . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.783 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 92' ' ' MET . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.783 HD23 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.598 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.899 ' HA ' HD12 ' A' ' 110' ' ' ILE . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.751 0.31 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.669 HG12 HD12 ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 73' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.871 HD13 HD11 ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 53' ' ' VAL . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HB3' HD11 ' A' ' 51' ' ' ILE . 1.1 m-70 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 49' ' ' HIS . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 52' ' ' PRO . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.871 HD11 HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.861 ' HB2' HG23 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.861 HG23 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 67' ' ' MET . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.584 ' SD ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' SD ' ' A' ' 67' ' ' MET . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 17.3 m80 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.765 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.207 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.696 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.517 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 91' ' ' GLY . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.603 0.24 . . . . 0.0 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.59 24.16 0.1 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.374 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.99 68.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.285 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m 51.43 97.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.237 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -174.34 160.2 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.79 102.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.429 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' HIS . 8.7 m170 -96.74 120.73 37.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -84.45 -28.97 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -61.41 -61.22 2.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.216 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.08 138.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 111.286 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 7' ' ' HIS . 34.8 m80 -96.9 55.49 1.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -60.22 90.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.86 160.89 18.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.68 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -113.9 116.55 29.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.28 148.97 37.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.7 81.98 1.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -100.64 33.09 2.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.467 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.39 34.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.834 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . -144.46 -76.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.172 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.21 -67.8 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -164.44 -65.56 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.613 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.736 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.83 HG21 HG12 ' A' ' 63' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 55' ' ' LEU . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.688 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER -150.53 -56.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.59 -108.18 0.33 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.53 -105.32 2.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.19 104.69 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.4 t -132.29 38.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 37' ' ' MET . . . 77.17 -33.94 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -64.25 -47.94 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.622 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 108' ' ' LEU . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 53' ' ' VAL . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 26' ' ' VAL . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.78 HG23 HG23 ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.83 HG12 HG21 ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.683 HG11 HG13 ' A' ' 25' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 63' ' ' ILE . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 27' ' ' ALA . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.487 HG21 ' SG ' ' A' ' 28' ' ' CYS . 43.8 p -80.38 69.43 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.22 84.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 11.7 tpt85 -151.6 -60.24 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 88' ' ' LEU . 6.6 p -66.86 170.4 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 p-10 -100.29 -23.04 14.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 88' ' ' LEU . 2.6 tmm_? 57.34 33.37 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.695 0.283 . . . . 0.0 111.149 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.6 t -121.57 11.42 10.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.511 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 86' ' ' ILE . 23.0 p90 -110.19 112.38 24.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.034 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.37 -110.26 3.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.357 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.638 HG21 ' CE1' ' A' ' 83' ' ' PHE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.805 HD22 HG11 ' A' ' 79' ' ' VAL . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HG2' HD22 ' A' ' 103' ' ' LEU . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.649 ' CE1' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.594 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.649 HG23 ' CE1' ' A' ' 94' ' ' PHE . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.692 HD22 ' HG2' ' A' ' 93' ' ' PRO . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 45' ' ' LEU . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.874 0.368 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.85 -16.44 6.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.589 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.97 -26.08 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.635 0.255 . . . . 0.0 111.248 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -120.7 159.99 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 86.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -113.47 78.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -177.56 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 176.96 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -127.89 148.85 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.193 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -21.45 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.37 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -92.33 140.97 29.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -59.22 154.87 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 92.75 3.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.7 89.29 2.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp 59.06 71.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -145.07 -53.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.35 27.6 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.53 93.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.9 -78.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.72 -175.97 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -132.38 -55.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.764 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.908 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.56 165.25 20.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.57 62.63 1.15 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.802 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.63 73.93 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.381 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.03 -76.34 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 111.575 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t 75.84 -21.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.103 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.55 -40.2 2.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.771 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.5 -6.43 58.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.075 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.724 ' HB3' HG13 ' A' ' 51' ' ' ILE . 6.4 t-80 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.855 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 51' ' ' ILE . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG21 ' A' ' 42' ' ' ILE . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.832 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.908 ' HB ' HD12 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG11 ' CG2' ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HG12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 18.2 p -98.66 79.5 2.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' THR . . . 177.89 -23.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.141 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' HA ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.9 53.09 1.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.099 0.476 . . . . 0.0 111.355 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 10.7 t -77.51 42.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.542 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 7.5 p-10 -99.03 -20.39 16.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -16.34 56.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -127.11 1.91 6.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.355 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.632 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 1.8 m-30 -91.48 -44.94 8.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.12 -71.13 0.48 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 1.028 HG12 HG21 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.893 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.507 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' HE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' GLY . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.668 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 6.8 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.712 0.292 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.54 138.26 2.42 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.562 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -116.15 29.35 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -127.9 176.67 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -158.52 89.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.4 61.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.92 48.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.988 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 86.24 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -106.99 107.47 18.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.256 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -133.43 -17.19 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.366 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.68 144.46 23.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -110.43 -22.84 11.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.49 119.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.8 41.13 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -75.83 -77.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.56 106.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.86 0.362 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -111.9 90.69 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -114.55 23.54 12.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.88 -73.64 0.85 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.73 162.46 13.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.656 0.265 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp -144.71 -82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -161.82 156.57 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.33 -146.06 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 94.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.383 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -73.53 -66.08 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.0 111.418 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 70.9 t 75.35 -43.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.4 64.23 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.93 0.395 . . . . 0.0 110.957 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.424 ' OG1' ' HB1' ' A' ' 31' ' ' ALA . 13.3 p -154.44 -40.23 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.896 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' OE2' HD13 ' A' ' 100' ' ' ILE . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.51 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 60' ' ' VAL . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 23' ' ' LYS . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 23' ' ' LYS . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.668 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.509 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -95.2 80.25 3.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.76 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.692 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.31 51.14 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.741 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' PHE . 23.9 m -74.91 47.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.392 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.588 ' HB2' ' CD2' ' A' ' 88' ' ' LEU . 11.4 t0 -101.9 -20.81 14.71 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -14.83 54.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.32 10.89 7.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.221 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 3.2 m-85 -106.24 -43.92 4.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.811 0.339 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.82 -68.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 78' ' ' ARG . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.431 ' NE2' ' HD2' ' A' ' 78' ' ' ARG . 50.9 m170 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 1.023 ' HG2' HD22 ' A' ' 103' ' ' LEU . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.843 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.16 123.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -149.89 -168.45 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -137.12 172.99 12.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -66.32 -59.45 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 64.0 140.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -134.59 113.52 11.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.325 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.05 9.95 1.72 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.268 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -92.02 82.35 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -63.96 134.97 56.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.23 80.01 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.09 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -110.74 -20.69 12.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.38 74.48 0.15 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.802 0.334 . . . . 0.0 110.988 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.75 141.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.2 26.97 5.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.826 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -122.51 41.8 3.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.82 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -114.34 157.47 22.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -124.45 -42.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.41 111.45 1.12 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.985 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -178.14 -62.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.3 -50.99 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG2' ' CG ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 42' ' ' ILE . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.12 -55.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.81 -6.39 33.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.842 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.99 -145.23 0.12 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.83 -168.31 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.785 0.326 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.0 t 48.77 70.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.368 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 69.26 50.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.49 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -133.55 -54.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.858 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 55' ' ' LEU . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD13 HG21 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.49 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 86' ' ' ILE . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.787 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 22' ' ' ARG . 52.7 t-80 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.864 HD13 HG23 ' A' ' 86' ' ' ILE . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 27' ' ' ALA . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.47 62.04 0.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.29 143.28 20.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -72.59 78.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.74 -171.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.225 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 32.4 m-20 -98.24 -13.85 20.6 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER 33.67 47.0 0.14 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -2.94 5.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.241 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -80.45 102.71 9.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.15 -103.0 1.41 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.3 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.584 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' MET . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD11 ' HA2' ' A' ' 97' ' ' GLY . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.484 ' HA ' HG22 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.67 ' HA ' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 107' ' ' ILE . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 107' ' ' ILE . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.78 53.24 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.964 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -114.88 148.1 39.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 111.165 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.4 m -118.93 104.13 10.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -159.58 147.38 17.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.41 -16.09 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.793 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.3 m80 59.83 -82.77 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.653 0.263 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.1 -171.27 2.0 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -76.0 178.33 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -59.8 -75.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.33 35.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.814 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -118.64 -37.76 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 66.8 35.84 4.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.83 145.48 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.81 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -107.61 -12.8 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -102.02 87.82 3.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.801 0.334 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.91 151.24 36.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -84.88 52.33 2.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.94 3.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.512 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.92 177.77 1.03 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.786 0.327 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -165.1 -77.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.602 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.653 HD12 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.775 HG13 ' HG2' ' A' ' 57' ' ' GLN . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.48 161.42 41.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.13 87.39 1.55 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.323 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.74 174.95 13.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.518 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 179.25 79.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -141.04 -42.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 37' ' ' MET . . . -140.78 -42.18 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.163 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -64.36 -57.57 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 53' ' ' VAL . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.775 ' HG2' HG13 ' A' ' 26' ' ' VAL . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.877 HG21 HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.543 ' HE3' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 25' ' ' ILE . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.877 HD13 HG21 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.486 ' O ' ' HD2' ' A' ' 90' ' ' HIS . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.61 70.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.79 147.91 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 60.49 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -62.88 -178.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.996 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -94.73 -22.56 18.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.05 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 42.87 40.17 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.9 p -126.0 2.82 7.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.015 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.847 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 28.7 p90 -94.09 99.8 12.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.902 0.382 . . . . 0.0 111.034 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.29 -119.4 5.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.794 HD12 HG12 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.628 HG23 ' SG ' ' A' ' 74' ' ' CYS . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 75' ' ' THR . 7.2 m170 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD1' HD22 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' GLY . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 98' ' ' VAL . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.793 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' HD21 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 111' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 109' ' ' THR . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 107' ' ' ILE . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.42 -85.22 0.12 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.36 142.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.8 t -165.23 -15.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m170 60.62 -178.76 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 175.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -59.01 88.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 -171.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.46 134.93 54.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 48.56 84.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -79.46 -172.82 3.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.63 -167.69 1.32 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 65.43 102.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.945 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -77.47 -76.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.82 75.65 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.115 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.84 6.25 2.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 17' ' ' PHE . 0.6 OUTLIER 61.14 22.69 12.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.248 . . . . 0.0 110.943 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -87.34 14.83 7.23 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.253 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.17 62.15 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -163.53 165.73 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.86 -52.48 1.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.667 ' O ' HG13 ' A' ' 70' ' ' VAL . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.719 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.87 156.32 22.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.71 123.7 7.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -157.27 51.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.82 -78.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 32' ' ' VAL . 24.9 t 46.99 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 66.98 49.78 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.973 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 95' ' ' VAL . 16.2 m -142.62 -49.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 51' ' ' ILE . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 57' ' ' GLN . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 55' ' ' LEU . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' VAL . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.726 HG22 HG21 ' A' ' 25' ' ' ILE . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 73' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.91 HG13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -129.07 45.84 2.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.01 1.03 13.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.647 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.6 64.16 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.017 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.59 -169.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 81' ' ' ARG . 20.3 p-10 -96.9 -20.74 17.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.341 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER 40.9 40.55 1.02 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.485 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.07 10.11 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 13.1 p90 -95.61 113.03 24.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.749 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.29 -110.2 3.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.91 HG23 HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 90' ' ' HIS . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.415 ' N ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.516 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 34' ' ' THR . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.408 HD13 ' OE2' ' A' ' 41' ' ' GLU . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.722 ' HA ' HG22 ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.659 0.266 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.49 -147.86 16.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.243 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.98 154.13 36.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.31 19.62 5.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -72.97 158.25 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -145.07 -78.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.54 72.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -145.59 22.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.002 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -151.9 -44.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -102.56 -169.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 112.17 4.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.38 174.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.84 -75.82 0.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.88 45.11 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.261 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 17' ' ' PHE . 0.2 OUTLIER 68.16 138.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.768 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.69 60.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.023 0.44 . . . . 0.0 111.099 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CE2' ' HG ' ' A' ' 15' ' ' LEU . 2.3 m-85 -141.74 17.9 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -122.57 112.41 17.97 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.91 -119.46 13.57 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 p -162.15 -34.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.7 0.286 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.49 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.816 ' HG2' HG23 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.05 -173.26 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.33 12.68 19.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.11 -34.64 4.74 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.64 106.67 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 33' ' ' ALA . 3.5 t -60.09 168.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.831 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.535 ' H ' HG12 ' A' ' 32' ' ' VAL . . . 82.18 -34.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.883 0.473 . . . . 0.0 111.425 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.634 HG23 HG13 ' A' ' 95' ' ' VAL . 2.2 m -70.67 -44.63 66.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' A' ' 38' ' ' ALA . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' HG11 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 2.2 m-70 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD12 ' HB ' ' A' ' 24' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.562 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.801 HG11 HG22 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.62 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.801 HG22 HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.16 69.93 7.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.96 -69.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.856 ' HG2' ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER 68.99 39.75 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.048 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 79' ' ' VAL . 7.1 p -66.42 85.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.12 -5.05 24.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.6 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -41.68 -31.75 0.32 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.624 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.6 36.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.767 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -110.49 38.81 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.183 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.5 -91.57 0.06 OUTLIER Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.767 HG22 ' HB3' ' A' ' 83' ' ' PHE . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.856 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 78' ' ' ARG . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.627 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 108' ' ' LEU . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.579 0.228 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.66 154.72 30.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 t -111.28 -26.79 8.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.02 163.05 2.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.73 112.74 13.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.738 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 48.19 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.92 111.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.83 78.32 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -96.78 43.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 26.97 10.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -117.46 128.39 54.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.964 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.22 28.87 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -97.11 177.98 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.722 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -67.11 -89.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.14 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER 178.05 50.47 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.828 0.347 . . . . 0.0 110.601 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -93.51 82.24 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -160.33 40.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -69.19 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.03 -99.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.334 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.97 -56.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -78.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 56' ' ' ILE . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.589 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.889 HD12 ' OH ' ' A' ' 66' ' ' TYR . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' VAL . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m 55.92 -168.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' A' ' 34' ' ' THR . . . -164.95 -115.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.011 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.32 -69.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 21.24 7.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.472 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 32' ' ' VAL . 2.7 t 60.65 15.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.185 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -146.57 13.71 1.21 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.697 0.284 . . . . 0.0 111.438 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.518 ' CG2' ' HA3' ' A' ' 29' ' ' GLY . 9.0 t -78.05 -17.64 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.996 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 53' ' ' VAL . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' A' ' 49' ' ' HIS . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 54' ' ' GLU . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 60' ' ' VAL . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG12 HG21 ' A' ' 25' ' ' ILE . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.889 ' OH ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 23' ' ' LYS . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p -93.2 73.09 4.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.66 175.28 2.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.65 52.52 1.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.9 m -77.03 27.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 1.58 56.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -61.94 -33.31 74.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 110.467 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 49.24 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.674 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -110.51 46.26 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.646 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.43 -90.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.351 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 73' ' ' ILE . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 74' ' ' CYS . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' HD22 ' A' ' 103' ' ' LEU . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.585 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG23 ' CE1' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 93' ' ' PRO . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.87 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.87 HD12 ' O ' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.643 0.258 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.53 -86.66 0.42 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 t -172.69 -170.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t 62.12 92.99 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.585 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.91 145.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.535 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 9.0 m-70 -95.52 -10.38 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 62.24 93.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.131 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 6' ' ' HIS . 8.9 m80 -102.23 -71.37 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.774 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.43 -74.08 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.039 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 39.48 3.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.747 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.86 77.04 9.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.516 ' CG ' ' H ' ' A' ' 13' ' ' GLU . 2.0 p-80 -162.41 -65.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 12' ' ' HIS . 4.9 mt-10 63.48 -71.41 0.06 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.502 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' HIS . 19.5 t30 -161.57 129.69 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -170.93 62.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 0.0 110.75 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 62.79 67.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.85 14.04 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -97.03 87.72 4.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.909 ' HA2' ' HB3' ' A' ' 52' ' ' PRO . . . -165.75 39.29 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.228 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -91.49 88.31 6.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.286 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt -145.36 -76.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.017 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.836 HG22 ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 51.33 -169.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.92 10.09 1.41 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.974 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 83.14 123.06 0.83 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.16 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 -160.96 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 t 56.9 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.307 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 46.92 55.19 8.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' GLY . 50.0 m -153.17 -47.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.971 HD13 HD11 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.909 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.625 HD12 HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.973 ' HB2' HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' VAL . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.67 HG21 HD12 ' A' ' 73' ' ' ILE . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.836 ' HB2' HG22 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -102.71 62.24 0.83 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.11 135.52 22.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -68.04 70.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.967 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.99 -177.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.992 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -102.14 -22.18 14.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 48.19 49.02 18.12 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.177 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.4 p -131.57 -1.54 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 83' ' ' PHE . 33.9 p90 -92.91 97.4 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.18 -115.8 4.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.348 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 73' ' ' ILE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 91' ' ' GLY . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.75 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' CD ' HD22 ' A' ' 45' ' ' LEU . 4.5 tp60 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' HD12 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 45' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.971 HD11 HD13 ' A' ' 51' ' ' ILE . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.92 0.391 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.86 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -54.58 42.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 111.094 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.2 120.89 40.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.12 -65.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.839 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -116.84 89.78 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 81.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 60.7 m80 -60.16 160.4 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -101.99 70.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.247 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 61.58 159.33 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.747 0.308 . . . . 0.0 110.707 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 34.8 m170 63.7 30.43 14.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 0.0 110.125 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 8' ' ' HIS . 0.6 OUTLIER -105.34 -179.28 3.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.935 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.58 100.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.66 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -145.57 -72.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.28 163.01 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -84.46 88.01 7.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.97 -56.63 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.48 45.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.32 -88.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -61.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -157.98 -75.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HB3' ' CB ' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.559 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.039 HD12 HG23 ' A' ' 63' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 56' ' ' ILE . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.097 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.41 -64.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.3 137.65 8.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.285 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' ALA . . . 88.02 -53.87 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.69 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . 67.75 80.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 32' ' ' VAL . 26.8 m -124.64 75.31 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.861 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' MET . . . 75.99 -28.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.517 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.1 p -66.84 -44.17 81.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.616 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 54' ' ' GLU . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 25' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.824 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 59' ' ' ARG . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.824 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.039 HG23 HD12 ' A' ' 25' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.863 HG21 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.097 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p -102.32 66.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.15 142.5 25.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.074 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 66.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -70.88 -176.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 26.6 p30 -102.01 -15.91 16.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.688 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 3.4 ppt_? 35.66 43.91 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 111.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.2 t -128.72 2.0 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.358 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 24.7 p90 -97.86 101.74 13.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.02 -130.53 9.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.408 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.728 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.64 HD23 HG23 ' A' ' 86' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 91' ' ' GLY . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.422 HD13 ' OE1' ' A' ' 41' ' ' GLU . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.657 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 10.3 mm100 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.842 0.353 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.94 56.98 0.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.475 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.73 178.24 5.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 p -168.77 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.27 163.2 31.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -165.24 155.4 13.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.8 78.29 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -121.93 135.64 54.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -57.94 167.78 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.85 -69.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.92 76.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -112.83 -10.12 13.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.23 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.29 140.66 16.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.03 128.65 36.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.74 171.01 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -143.29 -25.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.362 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -87.55 -59.97 2.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 111.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 73.38 45.63 0.25 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.85 73.81 0.25 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.613 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 p -156.18 101.65 2.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -63.61 -105.29 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.467 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' HG13 ' A' ' 53' ' ' VAL . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -126.65 176.29 7.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.24 73.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.332 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.03 -115.23 0.57 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' A' ' 34' ' ' THR . . . -70.86 126.54 29.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.33 -45.12 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' MET . . . -54.46 -25.37 24.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.603 HG23 HG13 ' A' ' 95' ' ' VAL . 5.3 m -68.89 -56.29 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 33' ' ' ALA . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 94' ' ' PHE . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.737 HG13 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.548 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' A' ' 25' ' ' ILE . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.537 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.921 HG22 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.87 70.06 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.26 175.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -117.13 80.21 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 t -99.06 24.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' ILE . 34.9 t0 -78.04 -1.11 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -99.83 32.24 2.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.637 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 t -142.9 -42.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.098 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 79' ' ' VAL . 15.0 m-85 -81.48 -37.46 27.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.322 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.53 -39.79 2.68 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.74 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.897 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 75' ' ' THR . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 103' ' ' LEU . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG13 HG23 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.627 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD11 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.748 HD21 ' CD2' ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.711 0.291 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.39 -33.91 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.185 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.09 74.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.969 0.414 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -136.78 -25.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.69 102.97 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.782 0.325 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 60.92 97.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.93 -167.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.97 75.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.756 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -92.09 174.08 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -167.9 -179.51 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.698 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.39 103.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -95.84 20.55 9.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' HIS . 11.6 pt-20 39.24 -166.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.899 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.98 44.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.93 0.395 . . . . 0.0 110.785 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.82 172.86 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.59 23.26 9.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -164.12 145.39 8.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -148.76 56.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.15 132.53 9.65 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.343 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 16.7 t -61.31 -61.1 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 4.8 mttt -171.66 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.607 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 56' ' ' ILE . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.784 ' CD1' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -178.62 172.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.29 105.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.211 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -127.91 -63.3 0.13 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.829 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.29 14.13 7.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.649 0.261 . . . . 0.0 111.161 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -128.09 -69.37 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.21 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' H ' HG23 ' A' ' 32' ' ' VAL . . . -151.19 53.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 111.219 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA3' ' A' ' 30' ' ' GLY . 32.3 p -145.09 -36.05 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.254 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 55' ' ' LEU . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.53 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 42' ' ' ILE . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 25' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 67' ' ' MET . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 73' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -91.17 75.27 6.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' THR . . . 178.17 -178.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.019 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.31 62.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.82 23.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.362 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.435 ' HB2' HD21 ' A' ' 88' ' ' LEU . 32.7 t0 -88.43 -0.3 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.276 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.79 -4.62 46.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -123.62 -24.81 4.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.219 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.822 ' CD2' HD13 ' A' ' 86' ' ' ILE . 8.3 m-85 -76.14 -45.72 32.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.259 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.01 0.52 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.581 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.527 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.764 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.764 HD11 ' HA2' ' A' ' 97' ' ' GLY . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.693 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 45' ' ' LEU . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.92 108.71 0.27 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.564 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -63.96 128.74 37.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 111.02 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -132.31 -67.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.45 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -28.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.303 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -164.67 97.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.84 -178.74 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.01 154.01 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.57 146.15 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.065 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -170.35 1.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -158.05 53.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -104.31 -179.89 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.41 151.76 46.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -123.59 151.78 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -88.03 92.63 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.966 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -78.68 179.59 7.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.979 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -141.93 -77.8 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -177.35 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.718 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 52' ' ' PRO . . . 177.99 -64.1 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.4 73.52 0.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.634 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -149.66 -88.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.26 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.829 ' HB3' HD11 ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.911 HG21 HG12 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m 48.58 -166.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.75 9.52 46.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.422 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.67 88.07 1.93 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.283 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HA ' ' HB2' ' A' ' 35' ' ' SER . . . -116.02 42.22 2.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.643 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.45 -40.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.635 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.18 -36.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.29 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.658 HG21 HG13 ' A' ' 95' ' ' VAL . 7.8 m -85.09 -20.22 30.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.176 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.87 ' HB2' ' HA ' ' A' ' 31' ' ' ALA . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 55' ' ' LEU . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 108' ' ' LEU . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 53' ' ' VAL . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 51' ' ' ILE . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 42' ' ' ILE . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.568 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 75' ' ' THR . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.911 HG12 HG21 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.81 51.12 2.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -105.44 -106.2 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 14.4 mmm-85 -157.15 40.3 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 80' ' ' ASP . 3.2 t -67.74 168.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.54 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.0 t0 -99.09 -22.32 15.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.693 0.282 . . . . 0.0 111.367 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HG3' HD11 ' A' ' 88' ' ' LEU . 6.0 ttt-85 57.42 37.32 27.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.942 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.58 15.92 7.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 27.7 p90 -110.07 109.11 19.54 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.0 -115.82 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.44 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.8 HD11 ' HG3' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 90' ' ' HIS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HB2' HD13 ' A' ' 103' ' ' LEU . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 34' ' ' THR . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.623 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.623 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 106' ' ' LYS . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 93' ' ' PRO . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' HA ' HG12 ' A' ' 107' ' ' ILE . 1.2 tt0 -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 109' ' ' THR . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 102' ' ' ALA . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 45' ' ' LEU . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' ASN . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.52 -10.0 0.42 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.196 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m -136.94 158.0 45.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.954 0.377 . . . . 0.0 110.816 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 68.02 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -129.78 44.35 2.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 -79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 18.36 8.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -147.8 170.64 17.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -123.71 169.01 11.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -178.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.71 -67.22 0.21 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.22 76.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.705 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 -166.24 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp 58.92 55.27 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.81 -8.8 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.724 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 17' ' ' PHE . 1.9 m-85 -110.59 30.1 7.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 58.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.51 175.34 53.2 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.0 p -114.84 -177.48 3.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.93 0.395 . . . . 0.0 110.561 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -147.75 -76.87 0.17 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.661 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.759 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' H ' HD12 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m -70.59 126.6 30.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.63 -12.94 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.976 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.27 -76.94 0.77 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.428 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.94 163.79 13.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.0 111.051 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.33 13.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.3 0.09 8.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.361 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -97.47 35.25 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.615 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' SER . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 51' ' ' ILE . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' ILE . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 73' ' ' ILE . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.775 HD13 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -88.13 73.28 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.49 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.721 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' HA ' HD11 ' A' ' 88' ' ' LEU . 9.6 ptm180 45.75 41.28 7.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.885 0.374 . . . . 0.0 111.229 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.2 m -66.35 66.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 15.3 t0 -100.3 -21.34 15.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -55.6 -35.04 65.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.15 4.46 16.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.371 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER -92.8 -49.79 5.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.2 -78.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.29 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.582 ' CG ' HD13 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 91' ' ' GLY . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HA ' HD12 ' A' ' 111' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.971 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.718 0.294 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.46 0.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.32 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -71.38 124.68 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.636 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.16 85.59 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -67.97 -168.78 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.039 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 38.98 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -62.37 176.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -94.43 -70.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.006 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.26 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -111.98 178.26 4.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -56.78 -42.37 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.988 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 64.0 177.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.91 67.64 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -68.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 15' ' ' LEU . 17.0 mt 62.08 134.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 122.73 18.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -176.05 156.54 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -113.35 -58.46 2.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.49 -61.96 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -176.32 140.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt -131.53 -73.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.889 ' HD3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.816 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.638 HG13 HG11 ' A' ' 70' ' ' VAL . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m -147.92 178.49 8.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.86 90.75 1.18 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.786 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.33 -132.04 32.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.745 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.98 104.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.72 -69.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.86 49.23 1.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.401 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 95' ' ' VAL . 99.1 m -158.67 -38.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.532 HD11 ' CZ ' ' A' ' 94' ' ' PHE . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HB2' HD11 ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.658 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.889 HG22 ' HD3' ' A' ' 22' ' ' ARG . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 24' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.718 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HB ' ' HD3' ' A' ' 78' ' ' ARG . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.718 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CD2' ' A' ' 83' ' ' PHE . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.651 ' CG ' HD11 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.646 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-80 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' ALA . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.59 72.67 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.64 95.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.542 ' HD3' ' HB ' ' A' ' 60' ' ' VAL . 6.5 tpm_? -120.71 -44.47 2.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.45 -172.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.03 -24.35 13.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.797 0.332 . . . . 0.0 111.219 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -91.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 m -160.4 105.73 1.49 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.006 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 86' ' ' ILE . 32.6 p90 -71.89 42.91 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.685 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.77 -107.46 0.52 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.739 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.781 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.651 HD11 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.781 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 90' ' ' HIS . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' N ' HG12 ' A' ' 89' ' ' VAL . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 34' ' ' THR . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.655 ' H ' HD11 ' A' ' 100' ' ' ILE . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.655 HD11 ' H ' ' A' ' 97' ' ' GLY . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.557 ' NE2' HD13 ' A' ' 45' ' ' LEU . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.721 ' HA ' HD21 ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.651 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 108' ' ' LEU . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.789 0.328 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.05 138.17 9.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.29 134.14 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -108.63 -68.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 42.4 m170 59.06 80.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 6.3 m170 -168.09 116.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.64 38.6 1.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.22 140.39 49.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -175.22 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.3 176.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -108.02 -178.03 3.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.806 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 113.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 63.38 47.48 3.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.527 ' HA ' HE22 ' A' ' 18' ' ' GLN . 0.2 OUTLIER 61.92 146.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -138.24 -100.53 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' LEU . 61.5 m-85 -163.72 82.17 0.44 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.67 0.272 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 43.5 m-85 67.71 71.74 0.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.186 0.517 . . . . 0.0 110.881 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.527 HE22 ' HA ' ' A' ' 14' ' ' ASN . 2.0 pt20 -105.69 -9.87 17.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.17 123.96 0.7 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.037 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.12 115.47 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 0.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -137.35 -81.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 56' ' ' ILE . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -73.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.81 66.87 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.35 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.612 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.31 164.54 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.327 . . . . 0.0 111.155 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -73.81 -9.24 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.384 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.11 25.08 3.0 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.184 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m -142.58 -63.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.717 HG23 HG21 ' A' ' 25' ' ' ILE . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 25' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.683 ' C ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.715 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 27' ' ' ALA . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -126.66 48.79 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . -110.07 0.25 18.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.805 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 76.43 62.2 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.017 0.436 . . . . 0.0 111.288 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG22 ' HE1' ' A' ' 90' ' ' HIS . 17.3 m -83.84 -174.44 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 4.7 m-20 -98.76 -22.28 15.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.586 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.624 ' CB ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 43.75 40.83 3.29 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.833 0.349 . . . . 0.0 111.552 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.4 m -130.81 5.43 4.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.22 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 25.7 p90 -96.22 114.24 25.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.71 -119.22 8.91 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.51 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.761 HG21 ' CZ ' ' A' ' 83' ' ' PHE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' HE1' HG22 ' A' ' 79' ' ' VAL . 5.5 m80 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.706 ' HE1' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.462 ' OG ' HG12 ' A' ' 98' ' ' VAL . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG12 ' OG ' ' A' ' 96' ' ' SER . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.706 HG23 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 106' ' ' LYS . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.783 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.654 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 109' ' ' THR . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.503 ' N ' HD12 ' A' ' 108' ' ' LEU . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.86 -137.54 13.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -133.1 -45.29 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.919 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.49 -175.26 0.19 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.092 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -171.32 154.39 3.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.858 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.9 t60 62.69 47.7 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -125.25 -46.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -176.33 132.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.76 126.47 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 59.81 111.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -72.14 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 24.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 61.72 -175.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.075 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -93.73 -34.7 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.052 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.64 115.4 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -121.31 76.28 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.3 96.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.58 154.89 11.86 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.373 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m 72.58 172.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.755 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -160.18 -81.52 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.607 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 55' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.751 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t -137.58 155.3 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.61 -58.46 13.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.98 -175.93 39.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.46 80.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.99 146.35 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.023 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HB1' ' HE3' ' A' ' 37' ' ' MET . . . 39.55 34.64 0.15 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m -142.99 -43.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.759 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 41' ' ' GLU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.751 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 HG23 ' A' ' 73' ' ' ILE . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.506 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 57.7 t-80 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.657 HG23 HD13 ' A' ' 63' ' ' ILE . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.901 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 72.03 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 45.09 -137.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 76.54 -54.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.74 HG23 ' HG3' ' A' ' 81' ' ' ARG . 29.7 m -65.71 177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.015 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.73 -19.94 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HG3' HG23 ' A' ' 79' ' ' VAL . 2.6 mtm180 50.53 34.77 10.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.353 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.19 26.52 2.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.811 ' CE2' HG21 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -96.67 28.08 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.762 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.35 -110.9 0.67 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.927 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.811 HG21 ' CE2' ' A' ' 83' ' ' PHE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HG2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.441 ' CE1' HH11 ' A' ' 81' ' ' ARG . 12.8 m-70 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 91' ' ' GLY . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.879 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.879 HD11 ' HA2' ' A' ' 97' ' ' GLY . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.704 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.903 HG22 ' CD1' ' A' ' 111' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.742 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' CD1' HG22 ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.37 39.95 0.6 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -117.15 179.13 4.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.9 96.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m80 54.48 33.09 18.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 5.8 t-80 63.42 -174.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.493 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 69.4 m-70 -56.18 152.98 9.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -41.35 83.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.073 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -175.11 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -115.43 -173.59 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -118.27 125.04 49.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.032 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.57 -77.81 0.19 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.773 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -174.65 121.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.02 107.93 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 59.03 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -76.34 45.37 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 53.12 94.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.212 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.95 112.76 25.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 32.22 47.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.73 80.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 110.727 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -139.19 -74.96 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 70' ' ' VAL . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.834 HD13 HG12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' VAL . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -135.8 177.65 7.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.8 62.21 0.59 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.508 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.99 -72.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 66.64 76.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 33' ' ' ALA . 9.0 p -136.01 -45.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 32' ' ' VAL . . . -131.61 -37.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.485 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -72.25 -22.96 61.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.262 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.644 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HG3' ' OE1' ' A' ' 47' ' ' GLN . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.432 ' SG ' HG21 ' A' ' 53' ' ' VAL . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HG3' ' A' ' 43' ' ' LYS . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.502 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 42' ' ' ILE . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 24' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 25' ' ' ILE . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 25' ' ' ILE . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.689 ' HA ' HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.56 62.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.54 137.93 14.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 82.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.01 -175.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.39 -22.59 18.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.778 0.323 . . . . 0.0 111.105 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.51 ' HG3' HD11 ' A' ' 88' ' ' LEU . 1.5 ttt-85 49.28 45.76 23.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -132.85 2.5 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.358 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 86' ' ' ILE . 19.0 p90 -94.79 98.37 10.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.997 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.27 -117.98 4.8 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.568 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.73 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.586 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.808 HD12 ' N ' ' A' ' 109' ' ' THR . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.808 ' N ' HD12 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.7 46.02 3.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.88 56.16 7.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.13 172.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.81 25.72 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 84.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.53 150.84 22.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 178.97 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.673 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m170 58.41 -168.06 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.756 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -70.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -157.83 -160.88 0.96 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.525 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -157.53 154.82 29.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.309 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 168.42 26.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.706 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -144.28 128.76 18.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.033 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.89 75.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.655 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -115.41 -9.25 12.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.076 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 151.26 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.823 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 58.16 76.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.8 -77.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.64 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -133.09 131.52 40.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? -137.19 -75.26 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 63' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 57' ' ' GLN . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -81.59 0.62 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.57 41.21 0.19 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.903 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.76 40.91 4.54 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.96 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB1' ' OG1' ' A' ' 34' ' ' THR . . . -120.08 74.99 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.05 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.163 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.53 40.59 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.249 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.437 ' OG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -167.16 -36.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.017 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 108' ' ' LEU . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.471 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.774 ' CG2' HG22 ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 60' ' ' VAL . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.933 HG21 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.603 ' N ' HD12 ' A' ' 73' ' ' ILE . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.495 HG22 HD13 ' A' ' 88' ' ' LEU . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.25 72.81 3.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . 52.77 -154.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.129 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 34.6 mtt180 74.56 -53.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.461 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.9 p -59.29 170.55 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -101.78 -22.7 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.145 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 53.1 36.47 22.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.189 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 m -133.15 14.1 4.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.416 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 38.5 p90 -105.57 115.83 30.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.5 -119.04 6.42 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.933 HG12 HG21 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.801 ' CA ' HG23 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.562 ' CG ' HD13 ' A' ' 103' ' ' LEU . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.783 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 92' ' ' MET . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.783 HD23 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.598 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.899 ' HA ' HD12 ' A' ' 110' ' ' ILE . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.93 74.24 0.78 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.606 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -78.46 57.63 2.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.01 35.87 20.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -132.35 26.34 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.549 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -126.59 70.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.991 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -148.74 -58.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -172.32 20.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.345 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 55.59 -84.15 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.459 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.475 ' NE2' ' HG2' ' A' ' 13' ' ' GLU . 0.6 OUTLIER 177.19 155.06 0.27 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.782 0.325 . . . . 0.0 110.92 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -146.56 -31.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.46 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -132.68 128.15 36.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -126.34 60.73 1.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 110.872 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 53.78 93.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.32 118.39 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.3 t80 62.99 138.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 99.51 4.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.13 87.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.05 -167.05 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.73 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.42 ' C ' ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -113.79 148.49 36.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.309 . . . . 0.0 110.962 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -139.47 -74.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.669 HG12 HD12 ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 73' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.51 124.35 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.29 102.04 0.97 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.158 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.31 -49.13 0.88 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 51.22 82.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.113 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 32' ' ' VAL . 27.8 m -147.49 110.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 72.9 -38.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.389 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 32' ' ' VAL . 43.1 p -79.55 -13.13 59.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.946 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.871 HD13 HD11 ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 53' ' ' VAL . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HB3' HD11 ' A' ' 51' ' ' ILE . 1.1 m-70 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 49' ' ' HIS . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 52' ' ' PRO . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.871 HD11 HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.861 ' HB2' HG23 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.861 HG23 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 83' ' ' PHE . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.584 ' SD ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' SD ' ' A' ' 67' ' ' MET . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 17.3 m80 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.765 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p -87.2 74.61 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.36 175.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.06 53.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 110.423 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 5.8 t -75.85 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -91.43 2.1 56.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.941 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.9 ttp85 -62.36 -34.21 76.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.155 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.0 m -160.84 45.53 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.887 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -110.65 48.7 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.69 -90.43 0.04 OUTLIER Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.802 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.696 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.517 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 91' ' ' GLY . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.736 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.83 HG21 HG12 ' A' ' 63' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 55' ' ' LEU . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.688 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.622 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 108' ' ' LEU . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 53' ' ' VAL . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 26' ' ' VAL . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.78 HG23 HG23 ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.83 HG12 HG21 ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.683 HG11 HG13 ' A' ' 25' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.502 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 63' ' ' ILE . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 27' ' ' ALA . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.487 HG21 ' SG ' ' A' ' 28' ' ' CYS . 43.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.561 HG13 HD13 ' A' ' 73' ' ' ILE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HG2' HD22 ' A' ' 103' ' ' LEU . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.649 ' CE1' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.594 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.649 HG23 ' CE1' ' A' ' 94' ' ' PHE . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.692 HD22 ' HG2' ' A' ' 93' ' ' PRO . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 45' ' ' LEU . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.764 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.908 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.6 0.238 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.724 ' HB3' HG13 ' A' ' 51' ' ' ILE . 3.0 t60 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.855 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 51' ' ' ILE . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG21 ' A' ' 42' ' ' ILE . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.832 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.908 ' HB ' HD12 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG11 ' CG2' ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HG12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.262 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 1.028 HG12 HG21 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.893 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.507 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' HE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' GLY . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.668 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 2.5 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.572 0.225 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 26' ' ' VAL . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' OE2' HD13 ' A' ' 100' ' ' ILE . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.51 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 60' ' ' VAL . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 23' ' ' LYS . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 23' ' ' LYS . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.668 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.509 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.774 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 75' ' ' THR . 50.9 m170 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 1.023 ' HG2' HD22 ' A' ' 103' ' ' LEU . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.843 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 120.603 0.24 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 42' ' ' ILE . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 55' ' ' LEU . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD13 HG21 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.639 ' HB2' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.49 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 86' ' ' ILE . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.787 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.406 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.5 t60 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.864 HD13 HG23 ' A' ' 86' ' ' ILE . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 27' ' ' ALA . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.584 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' MET . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD11 ' HA2' ' A' ' 97' ' ' GLY . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.484 ' HA ' HG22 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.67 ' HA ' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 107' ' ' ILE . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 107' ' ' ILE . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.563 0.22 . . . . 0.0 110.602 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.653 HD12 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.775 HG13 ' HG2' ' A' ' 57' ' ' GLN . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.778 0.323 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 34' ' ' THR . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 53' ' ' VAL . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.775 ' HG2' HG13 ' A' ' 26' ' ' VAL . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.877 HG21 HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.543 ' HE3' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 25' ' ' ILE . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.877 HD13 HG21 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.486 ' O ' ' HD2' ' A' ' 90' ' ' HIS . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.794 HD12 HG12 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.628 HG23 ' SG ' ' A' ' 74' ' ' CYS . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 75' ' ' THR . 7.2 m170 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD1' HD22 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' GLY . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 98' ' ' VAL . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.793 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' HD21 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 111' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 109' ' ' THR . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 107' ' ' ILE . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.921 0.391 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.667 ' O ' HG13 ' A' ' 70' ' ' VAL . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.719 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 95' ' ' VAL . 16.2 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 51' ' ' ILE . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 57' ' ' GLN . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 55' ' ' LEU . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' VAL . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.726 HG22 HG21 ' A' ' 25' ' ' ILE . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 73' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.91 HG13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.91 HG23 HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 90' ' ' HIS . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.415 ' N ' HG22 ' A' ' 89' ' ' VAL . 1.1 m170 -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.516 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 34' ' ' THR . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.408 HD13 ' OE2' ' A' ' 41' ' ' GLU . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.722 ' HA ' HG22 ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.816 ' HG2' HG23 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.634 HG23 HG13 ' A' ' 95' ' ' VAL . 2.2 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' A' ' 38' ' ' ALA . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' HG11 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 10.7 m170 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD12 ' HB ' ' A' ' 24' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.562 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.801 HG11 HG22 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.62 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.801 HG22 HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.316 0 CA-C-O 120.612 0.007 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 88' ' ' LEU . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.627 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 108' ' ' LEU . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 56' ' ' ILE . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.589 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.889 HD12 ' OH ' ' A' ' 66' ' ' TYR . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' VAL . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.679 0.276 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 53' ' ' VAL . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' A' ' 49' ' ' HIS . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 54' ' ' GLU . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 60' ' ' VAL . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG12 HG21 ' A' ' 25' ' ' ILE . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.889 ' OH ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 23' ' ' LYS . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 73' ' ' ILE . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 74' ' ' CYS . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' HD22 ' A' ' 103' ' ' LEU . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.585 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG23 ' CE1' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 93' ' ' PRO . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.87 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.87 HD12 ' O ' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.552 0.215 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.836 HG22 ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.971 HD13 HD11 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.625 HD12 HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.973 ' HB2' HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' VAL . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.67 HG21 HD12 ' A' ' 73' ' ' ILE . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.836 ' HB2' HG22 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 73' ' ' ILE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 91' ' ' GLY . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.75 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' CD ' HD22 ' A' ' 45' ' ' LEU . 4.4 tp-100 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' HD12 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 45' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.971 HD11 HD13 ' A' ' 51' ' ' ILE . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.743 0.306 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HG2' ' CD2' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.559 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.039 HD12 HG23 ' A' ' 63' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 56' ' ' ILE . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.097 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.616 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 54' ' ' GLU . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 25' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.824 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 59' ' ' ARG . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.824 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.039 HG23 HD12 ' A' ' 25' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.55 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 1.4 t60 -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.863 HG21 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.097 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.728 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.64 HD23 HG23 ' A' ' 86' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 91' ' ' GLY . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.422 HD13 ' OE1' ' A' ' 41' ' ' GLU . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.657 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 7.4 mm-40 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' HG13 ' A' ' 53' ' ' VAL . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.603 HG23 HG13 ' A' ' 95' ' ' VAL . 5.3 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 94' ' ' PHE . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.748 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.737 HG13 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.548 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' A' ' 25' ' ' ILE . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.537 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.921 HG22 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.897 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 75' ' ' THR . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 103' ' ' LEU . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.603 HG13 HG23 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.627 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.627 HD11 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.748 HD21 ' CD2' ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 4.8 mttt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.066 0.46 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 56' ' ' ILE . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.784 ' CD1' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 55' ' ' LEU . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.53 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 42' ' ' ILE . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 25' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 67' ' ' MET . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 73' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.194 0 N-CA-C 112.581 -0.207 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.527 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.764 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.764 HD11 ' HA2' ' A' ' 97' ' ' GLY . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.693 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 45' ' ' LEU . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 111.26 0.096 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.829 ' HB3' HD11 ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.911 HG21 HG12 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.658 HG21 HG13 ' A' ' 95' ' ' VAL . 7.8 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.753 0.311 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 55' ' ' LEU . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 108' ' ' LEU . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 53' ' ' VAL . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 51' ' ' ILE . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 42' ' ' ILE . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.568 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 75' ' ' THR . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.911 HG12 HG21 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 86' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 90' ' ' HIS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HB2' HD13 ' A' ' 103' ' ' LEU . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 34' ' ' THR . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.623 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.623 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 106' ' ' LYS . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 93' ' ' PRO . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.568 ' HA ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 109' ' ' THR . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 102' ' ' ALA . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 45' ' ' LEU . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' ASN . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.024 0.44 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.759 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' H ' HD12 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.615 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' SER . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 51' ' ' ILE . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' ILE . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 73' ' ' ILE . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.775 HD13 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.674 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.582 ' CG ' HD13 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 91' ' ' GLY . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HA ' HD12 ' A' ' 111' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.971 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.577 0.227 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.889 ' HD3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.816 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.638 HG13 HG11 ' A' ' 70' ' ' VAL . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 95' ' ' VAL . 99.1 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.704 0.288 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.532 HD11 ' CZ ' ' A' ' 94' ' ' PHE . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HB2' HD11 ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.658 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.889 HG22 ' HD3' ' A' ' 22' ' ' ARG . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 24' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.718 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.718 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.651 ' CG ' HD11 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.646 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.6 t60 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' ALA . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.781 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.651 HD11 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.781 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 90' ' ' HIS . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' N ' HG12 ' A' ' 89' ' ' VAL . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 34' ' ' THR . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.655 ' H ' HD11 ' A' ' 100' ' ' ILE . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.655 HD11 ' H ' ' A' ' 97' ' ' GLY . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.557 ' NE2' HD13 ' A' ' 45' ' ' LEU . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.721 ' HA ' HD21 ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.651 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 108' ' ' LEU . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.445 0.164 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 56' ' ' ILE . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 49' ' ' HIS . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 45' ' ' LEU . 33.7 m80 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.717 HG23 HG21 ' A' ' 25' ' ' ILE . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 25' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.683 ' C ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.715 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 27' ' ' ALA . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.51 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.715 ' CG1' HG13 ' A' ' 73' ' ' ILE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.706 ' HE1' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.462 ' OG ' HG12 ' A' ' 98' ' ' VAL . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.462 HG12 ' OG ' ' A' ' 96' ' ' SER . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.706 HG23 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 106' ' ' LYS . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.783 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.654 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 109' ' ' THR . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.503 ' N ' HD12 ' A' ' 108' ' ' LEU . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.838 0.351 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.607 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 55' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.751 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 41' ' ' GLU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.751 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 HG23 ' A' ' 73' ' ' ILE . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.516 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 55.4 t60 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.657 HG23 HD13 ' A' ' 63' ' ' ILE . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.901 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG13 HD13 ' A' ' 73' ' ' ILE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.605 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 91' ' ' GLY . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.879 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.879 HD11 ' HA2' ' A' ' 97' ' ' GLY . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.704 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 2.9 tp60 -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.903 HG22 ' CD1' ' A' ' 111' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.742 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' CD1' HG22 ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.821 0.343 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 70' ' ' VAL . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.834 HD13 HG12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' VAL . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.485 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.644 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HG3' ' OE1' ' A' ' 47' ' ' GLN . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.432 ' SG ' HG21 ' A' ' 53' ' ' VAL . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HG3' ' A' ' 43' ' ' LYS . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.502 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 42' ' ' ILE . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 24' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 25' ' ' ILE . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 25' ' ' ILE . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.689 ' HA ' HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.586 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.808 HD12 ' N ' ' A' ' 109' ' ' THR . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.808 ' N ' HD12 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.827 0.346 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 63' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 57' ' ' GLN . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.671 0.272 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 108' ' ' LEU . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.471 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.774 ' CG2' HG22 ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 60' ' ' VAL . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.933 HG21 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.603 ' N ' HD12 ' A' ' 73' ' ' ILE . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.495 HG22 HD13 ' A' ' 88' ' ' LEU . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.214 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.933 HG12 HG21 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.801 ' CA ' HG23 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.562 ' CG ' HD13 ' A' ' 103' ' ' LEU . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.783 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 92' ' ' MET . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.783 HD23 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.598 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.899 ' HA ' HD12 ' A' ' 110' ' ' ILE . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.751 0.31 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.669 HG12 HD12 ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 73' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.871 HD13 HD11 ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 53' ' ' VAL . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HB3' HD11 ' A' ' 51' ' ' ILE . 1.3 m80 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 49' ' ' HIS . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 52' ' ' PRO . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.871 HD11 HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.861 ' HB2' HG23 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.861 HG23 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 67' ' ' MET . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.584 ' SD ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' SD ' ' A' ' 67' ' ' MET . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 16.9 m-70 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.765 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.207 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.696 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.517 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 91' ' ' GLY . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.603 0.24 . . . . 0.0 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.59 24.16 0.1 OUTLIER Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.374 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.99 68.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.285 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m 51.43 97.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.237 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -174.34 160.2 3.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.79 102.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.429 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' HIS . 8.7 m170 -96.74 120.73 37.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -84.45 -28.97 26.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -61.41 -61.22 2.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.216 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.08 138.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 111.286 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 7' ' ' HIS . 34.8 m80 -96.9 55.49 1.35 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -60.22 90.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.86 160.89 18.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.68 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -113.9 116.55 29.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.28 148.97 37.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.7 81.98 1.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.758 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -100.64 33.09 2.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.467 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 34.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.834 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . -144.46 -76.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.172 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.21 -67.8 0.14 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -164.44 -65.56 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.613 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -129.94 154.5 47.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.332 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -133.44 123.62 25.62 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.738 179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.736 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mt -108.31 157.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.162 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.83 HG21 HG12 ' A' ' 63' ' ' ILE . 1.1 mt -125.16 145.61 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 120.808 0.337 . . . . 0.0 110.728 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 55' ' ' LEU . 38.2 t -120.95 120.02 61.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.136 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.688 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.18 122.47 43.1 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.14 0.495 . . . . 0.0 111.756 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER -150.53 -56.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.044 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.59 -108.18 0.33 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.53 -105.32 2.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.19 104.69 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.043 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.4 t -132.29 38.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 37' ' ' MET . . . 77.17 -33.94 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -64.25 -47.94 77.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -53.87 49.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.3 p -56.12 -27.57 54.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.671 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 68.4 mmm -70.8 -52.54 19.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.874 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.622 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.14 -58.55 7.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -44.74 -55.61 5.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.392 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -41.99 97.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.253 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 37' ' ' MET . 2.4 mt-10 -64.21 -52.76 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.688 0.28 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' ALA . 20.7 mm -62.5 -33.14 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.085 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -68.48 -53.14 25.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -57.37 -38.74 74.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 108' ' ' LEU . 1.1 tp -68.77 -50.95 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.047 0.451 . . . . 0.0 110.657 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 53' ' ' VAL . 1.2 m -53.6 -36.67 62.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.117 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.14 -26.99 30.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -53.19 -45.14 68.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.951 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -102.57 9.54 39.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.384 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 14.1 m-80 60.06 60.6 2.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.406 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -109.02 90.47 7.88 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.292 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.8 Cg_exo -53.32 117.9 4.28 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.484 2.123 . . . . 0.0 112.319 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.8 m -160.09 170.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -126.18 118.06 24.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 26' ' ' VAL . 2.6 tt -96.81 118.53 33.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.202 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.78 HG23 HG23 ' A' ' 25' ' ' ILE . 4.6 tp -110.14 150.79 12.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.968 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -115.63 148.19 39.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 m -156.65 168.28 27.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.529 0.204 . . . . 0.0 110.665 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.24 -168.68 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 3.6 m -69.9 -20.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 64.93 1.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 111.335 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 55.0 mm-40 -143.99 -35.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.841 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.83 HG12 HG21 ' A' ' 25' ' ' ILE . 13.1 mt -52.47 -38.91 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.654 0.264 . . . . 0.0 110.77 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -61.92 -43.18 99.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.879 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.0 p -72.51 -40.63 66.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.4 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -90.46 11.02 22.95 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.22 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.77 49.8 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.529 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.51 -45.24 14.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.51 57.15 0.52 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.43 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.683 HG11 HG13 ' A' ' 25' ' ' ILE . 21.8 t -100.81 130.35 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.286 . . . . 0.0 111.066 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 2.3 t-80 -93.3 -17.73 23.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.652 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 31.2 mt -156.63 143.38 18.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.703 0.287 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 63' ' ' ILE . 2.1 mp -126.39 143.44 39.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.086 0.469 . . . . 0.0 111.449 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.1 m -127.23 104.37 7.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 27' ' ' ALA . 1.3 p -119.45 140.81 49.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.487 HG21 ' SG ' ' A' ' 28' ' ' CYS . 43.8 p -80.38 69.43 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.368 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 52.22 84.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HG2' ' HB ' ' A' ' 60' ' ' VAL . 11.7 tpt85 -151.6 -60.24 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG11 HD22 ' A' ' 88' ' ' LEU . 6.6 p -66.86 170.4 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 79' ' ' VAL . 11.8 p-10 -100.29 -23.04 14.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 88' ' ' LEU . 2.6 tmm_? 57.34 33.37 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.695 0.283 . . . . 0.0 111.149 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.6 t -121.57 11.42 10.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.511 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' HG21 ' A' ' 86' ' ' ILE . 23.0 p90 -110.19 112.38 24.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 111.034 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.37 -110.26 3.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.357 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 t70 -156.41 30.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.517 0.199 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.638 HG21 ' CE1' ' A' ' 83' ' ' PHE . 11.3 tt -53.33 104.22 0.42 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 0.0 110.909 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.7 Cg_endo -69.17 72.91 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.293 1.995 . . . . 0.0 112.688 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.805 HD22 HG11 ' A' ' 79' ' ' VAL . 3.2 pp -104.77 160.92 14.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.144 0.497 . . . . 0.0 111.606 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.89 160.43 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.636 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.79 122.01 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.968 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -89.48 40.84 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.788 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -45.79 -52.7 23.77 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.526 0.163 . . . . 0.0 111.261 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HG2' HD22 ' A' ' 103' ' ' LEU . 70.2 Cg_endo -71.82 -25.4 20.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.09 1.86 . . . . 0.0 112.486 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.649 ' CE1' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -66.15 -35.0 79.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.387 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.594 HG13 ' CG2' ' A' ' 34' ' ' THR . 15.9 t -72.24 -23.68 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.534 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.56 -31.21 69.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.449 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 77.27 0.91 73.05 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.604 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.12 -34.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.54 64.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.28 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.649 HG23 ' CE1' ' A' ' 94' ' ' PHE . 10.1 mt -74.87 -46.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 117.086 0.443 . . . . 0.0 111.413 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.48 -52.88 34.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.448 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.53 -44.01 83.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.692 HD22 ' HG2' ' A' ' 93' ' ' PRO . 4.7 tp -64.88 -42.06 95.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -47.47 -48.29 26.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.729 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.24 -41.83 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -42.47 93.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.281 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 103' ' ' LEU . 12.2 mm -60.42 -48.68 87.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 45' ' ' LEU . 19.1 mt -62.48 -38.99 92.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 m -55.76 -45.25 78.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 24.3 mm -81.37 -33.75 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.369 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 107' ' ' ILE . 19.5 mt -60.4 -31.12 70.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -89.54 -28.05 19.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.433 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.874 0.368 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.85 -16.44 6.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.589 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.97 -26.08 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.635 0.255 . . . . 0.0 111.248 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -120.7 159.99 24.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.79 86.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -113.47 78.97 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.12 -177.56 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.815 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 176.96 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -127.89 148.85 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.193 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -21.45 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.37 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -92.33 140.97 29.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -59.22 154.87 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 92.75 3.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -129.7 89.29 2.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp 59.06 71.03 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -145.07 -53.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.35 27.6 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.53 93.13 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.9 -78.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.72 -175.97 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.956 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.855 ' HB2' ' HB2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -132.38 -55.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.764 ' HB2' HG12 ' A' ' 53' ' ' VAL . 4.9 mtm-85 -129.92 159.28 37.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.412 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 54' ' ' GLU . 4.2 mptt -134.95 116.5 14.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.634 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.6 mp -101.82 154.05 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.242 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.908 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.3 pt -120.27 145.14 27.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 120.891 0.376 . . . . 0.0 111.144 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.22 114.75 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.721 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -118.5 123.76 45.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.451 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.56 165.25 20.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.209 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.57 62.63 1.15 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.802 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.63 73.93 0.9 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.381 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.03 -76.34 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 0.0 111.575 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t 75.84 -21.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.103 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.55 -40.2 2.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.771 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.5 -6.43 58.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.075 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 m -66.77 -49.55 65.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.183 0.516 . . . . 0.0 110.402 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -28.98 69.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.629 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -62.98 -54.1 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.736 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.43 -58.8 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.11 -54.16 11.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.5 OUTLIER -61.3 -39.22 89.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.701 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -67.21 -50.36 61.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.498 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' ALA . 15.2 mm -67.47 -41.05 85.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.819 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -57.4 -56.64 19.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.035 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -58.74 -33.85 70.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.751 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 108' ' ' LEU . 11.1 tp -70.31 -53.51 16.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 15.9 p -57.9 -35.37 70.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.01 -51.99 12.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -50.36 -37.95 39.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.724 ' HB3' HG13 ' A' ' 51' ' ' ILE . 3.0 t60 -90.05 -7.63 53.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 16.6 m-80 62.12 29.44 17.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.739 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -84.08 108.96 15.88 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.855 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 44.3 Cg_exo -55.45 98.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.125 1.883 . . . . 0.0 111.679 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 51' ' ' ILE . 4.2 m -153.27 162.69 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -129.94 121.09 25.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.916 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG21 ' A' ' 42' ' ' ILE . 1.1 tm? -85.8 110.79 19.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.357 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.832 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.5 tp -103.79 150.36 7.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 136.59 54.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.8 m -149.56 168.35 23.76 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.472 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -84.89 -164.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.159 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -69.83 -21.83 24.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.605 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.55 67.64 1.42 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.0 111.052 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -153.9 -34.85 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.708 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.908 ' HB ' HD12 ' A' ' 25' ' ' ILE . 2.7 pt -52.08 -33.78 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 64.4 tt0 -70.18 -32.72 70.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.725 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -76.51 -42.17 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.274 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -90.18 8.4 33.17 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 1.1 ppp? -77.03 46.78 0.5 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.343 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -27.6 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.731 0.301 . . . . 0.0 111.108 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 23' ' ' LYS . . . -171.54 53.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.221 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG11 ' CG2' ' A' ' 25' ' ' ILE . 17.6 m -85.68 130.17 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.092 0.472 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -95.7 -12.25 25.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -154.02 148.33 25.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.921 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.028 HG21 HG12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -140.01 144.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 111.451 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.99 104.84 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 m -141.97 147.9 37.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.441 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 18.2 p -98.66 79.5 2.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.778 0.323 . . . . 0.0 111.183 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' THR . . . 177.89 -23.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.141 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' HA ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.9 53.09 1.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.099 0.476 . . . . 0.0 111.355 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 10.7 t -77.51 42.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.542 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 7.5 p-10 -99.03 -20.39 16.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -16.34 56.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.05 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -127.11 1.91 6.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.355 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.632 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 1.8 m-30 -91.48 -44.94 8.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.12 -71.13 0.48 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.3 t70 -154.1 18.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.508 0.194 . . . . 0.0 110.801 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 1.028 HG12 HG21 ' A' ' 73' ' ' ILE . 6.9 tt -55.85 103.6 0.37 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.287 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 41.2 Cg_endo -66.24 74.41 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.569 2.179 . . . . 0.0 112.858 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.893 ' CA ' HG23 ' A' ' 73' ' ' ILE . 1.6 pt? -98.61 161.96 13.39 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.336 0.589 . . . . 0.0 112.011 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.32 155.18 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.354 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -82.98 140.89 32.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -110.36 26.21 13.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.411 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.507 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 7.7 ttt -56.2 -49.19 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.37 0.129 . . . . 0.0 111.275 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 92' ' ' MET . 74.4 Cg_endo -75.51 -15.06 19.86 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.113 1.876 . . . . 0.0 112.795 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' HE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.93 -37.98 18.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.875 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' GLY . 40.7 t -77.9 -23.4 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -40.15 82.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.678 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 100.51 -9.13 58.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.713 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 -13.24 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.86 28.35 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.436 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . 20.5 mt -66.49 -50.39 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.125 0.462 . . . . 0.0 111.205 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.21 -47.79 82.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.965 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.75 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.6 tp -70.55 -30.25 66.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.668 ' O ' HG13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -57.75 -52.34 65.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.64 -41.99 99.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 110.778 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 110' ' ' ILE . 65.6 mttt -65.65 -48.99 70.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.241 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.1 pt -62.81 -32.02 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 45' ' ' LEU . 6.0 mt -67.8 -48.19 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.717 0.294 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.513 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -58.26 -39.69 79.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 106' ' ' LYS . 57.4 mt -67.32 -51.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.42 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 26.7 mt -59.75 -34.35 72.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.133 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 2.5 pt20 -80.19 -32.06 38.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 112' ' ' GLN . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.38 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.712 0.292 . . . . 0.0 110.86 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.54 138.26 2.42 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.562 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -116.15 29.35 8.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.798 0.332 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -127.9 176.67 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -158.52 89.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.4 61.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.92 48.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.988 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 86.24 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.712 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -106.99 107.47 18.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.256 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -133.43 -17.19 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.366 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.68 144.46 23.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -110.43 -22.84 11.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.49 119.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.8 41.13 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -75.83 -77.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.56 106.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.86 0.362 . . . . 0.0 110.762 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -111.9 90.69 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -114.55 23.54 12.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.88 -73.64 0.85 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.501 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.73 162.46 13.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.656 0.265 . . . . 0.0 110.817 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 52' ' ' PRO . 7.1 mtpp -144.71 -82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HD2' ' CD2' ' A' ' 71' ' ' HIS . 11.9 mtm180 -116.05 147.63 41.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.675 0.274 . . . . 0.0 110.488 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -131.62 110.93 11.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.013 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.7 mp -94.13 149.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.777 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 63' ' ' ILE . 3.0 tp -125.05 145.8 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.767 0.317 . . . . 0.0 110.34 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 26' ' ' VAL . 26.8 m -124.13 116.23 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.993 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -118.88 123.43 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 111.438 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -161.82 156.57 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.145 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.33 -146.06 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 94.13 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.383 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -73.53 -66.08 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.0 111.418 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 70.9 t 75.35 -43.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.566 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -153.4 64.23 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.93 0.395 . . . . 0.0 110.957 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.424 ' OG1' ' HB1' ' A' ' 31' ' ' ALA . 13.3 p -154.44 -40.23 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.896 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -48.53 76.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.788 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.8 m -62.27 -39.62 93.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -54.3 42.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.081 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' LYS . . . -54.86 -54.86 36.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -57.01 -42.17 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.133 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' OE2' HD13 ' A' ' 100' ' ' ILE . 5.3 mt-10 -65.36 -53.18 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.966 0.413 . . . . 0.0 111.192 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.6 mt -61.83 -41.87 92.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -54.06 -57.54 10.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.929 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.3 pt-20 -53.95 -34.51 59.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -66.89 -50.94 60.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.7 m -51.37 -37.6 48.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.68 -27.25 58.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -58.83 -45.22 90.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.16 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' HG13 ' A' ' 51' ' ' ILE . 11.1 t-80 -103.76 3.71 34.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.418 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 45.7 m-80 58.34 47.83 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.699 0.285 . . . . 0.0 110.938 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 49' ' ' HIS . 25.4 mt -108.35 88.63 5.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.68 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 52.8 Cg_exo -51.52 134.24 45.57 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.393 2.062 . . . . 0.0 112.108 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 8.7 m -159.51 167.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.292 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -126.52 116.11 20.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 0.0 110.418 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.68 116.82 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.821 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.51 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -103.98 150.8 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.85 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -125.75 130.38 51.37 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -151.47 168.29 25.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -72.8 -163.89 0.14 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.735 0.302 . . . . 0.0 110.811 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 60' ' ' VAL . 10.1 p -79.18 -3.97 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.108 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 13.9 m-20 -151.3 69.95 0.96 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.318 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 1.2 mm-40 -150.05 -33.47 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.928 HG12 HG12 ' A' ' 25' ' ' ILE . 3.5 mp -61.52 -33.17 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.423 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -56.47 -44.21 80.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.802 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.4 p -77.16 -40.41 45.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -87.06 12.43 11.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.523 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 49.46 0.37 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.75 -36.04 82.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.761 0.315 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 23' ' ' LYS . . . -171.62 73.89 0.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.696 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 23' ' ' LYS . 77.4 t -98.32 129.52 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.745 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.668 ' CD2' ' HD2' ' A' ' 22' ' ' ARG . 3.7 t60 -95.07 -24.6 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.99 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 83.5 mt -153.25 148.87 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.123 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -138.97 144.56 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.987 0.423 . . . . 0.0 110.468 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.509 ' N ' HG13 ' A' ' 73' ' ' ILE . 6.1 m -121.58 104.25 9.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.966 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -142.41 145.47 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 m -95.2 80.25 3.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.665 0.269 . . . . 0.0 111.141 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.76 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.692 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.929 ' HA ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 63.31 51.14 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 110.741 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' PHE . 23.9 m -74.91 47.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.392 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.588 ' HB2' ' CD2' ' A' ' 88' ' ' LEU . 11.4 t0 -101.9 -20.81 14.71 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -14.83 54.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.32 10.89 7.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.221 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 3.2 m-85 -106.24 -43.92 4.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.811 0.339 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.82 -68.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.377 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 p-10 -159.58 22.36 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.622 0.248 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 73' ' ' ILE . 7.7 tt -55.07 104.79 0.45 Allowed Pre-proline 0 N--CA 1.454 -0.244 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.915 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -66.82 74.3 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.648 2.232 . . . . 0.0 112.988 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 78' ' ' ARG . 1.3 pt? -99.75 162.29 13.09 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.207 0.527 . . . . 0.0 112.017 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -143.52 151.99 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.972 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.431 ' NE2' ' HD2' ' A' ' 78' ' ' ARG . 50.9 m170 -82.68 142.5 31.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -115.71 20.39 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.693 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.94 -44.27 99.42 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 1.023 ' HG2' HD22 ' A' ' 103' ' ' LEU . 65.4 Cg_endo -72.27 -35.5 6.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.949 1.766 . . . . 0.0 112.39 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.843 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -34.4 77.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 111.031 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 20.9 t -75.56 -15.57 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.418 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -65.3 -34.27 77.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 111.176 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.27 -10.58 58.27 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.622 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.42 -18.26 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.21 -2.46 44.83 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.608 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' A' ' 94' ' ' PHE . 1.7 pt -59.2 -34.91 55.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.278 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.9 mt-10 -54.63 -53.16 58.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.42 -48.78 68.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.103 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.023 HD22 ' HG2' ' A' ' 93' ' ' PRO . 33.5 tp -58.45 -51.67 68.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.4 tt0 -49.4 -54.32 18.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -55.41 34.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.707 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.619 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -53.54 -49.14 68.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.475 -179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 108' ' ' LEU . 33.4 pt -61.46 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.448 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' N ' HG13 ' A' ' 107' ' ' ILE . 81.3 mt -58.64 -46.83 86.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.673 0.273 . . . . 0.0 111.308 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.4 m -55.62 -39.73 71.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.771 0.32 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 106' ' ' LYS . 14.0 mt -74.98 -42.56 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.256 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 96.2 mt -56.01 -29.34 60.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -81.36 -14.61 57.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.211 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.587 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.16 123.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -149.89 -168.45 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -137.12 172.99 12.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -66.32 -59.45 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 64.0 140.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -134.59 113.52 11.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.325 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.05 9.95 1.72 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.268 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -92.02 82.35 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -63.96 134.97 56.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.23 80.01 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.09 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -110.74 -20.69 12.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.38 74.48 0.15 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.802 0.334 . . . . 0.0 110.988 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.75 141.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.2 26.97 5.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.826 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -122.51 41.8 3.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.82 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -114.34 157.47 22.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -124.45 -42.71 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.41 111.45 1.12 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.985 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -178.14 -62.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 110.762 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.3 -50.99 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HG2' ' CD2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -116.01 143.89 44.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.922 0.392 . . . . 0.0 110.662 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -129.97 120.72 25.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.286 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -103.37 153.19 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.114 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 63' ' ' ILE . 11.1 tp -119.38 145.05 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.545 0.212 . . . . 0.0 110.664 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 42' ' ' ILE . 17.7 m -124.36 123.62 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.21 123.5 38.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.824 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.12 -55.15 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.81 -6.39 33.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.842 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.99 -145.23 0.12 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -176.83 -168.31 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.785 0.326 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 3.0 t 48.77 70.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.368 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 69.26 50.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.49 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -133.55 -54.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.858 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -69.72 -50.51 42.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.9 p -67.61 -41.6 83.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.719 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.695 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -49.22 -55.04 13.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.903 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.95 -57.6 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.47 -55.22 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.203 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -62.82 -48.68 78.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -57.92 -54.66 44.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.663 0.268 . . . . 0.0 111.296 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.912 HG21 HD13 ' A' ' 55' ' ' LEU . 6.5 mt -63.09 -30.83 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -74.21 -53.98 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.694 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 18.5 pt-20 -54.73 -40.47 69.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.225 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 41' ' ' GLU . 63.3 mt -64.57 -54.33 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.557 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.6 m -55.05 -44.47 74.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -74.37 -43.89 54.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.001 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 -43.17 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.072 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.06 0.02 57.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.353 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 61.97 51.88 3.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 53' ' ' VAL . 6.5 mt -112.07 89.61 12.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.978 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.1 Cg_exo -52.0 116.7 2.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.296 1.997 . . . . 0.0 112.506 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.4 m -158.67 165.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.168 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -124.55 115.97 21.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.86 0.362 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD13 HG21 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -104.23 126.39 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.483 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -102.98 151.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.346 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -127.15 124.73 39.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 27.7 m -152.67 168.75 24.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.639 ' HB2' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -72.54 -163.02 0.11 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.946 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.26 -15.29 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.79 63.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.411 . . . . 0.0 111.487 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 13.2 mt-10 -142.79 -35.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.623 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG12 HG12 ' A' ' 25' ' ' ILE . 1.2 mt -58.2 -47.53 87.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.244 0.545 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -44.66 44.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -38.16 32.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.291 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.49 ' N ' ' HD1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -86.41 12.81 9.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.963 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 86' ' ' ILE . 2.4 tmm? -70.98 46.94 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.826 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -65.14 -43.04 93.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.873 0.368 . . . . 0.0 111.157 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 23' ' ' LYS . . . -167.67 72.14 0.16 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.28 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.787 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.2 m -104.71 130.09 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.979 0.418 . . . . 0.0 111.007 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.406 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.5 t60 -92.8 -15.62 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.163 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 2.8 mt -158.02 149.93 21.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.153 0.501 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.864 HD13 HG23 ' A' ' 86' ' ' ILE . 3.4 mp -128.43 135.59 62.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 111.514 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 71.3 m -127.39 103.33 7.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.614 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 27' ' ' ALA . 51.7 m -125.07 146.21 49.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.47 62.04 0.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.634 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.29 143.28 20.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -72.59 78.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.74 -171.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.225 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 32.4 m-20 -98.24 -13.85 20.6 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER 33.67 47.0 0.14 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.17 -2.94 5.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.241 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -80.45 102.71 9.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.15 -103.0 1.41 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.3 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -164.67 29.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.699 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.864 HG23 HD13 ' A' ' 73' ' ' ILE . 11.4 mm -59.99 102.82 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 55.8 Cg_endo -67.79 79.11 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.613 2.208 . . . . 0.0 111.847 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.0 pp -99.17 157.41 16.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.51 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.69 150.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -82.9 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.743 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.05 25.66 8.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.833 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.584 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 ttp -55.96 -53.41 63.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.462 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 92' ' ' MET . 56.0 Cg_endo -70.05 -33.16 15.99 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.782 2.321 . . . . 0.0 113.257 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.24 -36.68 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 111.231 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' MET . 11.7 p -77.34 -21.11 14.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.2 m -59.87 -26.64 66.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.9 -4.0 81.65 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.967 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.28 -25.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.829 0.315 . . . . 0.0 111.479 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -101.65 13.28 58.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.25 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD11 ' HA2' ' A' ' 97' ' ' GLY . 16.0 mt -72.87 -50.42 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.962 0.381 . . . . 0.0 111.647 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.32 -55.1 31.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.214 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.9 84.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.037 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -68.98 -46.38 68.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.484 ' HA ' HG22 ' A' ' 107' ' ' ILE . 3.6 tt0 -52.62 -52.43 55.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.97 -37.88 77.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.426 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' O ' HG13 ' A' ' 110' ' ' ILE . 6.2 mttt -77.27 -44.24 30.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.431 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.67 ' HA ' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -63.43 -45.79 97.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.867 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.4 mt -60.04 -47.15 87.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -57.23 -35.36 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.159 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 107' ' ' ILE . 15.0 mt -69.07 -46.8 77.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD11 HD11 ' A' ' 107' ' ' ILE . 15.1 mt -68.22 -37.68 81.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 110.79 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.02 -39.51 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.458 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.78 53.24 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.964 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -114.88 148.1 39.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 0.0 111.165 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.4 m -118.93 104.13 10.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -159.58 147.38 17.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.41 -16.09 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.793 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.3 m80 59.83 -82.77 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.653 0.263 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.1 -171.27 2.0 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -76.0 178.33 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -59.8 -75.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.33 35.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.814 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -118.64 -37.76 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 66.8 35.84 4.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.83 145.48 30.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 15' ' ' LEU . 2.1 pt? -107.61 -12.8 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -102.02 87.82 3.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.801 0.334 . . . . 0.0 111.083 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.91 151.24 36.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -84.88 52.33 2.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.94 3.85 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.512 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.92 177.77 1.03 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.786 0.327 . . . . 0.0 110.469 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -165.1 -77.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.602 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 0.4 OUTLIER -118.2 149.05 41.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.041 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.64 113.43 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 6.5 mt -102.34 152.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.653 HD12 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -127.44 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.775 HG13 ' HG2' ' A' ' 57' ' ' GLN . 8.8 p -125.59 122.94 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.335 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -121.22 126.17 48.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.0 111.947 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.48 161.42 41.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.185 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.13 87.39 1.55 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.323 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.74 174.95 13.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.518 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 179.25 79.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -141.04 -42.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.628 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 37' ' ' MET . . . -140.78 -42.18 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.163 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -64.36 -57.57 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.129 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -50.11 -39.13 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -70.17 -30.72 67.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.755 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 33' ' ' ALA . 6.3 mtp -58.04 -54.14 50.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.9 -58.48 7.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.968 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.92 -57.68 8.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -57.35 -36.51 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.226 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -72.66 -53.75 10.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 38' ' ' ALA . 32.7 mm -60.56 -34.54 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.798 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -61.81 -59.1 5.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.22 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.2 pt-20 -54.09 -33.66 58.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 104' ' ' GLN . 2.0 tp -68.36 -53.31 24.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.816 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.6 m -48.96 -36.57 17.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.13 49.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.667 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -42.21 60.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -2.56 46.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.57 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 7.9 m-80 54.41 50.64 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.776 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.669 ' O ' HG22 ' A' ' 53' ' ' VAL . 24.5 mt -104.94 96.85 11.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.594 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' O ' HG13 ' A' ' 53' ' ' VAL . 50.9 Cg_exo -55.57 114.24 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.39 2.06 . . . . 0.0 112.614 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 51' ' ' ILE . 2.5 m -158.99 166.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -128.12 119.25 24.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 tt -99.31 120.88 40.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -107.19 150.71 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.856 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.775 ' HG2' HG13 ' A' ' 26' ' ' VAL . 21.2 tm0? -121.66 132.11 54.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.634 0.254 . . . . 0.0 110.324 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 5.6 m -154.23 167.5 29.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 5.9 mtt85 -72.57 -155.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.729 0.299 . . . . 0.0 111.435 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.84 -4.4 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -132.79 49.73 2.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 110.582 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.2 -36.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.605 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.877 HG21 HD13 ' A' ' 73' ' ' ILE . 4.2 mt -52.75 -36.88 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.05 -36.3 77.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -77.36 -42.65 35.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 62' ' ' GLU . 45.6 m-85 -90.7 12.27 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.305 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.543 ' HE3' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -73.02 47.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.208 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.97 -39.96 79.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.22 60.04 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG21 HG13 ' A' ' 25' ' ' ILE . 14.8 p -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.83 0.348 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 35.1 t-80 -92.09 -21.1 20.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 4.0 mt -155.85 145.31 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.476 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.877 HD13 HG21 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -131.97 142.41 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 111.193 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.628 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.52 116.87 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.059 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.486 ' O ' ' HD2' ' A' ' 90' ' ' HIS . 22.7 m -141.7 150.07 41.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.382 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.61 70.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 110.877 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.79 147.91 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.136 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 60.49 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -62.88 -178.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.996 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -94.73 -22.56 18.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.05 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 42.87 40.17 2.02 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.194 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.9 p -126.0 2.82 7.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.015 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.847 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 28.7 p90 -94.09 99.8 12.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.902 0.382 . . . . 0.0 111.034 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.29 -119.4 5.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 2.5 m-20 -149.52 28.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.722 0.296 . . . . 0.0 110.581 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -55.56 102.48 0.31 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.221 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.5 Cg_endo -66.38 80.96 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.235 1.956 . . . . 0.0 112.049 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.794 HD12 HG12 ' A' ' 73' ' ' ILE . 3.4 tt -98.18 144.38 27.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.402 0.62 . . . . 0.0 112.126 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.628 HG23 ' SG ' ' A' ' 74' ' ' CYS . 2.6 m -135.5 149.57 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 75' ' ' THR . 7.2 m170 -82.54 140.76 33.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.612 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.52 10.73 14.33 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.79 -44.64 99.49 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 92' ' ' MET . 58.3 Cg_endo -72.26 -35.11 7.07 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.103 1.869 . . . . 0.0 112.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.573 ' CD1' HD22 ' A' ' 103' ' ' LEU . 1.5 t80 -72.02 -36.79 69.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 91' ' ' GLY . 30.3 t -72.26 -21.78 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -53.12 -38.19 62.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 92.72 -8.47 76.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.878 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 98' ' ' VAL . 19.9 t -111.01 -2.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.28 12.43 9.68 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.625 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 45.0 mt -64.66 -50.37 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.398 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -46.5 45.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.544 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.4 -44.49 58.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.573 HD22 ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -64.1 -43.05 96.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.757 0.313 . . . . 0.0 110.797 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.793 ' HG3' HD21 ' A' ' 45' ' ' LEU . 20.1 tt0 -48.63 -54.82 13.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.244 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' HD21 ' A' ' 108' ' ' LEU . 1.5 m-80 -54.7 -37.83 66.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -39.65 82.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 111' ' ' LEU . 25.3 mm -62.12 -57.77 10.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.313 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 109' ' ' THR . 3.0 pp -52.53 -43.19 64.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.573 0.225 . . . . 0.0 111.176 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 108' ' ' LEU . 74.4 m -55.32 -42.15 73.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.728 0.299 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.69 -35.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 107' ' ' ILE . 1.4 mm? -76.88 -10.18 59.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.276 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 8.9 mt-30 -98.71 -3.75 35.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.437 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.423 -1.21 . . . . 0.0 112.469 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.42 -85.22 0.12 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.342 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.36 142.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.8 t -165.23 -15.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m170 60.62 -178.76 0.1 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.3 175.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -59.01 88.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 -171.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -116.46 134.93 54.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 48.56 84.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -79.46 -172.82 3.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.63 -167.69 1.32 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 65.43 102.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.945 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -77.47 -76.92 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.82 75.65 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.115 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.84 6.25 2.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER 61.14 22.69 12.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.248 . . . . 0.0 110.943 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -87.34 14.83 7.23 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.253 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.17 62.15 0.3 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -163.53 165.73 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.86 -52.48 1.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 1.6 mtp180 -131.27 155.82 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.217 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.667 ' O ' HG13 ' A' ' 70' ' ' VAL . 19.2 mttt -129.4 112.76 14.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.883 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 72' ' ' LEU . 9.3 mt -100.82 148.68 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.573 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 56' ' ' ILE . 2.0 mt -115.31 145.78 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 120.728 0.299 . . . . 0.0 111.003 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.26 114.55 41.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.714 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.719 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -114.03 123.2 49.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.87 156.32 22.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.957 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.71 123.7 7.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -157.27 51.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.82 -78.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 32' ' ' VAL . 24.9 t 46.99 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 66.98 49.78 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.973 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 95' ' ' VAL . 16.2 m -142.62 -49.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -69.34 -57.29 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.352 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -61.96 -36.08 80.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 2.9 ttt -60.77 -53.95 51.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.63 -58.66 7.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -54.75 12.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.334 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -34.54 75.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -67.12 -53.4 31.1 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 38' ' ' ALA . 1.2 mm -64.59 -35.88 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.773 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -55.71 -57.76 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.923 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -58.55 -34.86 71.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.741 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.8 -62.47 1.85 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.243 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.1 p -52.56 -37.55 58.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.248 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -72.53 -48.57 39.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.38 -42.91 70.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -83.67 -6.3 59.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.397 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 28.5 m120 64.72 42.62 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . 34.9 mt -108.11 95.5 15.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.96 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.6 Cg_exo -53.2 114.74 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 112.322 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 51' ' ' ILE . 1.9 m -153.25 165.26 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.921 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.35 116.02 20.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 57' ' ' GLN . 0.9 OUTLIER -91.89 115.37 28.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.058 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 25' ' ' ILE . 5.0 tt -104.89 150.73 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.8 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 55' ' ' LEU . 1.4 mp0 -118.53 141.67 48.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -161.87 167.36 24.86 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -163.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.733 0.301 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' VAL . 23.7 t -83.29 -6.51 10.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.465 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.82 55.98 1.87 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 111.106 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 6.5 mm-40 -152.67 -36.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.726 HG22 HG21 ' A' ' 25' ' ' ILE . 1.8 pt -52.19 -34.08 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.411 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 2.6 mt-10 -67.68 -35.01 78.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.5 p -76.66 -42.29 42.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 59.4 m-85 -90.79 4.37 51.83 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -78.0 46.5 0.59 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.328 -0.233 . . . . 0.0 111.07 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.95 -35.75 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 111.281 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.04 38.66 1.68 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 25' ' ' ILE . 55.9 t -93.28 130.87 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.12 0.486 . . . . 0.0 111.117 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 8.5 t60 -94.31 -20.18 20.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.649 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.811 ' C ' HD13 ' A' ' 73' ' ' ILE . 8.2 mt -155.02 155.64 34.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.386 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.91 HG13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.43 142.87 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.3 m -127.85 108.9 11.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.052 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.3 m -128.11 144.48 51.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 111.067 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -129.07 45.84 2.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.01 1.03 13.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.647 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' HD3' ' HE1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER 72.6 64.16 0.12 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.017 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.59 -169.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 81' ' ' ARG . 20.3 p-10 -96.9 -20.74 17.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.341 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER 40.9 40.55 1.02 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.485 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.07 10.11 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 13.1 p90 -95.61 113.03 24.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.749 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.29 -110.2 3.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -155.26 24.15 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.617 0.246 . . . . 0.0 110.611 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.91 HG23 HG13 ' A' ' 73' ' ' ILE . 3.2 mm -55.37 102.55 0.31 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.2 Cg_endo -68.94 73.51 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.811 2.341 . . . . 0.0 112.233 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -98.71 161.47 13.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 90' ' ' HIS . 11.1 p -145.88 156.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.389 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' HE1' ' HD3' ' A' ' 78' ' ' ARG . 1.1 m170 -88.82 148.56 23.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.557 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.14 21.72 7.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.471 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.516 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.86 -48.9 76.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.433 0.158 . . . . 0.0 111.189 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 92' ' ' MET . 72.3 Cg_endo -75.2 -26.96 10.11 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.664 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -67.07 -37.7 84.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.862 0.363 . . . . 0.0 110.631 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 34' ' ' THR . 57.9 t -73.56 -23.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.183 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.6 p -57.22 -36.34 70.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 -8.0 75.66 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.85 -28.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.31 1.19 88.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.605 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.408 HD13 ' OE2' ' A' ' 41' ' ' GLU . 10.5 mt -66.95 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.901 0.381 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.41 -57.23 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.8 -40.68 72.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.874 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 94' ' ' PHE . 21.9 tp -59.81 -53.38 58.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.722 ' HA ' HG22 ' A' ' 107' ' ' ILE . 40.7 tt0 -50.42 -49.99 53.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -52.67 -49.47 65.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.408 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -76.32 -40.28 51.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.974 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -66.13 -33.32 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.17 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.1 mt -75.94 -43.19 46.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 1.2 p -59.68 -38.39 81.4 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.24 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.12 -43.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.917 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -52.74 -43.69 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.012 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -70.65 -31.17 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.368 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.659 0.266 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.49 -147.86 16.58 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.243 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.98 154.13 36.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.31 19.62 5.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -72.97 158.25 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -145.07 -78.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.54 72.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -145.59 22.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.002 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -151.9 -44.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -102.56 -169.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 112.17 4.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.38 174.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.84 -75.82 0.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 57.88 45.11 18.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.261 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 17' ' ' PHE . 0.2 OUTLIER 68.16 138.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.768 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.69 60.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.023 0.44 . . . . 0.0 111.099 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CE2' ' HG ' ' A' ' 15' ' ' LEU . 2.3 m-85 -141.74 17.9 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.869 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -122.57 112.41 17.97 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.761 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.91 -119.46 13.57 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 p -162.15 -34.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.7 0.286 . . . . 0.0 111.198 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.49 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.816 ' HG2' HG23 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -127.19 156.98 40.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.153 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -136.89 118.33 14.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.749 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 41.1 mt -102.66 150.28 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 111.677 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -118.51 145.12 24.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.83 114.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.599 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -115.65 123.37 48.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 111.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.05 -173.26 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.358 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.33 12.68 19.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.11 -34.64 4.74 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.64 106.67 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 33' ' ' ALA . 3.5 t -60.09 168.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.831 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.535 ' H ' HG12 ' A' ' 32' ' ' VAL . . . 82.18 -34.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.883 0.473 . . . . 0.0 111.425 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.634 HG23 HG13 ' A' ' 95' ' ' VAL . 2.2 m -70.67 -44.63 66.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.69 80.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -34.41 77.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.3 tpp -58.01 -53.54 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 42' ' ' ILE . . . -62.85 -45.47 92.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 55' ' ' LEU . . . -49.27 -57.74 6.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.464 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 11.3 mt-10 -61.92 -46.22 90.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 70.9 mt-10 -57.95 -52.16 66.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' A' ' 38' ' ' ALA . 7.4 mt -66.22 -30.7 50.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 6.0 mmtp -72.59 -55.0 7.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.346 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -53.69 -34.88 60.24 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 111.074 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -70.06 -45.8 66.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' HG11 ' A' ' 53' ' ' VAL . 86.8 m -56.84 -39.02 73.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.48 -34.47 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -51.54 -45.26 62.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 10.7 m170 -97.97 4.6 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.586 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.55 63.4 1.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.637 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 49' ' ' HIS . 6.5 mt -120.71 100.63 46.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.966 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.84 118.56 4.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.181 1.921 . . . . 0.0 111.861 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 22' ' ' ARG . 5.2 p -157.12 162.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.963 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -122.77 114.36 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 110.614 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD12 ' HB ' ' A' ' 24' ' ' ILE . 7.4 tp -97.32 118.3 33.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.79 150.65 13.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.655 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -117.8 128.22 54.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 79.6 m -138.14 167.97 20.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.869 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -80.0 -168.0 1.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.09 -19.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.906 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -138.84 68.17 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 111.197 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 5.3 mm-40 -146.69 -33.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.229 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -58.58 -32.62 46.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -65.42 -42.39 92.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.451 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -36.79 57.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -88.89 13.74 12.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.562 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -73.58 46.6 0.21 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.56 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.98 -39.98 87.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.622 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HE2' ' A' ' 23' ' ' LYS . . . -165.99 70.07 0.19 Allowed Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.037 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.801 HG11 HG22 ' A' ' 73' ' ' ILE . 40.0 t -103.13 130.67 52.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.143 0.497 . . . . 0.0 111.832 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.62 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.7 t-80 -91.71 -23.2 19.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.201 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.1 mt -161.21 140.23 10.11 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.801 HG22 HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -126.54 146.49 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 32.5 t -124.44 104.85 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.718 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.7 m -142.04 156.54 45.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.16 69.93 7.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.009 0.433 . . . . 0.0 110.397 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.96 -69.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.856 ' HG2' ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER 68.99 39.75 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.048 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 79' ' ' VAL . 7.1 p -66.42 85.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.12 -5.05 24.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.6 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -41.68 -31.75 0.32 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.624 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.6 36.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.767 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -110.49 38.81 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.183 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.5 -91.57 0.06 OUTLIER Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 1.4 t0 -154.7 27.84 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.767 0.317 . . . . 0.0 110.352 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.767 HG22 ' HB3' ' A' ' 83' ' ' PHE . 16.1 tt -57.95 106.27 0.67 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.4 Cg_endo -68.34 81.02 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.464 2.109 . . . . 0.0 112.402 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.856 ' HB2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.61 153.66 18.89 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.66 144.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.135 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 78' ' ' ARG . 8.1 m80 -83.02 147.96 27.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.82 27.0 5.26 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.546 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 5.3 ttp -52.03 -49.66 82.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.559 0.219 . . . . 0.0 111.535 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' ' CD1' ' A' ' 103' ' ' LEU . 73.7 Cg_endo -73.06 -30.04 11.19 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.576 2.184 . . . . 0.0 112.822 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -62.15 -35.41 78.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.97 0.414 . . . . 0.0 110.432 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 34' ' ' THR . 64.4 t -75.25 -18.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.378 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -60.99 -35.53 77.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.039 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.74 -6.06 59.68 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.0 p -111.39 -6.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.313 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.27 12.75 5.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 104' ' ' GLN . 39.0 pt -64.08 -41.79 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.671 0.272 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -56.14 -49.18 74.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.138 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.48 77.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.2 tt -65.89 -40.73 91.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.807 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.627 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -56.87 -50.27 72.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 110.086 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 16.0 t-20 -59.24 -36.65 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.506 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -40.89 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.068 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 104' ' ' GLN . 6.1 tp -64.37 -37.19 79.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 108' ' ' LEU . 2.7 pp -73.55 -39.23 64.88 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.87 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 108' ' ' LEU . 19.9 m -58.18 -40.14 80.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -71.16 -43.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD22 ' NH2' ' A' ' 22' ' ' ARG . 25.9 mt -58.19 -36.67 73.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 12.1 pt20 -86.87 4.4 41.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.292 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.542 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.579 0.228 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.66 154.72 30.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 t -111.28 -26.79 8.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 111.095 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.02 163.05 2.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.73 112.74 13.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.738 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 48.19 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.92 111.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 59.83 78.32 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.898 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -96.78 43.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 26.97 10.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -117.46 128.39 54.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.964 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.22 28.87 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -97.11 177.98 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.722 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -67.11 -89.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.14 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER 178.05 50.47 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.828 0.347 . . . . 0.0 110.601 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -93.51 82.24 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -160.33 40.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.743 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -69.19 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.03 -99.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.334 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.97 -56.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -78.34 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 71' ' ' HIS . 2.0 mtm180 -126.74 156.26 41.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 56' ' ' ILE . 36.6 mttt -134.35 115.2 13.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.601 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.589 ' O ' HG12 ' A' ' 56' ' ' ILE . 4.3 mt -97.52 145.35 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.781 -0.191 . . . . 0.0 110.83 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.889 HD12 ' OH ' ' A' ' 66' ' ' TYR . 2.2 mm -116.3 145.61 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 111.077 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' VAL . 5.8 p -127.6 117.89 47.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.344 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -115.53 123.84 49.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.697 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m 55.92 -168.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' A' ' 34' ' ' THR . . . -164.95 -115.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.011 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.32 -69.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.094 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 21.24 7.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.707 0.289 . . . . 0.0 111.472 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 32' ' ' VAL . 2.7 t 60.65 15.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.185 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -146.57 13.71 1.21 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.697 0.284 . . . . 0.0 111.438 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.518 ' CG2' ' HA3' ' A' ' 29' ' ' GLY . 9.0 t -78.05 -17.64 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.996 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -50.6 -51.4 48.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.917 0.389 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.3 -52.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.611 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -54.34 42.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.03 -54.58 43.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.232 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.66 -55.03 5.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.482 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -36.46 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -69.56 -48.25 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.184 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' ALA . 23.7 mt -66.6 -40.4 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.78 -53.98 46.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.992 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.16 -35.05 66.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.129 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -68.78 -49.81 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.468 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 53' ' ' VAL . 71.6 m -50.57 -34.86 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.048 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.92 -33.79 33.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.013 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.5 m -54.49 -45.24 73.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.009 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.432 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.43 0.61 48.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.358 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.7 m120 56.98 54.32 7.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.914 0.387 . . . . 0.0 111.053 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' A' ' 49' ' ' HIS . 3.3 mt -111.95 99.3 45.17 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.92 120.49 7.22 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.077 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 54' ' ' GLU . 7.2 p -157.77 160.0 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.689 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.3 mt-10 -123.14 117.92 26.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.841 0.353 . . . . 0.0 110.923 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -91.81 113.2 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -105.9 151.51 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.62 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.36 132.29 54.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.706 0.289 . . . . 0.0 110.663 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.72 167.56 27.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.142 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.34 -162.2 0.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 60' ' ' VAL . 1.4 m -85.75 -11.07 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.53 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -138.13 71.78 1.4 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.04 0.448 . . . . 0.0 110.549 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -35.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG12 HG21 ' A' ' 25' ' ' ILE . 62.3 mt -53.98 -26.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.129 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.58 -36.4 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 -43.13 28.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.889 ' OH ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -91.48 14.08 15.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.529 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 51.27 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.774 0.321 . . . . 0.0 111.19 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -43.1 99.41 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.729 0.299 . . . . 0.0 111.479 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.25 74.26 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.038 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 23' ' ' LYS . 60.1 t -105.22 127.68 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.632 0.253 . . . . 0.0 110.754 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -94.81 -16.23 23.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.427 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 13.4 mt -156.6 147.73 22.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG13 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -133.01 143.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 111.161 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -127.87 109.35 11.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.812 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.8 m -140.72 153.65 46.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.769 0.319 . . . . 0.0 111.037 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 p -93.2 73.09 4.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.66 175.28 2.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.65 52.52 1.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.401 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.9 m -77.03 27.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 1.58 56.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -61.94 -33.31 74.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 110.467 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -160.48 49.24 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.674 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -110.51 46.26 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.646 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.43 -90.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.351 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -160.49 23.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.687 0.28 . . . . 0.0 111.059 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 73' ' ' ILE . 5.8 tt -48.99 102.16 0.3 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.137 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 73' ' ' ILE . 43.6 Cg_endo -66.38 70.14 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.436 2.091 . . . . 0.0 112.847 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -98.34 162.48 13.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.262 0.553 . . . . 0.0 111.942 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 74' ' ' CYS . 7.6 p -136.2 151.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -87.42 145.16 26.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.13 37.96 3.23 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.704 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.0 tpt -65.82 -46.72 65.94 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.893 -0.181 . . . . 0.0 111.434 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.641 ' HG2' HD22 ' A' ' 103' ' ' LEU . 68.8 Cg_endo -77.06 -36.91 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.998 1.799 . . . . 0.0 112.385 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.585 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -64.97 -33.95 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.5 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 92' ' ' MET . 10.4 p -76.33 -22.67 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.762 0.315 . . . . 0.0 111.384 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -29.59 57.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.7 -1.96 70.43 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.975 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.18 -30.92 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 117.003 0.402 . . . . 0.0 111.347 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.86 17.28 42.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.052 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG23 ' CE1' ' A' ' 94' ' ' PHE . 18.5 mt -65.6 -45.92 90.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 110.831 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -40.84 87.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.219 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.12 63.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.207 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 93' ' ' PRO . 8.4 tp -70.69 -39.58 73.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.87 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.2 tm0? -48.15 -48.67 34.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.048 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -44.28 95.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 110' ' ' ILE . 1.2 mmtp -56.44 -48.91 76.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.303 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.9 mm -62.18 -43.46 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.778 0.323 . . . . 0.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.87 HD12 ' O ' ' A' ' 104' ' ' GLN . 0.3 OUTLIER -55.95 -51.38 67.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 5.7 p -54.39 -39.48 67.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.11 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 106' ' ' LYS . 5.5 mm -65.78 -44.3 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.551 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -69.76 -39.96 76.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.418 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 6.2 pt20 -78.05 -33.19 51.08 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.855 179.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.643 0.258 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.53 -86.66 0.42 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 t -172.69 -170.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.366 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t 62.12 92.99 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.585 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.91 145.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.535 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 9.0 m-70 -95.52 -10.38 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.026 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 62.24 93.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.131 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 6' ' ' HIS . 8.9 m80 -102.23 -71.37 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.774 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.43 -74.08 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.039 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' CD2' ' HE1' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -127.97 39.48 3.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 110.747 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.86 77.04 9.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.516 ' CG ' ' H ' ' A' ' 13' ' ' GLU . 2.0 p-80 -162.41 -65.62 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 12' ' ' HIS . 4.9 mt-10 63.48 -71.41 0.06 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.502 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' HIS . 19.5 t30 -161.57 129.69 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -170.93 62.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.078 0.466 . . . . 0.0 110.75 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 62.79 67.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.85 14.04 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -97.03 87.72 4.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.909 ' HA2' ' HB3' ' A' ' 52' ' ' PRO . . . -165.75 39.29 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.228 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -91.49 88.31 6.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.286 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HD2' ' HG3' ' A' ' 22' ' ' ARG . 6.1 ttmt -145.36 -76.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.017 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' ' HD2' ' A' ' 21' ' ' LYS . 7.5 mtt-85 -122.45 152.81 39.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -135.51 127.09 28.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.001 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.836 HG22 ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -106.31 147.36 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 58' ' ' CYS . 0.6 OUTLIER -117.53 145.11 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 t -125.72 115.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -112.77 123.7 50.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 111.547 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 51.33 -169.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.769 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.92 10.09 1.41 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.974 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 83.14 123.06 0.83 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.16 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 -160.96 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 t 56.9 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.307 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 46.92 55.19 8.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.963 0.411 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' GLY . 50.0 m -153.17 -47.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -46.52 88.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.456 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -72.56 -39.12 67.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 4.6 mtp -49.22 -54.43 16.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -67.36 -58.76 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.296 . . . . 0.0 110.734 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -45.62 -58.0 3.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -58.81 -37.54 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.237 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.6 tp10 -69.48 -49.86 50.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.244 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 38' ' ' ALA . 7.5 mm -66.68 -36.98 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.816 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -72.13 -55.29 7.55 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.174 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -52.23 -31.39 31.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.034 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -79.18 -40.47 30.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.06 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 m -55.92 -34.97 66.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -79.59 -45.64 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.0 t -53.01 -42.1 65.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.21 -10.8 51.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 13.6 t-20 60.88 47.44 7.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.401 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.971 HD13 HD11 ' A' ' 111' ' ' LEU . 36.3 mt -102.73 103.91 35.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.286 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.909 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 72.4 Cg_exo -53.2 99.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.886 2.391 . . . . 0.0 112.63 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 51' ' ' ILE . 25.1 m -154.96 163.4 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -132.14 124.04 28.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.855 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.625 HD12 HG12 ' A' ' 24' ' ' ILE . 11.1 tp -93.73 118.68 31.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -102.83 151.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.539 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.44 127.55 47.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.53 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.973 ' HB2' HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -148.78 167.68 24.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.106 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.4 ttt-85 -79.81 -152.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.496 0.189 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' VAL . 21.4 t -93.81 -5.52 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.85 46.26 2.64 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.355 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -143.12 -33.62 0.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.67 HG21 HD12 ' A' ' 73' ' ' ILE . 1.2 mp -52.93 -41.25 39.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 1.1 tt0 -53.65 -36.14 61.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.182 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 p -83.17 -42.72 16.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.067 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -80.84 -4.26 54.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.608 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -77.28 47.58 0.57 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.518 0.199 . . . . 0.0 111.223 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.8 -29.98 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.362 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.7 40.21 0.68 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.24 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 67' ' ' MET . 48.1 t -84.69 131.04 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 5.0 m80 -94.84 -16.88 22.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.37 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.836 ' HB2' HG22 ' A' ' 24' ' ' ILE . 1.3 mp -158.32 147.49 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.297 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -135.82 145.61 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.294 0.568 . . . . 0.0 111.526 179.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.7 m -127.49 115.16 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 27' ' ' ALA . 4.3 m -138.89 146.78 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.719 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -102.71 62.24 0.83 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.11 135.52 22.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -68.04 70.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.967 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.99 -177.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.992 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -102.14 -22.18 14.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.073 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 48.19 49.02 18.12 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.177 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.4 p -131.57 -1.54 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.307 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 33.9 p90 -92.91 97.4 10.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.18 -115.8 4.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.348 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -160.77 26.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.695 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.712 HG12 HG21 ' A' ' 73' ' ' ILE . 8.0 tt -58.57 104.2 0.41 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.347 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.2 Cg_endo -66.36 81.17 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.565 2.177 . . . . 0.0 112.997 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 73' ' ' ILE . 3.2 pp -98.89 151.09 21.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.336 0.588 . . . . 0.0 112.213 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.03 147.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.974 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 144.11 30.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.116 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -112.33 20.49 21.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.59 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.591 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 24.4 tpp -54.4 -47.03 98.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.508 0.194 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.75 ' HG2' HD22 ' A' ' 103' ' ' LEU . 56.0 Cg_endo -71.87 -36.57 5.99 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.246 1.964 . . . . 0.0 112.967 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -36.19 81.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.905 0.384 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 91' ' ' GLY . 58.6 t -73.19 -21.99 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.342 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.06 -37.86 69.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.94 67.14 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.824 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.51 -35.58 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.92 18.18 40.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.695 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.0 pt -62.84 -42.87 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.833 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.72 -53.39 55.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.77 89.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.75 HD22 ' HG2' ' A' ' 93' ' ' PRO . 9.4 tp -62.32 -57.15 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.993 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' CD ' HD22 ' A' ' 45' ' ' LEU . 4.4 tp-100 -47.57 -44.56 26.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -50.2 74.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 -41.36 84.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' HD12 ' A' ' 110' ' ' ILE . 38.8 mm -64.14 -34.97 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 45' ' ' LEU . 21.9 mt -66.61 -43.94 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -43.2 99.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.332 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 107' ' ' ILE . 4.8 mt -61.62 -48.4 88.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.542 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.971 HD11 HD13 ' A' ' 51' ' ' ILE . 1.5 pp -62.04 -27.41 68.87 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.911 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -97.81 -2.17 41.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.597 0.237 . . . . 0.0 110.992 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.437 -1.202 . . . . 0.0 112.333 -179.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.92 0.391 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.86 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -54.58 42.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 111.094 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.2 120.89 40.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.12 -65.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.839 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -116.84 89.78 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 81.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 60.7 m80 -60.16 160.4 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -101.99 70.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.247 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' HD2' ' H ' ' A' ' 11' ' ' HIS . 2.2 t-160 61.58 159.33 0.05 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.747 0.308 . . . . 0.0 110.707 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.529 ' H ' ' HD2' ' A' ' 10' ' ' HIS . 34.8 m170 63.7 30.43 14.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 0.0 110.125 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 8' ' ' HIS . 0.6 OUTLIER -105.34 -179.28 3.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.935 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.58 100.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.66 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -145.57 -72.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.28 163.01 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -84.46 88.01 7.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.97 -56.63 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.48 45.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.32 -88.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -61.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HE3' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -157.98 -75.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HG2' ' CD2' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -125.7 157.39 37.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 111.384 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.559 ' HD3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -138.51 125.6 21.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.016 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.0 mt -110.46 149.82 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.263 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.039 HD12 HG23 ' A' ' 63' ' ' ILE . 1.8 mt -118.62 144.78 25.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.525 0.202 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 56' ' ' ILE . 2.1 m -126.23 115.58 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.687 0.279 . . . . 0.0 110.549 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.097 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -109.63 123.51 49.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.166 0.507 . . . . 0.0 111.928 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.41 -64.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.087 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.3 137.65 8.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.285 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' ALA . . . 88.02 -53.87 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.69 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . 67.75 80.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 32' ' ' VAL . 26.8 m -124.64 75.31 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.861 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 37' ' ' MET . . . 75.99 -28.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.517 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.1 p -66.84 -44.17 81.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.728 0.299 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.6 p -68.41 -53.57 22.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.685 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 2.3 m -55.63 -32.35 63.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.724 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -74.2 -52.43 12.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.392 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -58.68 -58.19 9.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -49.18 -58.44 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.4 mt-10 -56.78 -43.57 80.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -63.88 -53.95 42.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.899 0.38 . . . . 0.0 111.29 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 38' ' ' ALA . 13.1 mm -62.19 -38.19 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -61.32 -57.52 12.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.839 0.352 . . . . 0.0 110.823 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 6.5 pt-20 -55.03 -36.36 65.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.977 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 41' ' ' GLU . 4.6 mp -63.27 -56.51 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 87.8 m -50.14 -38.99 41.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.061 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.12 -26.82 61.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -55.67 -45.84 77.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.382 . . . . 0.0 110.846 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -113.37 10.31 18.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.406 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.616 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 36.9 t-20 52.36 58.26 5.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.697 0.285 . . . . 0.0 110.715 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 mt -93.08 101.35 5.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -53.83 103.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.35 2.033 . . . . 0.0 112.24 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 54' ' ' GLU . 13.4 p -156.55 159.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.62 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 1.6 mt-10 -123.09 116.48 23.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -87.22 114.93 24.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.912 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 25' ' ' ILE . 2.7 tt -110.06 149.94 12.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.73 139.76 51.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.824 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 59.1 m -152.65 168.55 25.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.879 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -77.79 -167.87 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.0 0.429 . . . . 0.0 111.227 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 59' ' ' ARG . 11.8 p -70.01 -22.0 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.196 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -128.95 65.85 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 0.0 111.439 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.824 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 15.0 mm-40 -141.26 -37.18 0.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.039 HG23 HD12 ' A' ' 25' ' ' ILE . 23.3 mt -54.09 -40.9 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -61.07 -45.37 95.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -41.83 63.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' A' ' 62' ' ' GLU . 82.7 m-85 -87.21 12.62 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.324 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -73.73 46.94 0.23 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.644 0.259 . . . . 0.0 111.258 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -47.31 25.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.024 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.04 59.85 0.41 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 25' ' ' ILE . 27.6 m -96.91 129.13 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 1.4 t60 -94.23 -25.49 17.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -152.04 147.06 26.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.276 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.863 HG21 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -128.05 139.03 53.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 1.1 m -124.45 104.2 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.097 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.46 143.87 50.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.689 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 p -102.32 66.68 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.769 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.15 142.5 25.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.074 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 66.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -70.88 -176.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 26.6 p30 -102.01 -15.91 16.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.688 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 3.4 ppt_? 35.66 43.91 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 111.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.2 t -128.72 2.0 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.358 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 24.7 p90 -97.86 101.74 13.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.02 -130.53 9.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.408 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -142.5 22.45 2.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 110.258 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.728 HG12 HG13 ' A' ' 73' ' ' ILE . 16.9 tt -54.22 101.75 0.28 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.49 73.36 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.64 HD23 HG23 ' A' ' 86' ' ' ILE . 3.1 pp -100.67 156.62 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 151.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' THR . 29.6 m170 -82.87 147.62 28.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.365 . . . . 0.0 110.764 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -116.22 31.89 5.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.185 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -62.87 -52.87 60.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 92' ' ' MET . 73.1 Cg_endo -75.06 -29.58 7.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.235 1.957 . . . . 0.0 112.652 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -37.42 84.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.012 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 91' ' ' GLY . 88.9 t -75.16 -23.25 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -33.16 68.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.28 -4.62 86.05 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.809 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.3 p -116.92 -21.93 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.785 0.326 . . . . 0.0 111.191 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.22 7.91 64.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.963 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.422 HD13 ' OE1' ' A' ' 41' ' ' GLU . 57.8 mt -71.73 -48.87 49.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 117.109 0.455 . . . . 0.0 111.268 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.83 -49.92 61.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.765 0.317 . . . . 0.0 111.357 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.1 81.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.208 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -68.04 -34.64 76.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.752 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -60.16 -56.09 25.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 111.001 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -36.44 57.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.657 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -81.05 -40.89 23.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 104' ' ' GLN . 1.1 tt -62.91 -37.66 79.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 81.3 mt -72.93 -47.25 47.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.759 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.4 m -53.09 -34.52 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.6 mm -85.85 -41.78 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.281 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -34.49 75.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 7.4 mm-40 -68.11 -39.46 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.567 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.842 0.353 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.94 56.98 0.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.475 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.73 178.24 5.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.796 0.331 . . . . 0.0 111.014 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 p -168.77 -41.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.27 163.2 31.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -165.24 155.4 13.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.8 78.29 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -121.93 135.64 54.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -57.94 167.78 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.85 -69.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.92 76.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -112.83 -10.12 13.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.23 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.29 140.66 16.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.03 128.65 36.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.74 171.01 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -143.29 -25.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.362 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -87.55 -59.97 2.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.84 0.353 . . . . 0.0 111.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 73.38 45.63 0.25 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.85 73.81 0.25 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.613 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 p -156.18 101.65 2.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -63.61 -105.29 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.467 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.737 ' HG3' HG13 ' A' ' 53' ' ' VAL . 2.0 ptp180 -107.3 142.75 36.58 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.686 0.279 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -128.61 116.0 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.838 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -101.09 155.02 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -121.07 144.7 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 0.0 111.074 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -125.86 114.79 40.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -123.38 125.1 44.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.277 0.56 . . . . 0.0 111.126 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -126.65 176.29 7.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.22 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.24 73.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.332 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.03 -115.23 0.57 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' A' ' 34' ' ' THR . . . -70.86 126.54 29.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.33 -45.12 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' MET . . . -54.46 -25.37 24.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.603 HG23 HG13 ' A' ' 95' ' ' VAL . 5.3 m -68.89 -56.29 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.059 0.457 . . . . 0.0 111.158 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -42.32 70.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 33' ' ' ALA . 8.7 t -76.78 -31.01 56.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.673 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 10.5 tpp -51.51 -54.08 30.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.863 0.364 . . . . 0.0 110.49 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.66 -56.02 18.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.228 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.91 -58.89 2.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.767 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -59.02 -30.59 68.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.1 -51.46 17.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 94' ' ' PHE . 11.1 mm -61.86 -31.15 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -57.7 6.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.329 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 45' ' ' LEU . 2.1 pt-20 -52.57 -33.75 47.29 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.969 0.414 . . . . 0.0 110.665 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.748 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.8 tt -69.51 -56.82 6.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.896 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -40.87 9.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.309 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -71.16 -42.51 69.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -50.17 -42.91 51.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.294 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' HD11 ' A' ' 51' ' ' ILE . 14.9 t-160 -98.23 0.09 45.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.513 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 58.48 56.78 4.15 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.429 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 49' ' ' HIS . 2.1 mt -111.69 99.16 43.92 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.923 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.9 108.43 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.268 1.979 . . . . 0.0 112.485 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.737 HG13 ' HG3' ' A' ' 22' ' ' ARG . 48.4 t -149.73 160.87 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.548 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.1 mm-40 -127.66 120.09 27.3 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HB ' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -102.73 122.3 44.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.808 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.2 tt -103.3 150.15 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.759 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -123.67 128.05 49.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -146.37 167.84 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.476 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -162.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.294 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.53 -17.15 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.387 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.8 63.89 1.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 110.657 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.33 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 25' ' ' ILE . 1.1 pp -56.03 -32.53 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.279 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.86 -40.87 97.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.982 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 p -77.48 -37.48 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -82.06 12.04 4.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.328 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 70' ' ' VAL . 3.3 mmm -75.1 47.01 0.34 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -40.99 94.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.819 0.343 . . . . 0.0 111.266 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.8 70.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.465 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' A' ' 25' ' ' ILE . 46.4 t -104.28 130.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 111.529 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.537 ' CG ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m80 -95.72 -18.05 20.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.407 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -151.93 146.72 25.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.441 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.921 HG22 HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -127.63 132.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.963 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.4 104.28 7.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.698 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 27' ' ' ALA . 2.1 m -142.35 157.5 44.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.87 70.06 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.671 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.26 175.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -117.13 80.21 1.45 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.994 0.426 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 t -99.06 24.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' ILE . 34.9 t0 -78.04 -1.11 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -99.83 32.24 2.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.637 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 t -142.9 -42.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.098 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 79' ' ' VAL . 15.0 m-85 -81.48 -37.46 27.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.322 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.53 -39.79 2.68 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.74 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -158.68 24.19 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.69 0.281 . . . . 0.0 111.171 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.897 HG12 HG13 ' A' ' 73' ' ' ILE . 14.4 tt -49.58 106.98 0.69 Allowed Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 73' ' ' ILE . 30.9 Cg_endo -64.8 62.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.441 2.094 . . . . 0.0 112.002 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 75' ' ' THR . 4.4 tt -98.26 161.02 13.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.903 0.383 . . . . 0.0 111.207 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.471 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 7.1 p -144.14 154.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.066 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -82.9 146.89 28.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.652 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -113.88 28.96 8.08 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.866 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -60.83 -46.26 96.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 103' ' ' LEU . 73.5 Cg_endo -75.36 -28.6 8.46 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.293 1.995 . . . . 0.0 113.131 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -64.73 -37.89 89.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.995 0.426 . . . . 0.0 110.541 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG13 HG23 ' A' ' 34' ' ' THR . 13.6 t -77.45 -16.94 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.36 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 m -56.82 -40.63 76.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.526 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.627 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 81.85 -5.81 68.84 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.929 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.13 -34.53 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.47 15.11 59.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.627 HD11 ' HA2' ' A' ' 97' ' ' GLY . 17.2 mt -60.74 -40.87 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.403 . . . . 0.0 110.792 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -48.3 71.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.094 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -48.08 56.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -58.66 -56.2 25.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.38 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 107' ' ' ILE . 2.1 tt0 -49.42 -48.77 47.06 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.079 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -55.85 -42.03 75.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.128 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -43.74 50.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.594 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 104' ' ' GLN . 2.5 pp -63.74 -30.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.769 0.318 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.748 HD21 ' CD2' ' A' ' 45' ' ' LEU . 10.9 mt -73.38 -48.14 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 112' ' ' GLN . 0.6 OUTLIER -56.07 -37.45 69.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.063 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.7 mt -70.38 -45.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.178 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 95.4 mt -69.31 -28.54 66.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.48 -11.46 34.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.165 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.489 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.711 0.291 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.39 -33.91 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.185 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.09 74.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.969 0.414 . . . . 0.0 111.184 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.0 p -136.78 -25.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -111.69 102.97 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.782 0.325 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 60.92 97.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.231 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.93 -167.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.524 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.97 75.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.756 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -92.09 174.08 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -167.9 -179.51 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.698 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.39 103.82 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.914 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -95.84 20.55 9.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.307 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' HIS . 11.6 pt-20 39.24 -166.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.899 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.98 44.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.93 0.395 . . . . 0.0 110.785 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.82 172.86 0.15 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.59 23.26 9.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.924 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -164.12 145.39 8.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.818 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -148.76 56.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.15 132.53 9.65 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.343 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 16.7 t -61.31 -61.1 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 4.8 mttt -171.66 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.607 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -111.58 149.71 31.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.145 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -133.1 109.55 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 56' ' ' ILE . 15.9 mt -95.1 153.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.784 ' CD1' HG23 ' A' ' 56' ' ' ILE . 4.8 tp -128.73 144.49 37.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.414 . . . . 0.0 110.354 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.6 p -127.38 114.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.591 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -107.69 123.48 48.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.416 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -178.62 172.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.859 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.29 105.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.211 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -127.91 -63.3 0.13 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.829 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 63.29 14.13 7.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.649 0.261 . . . . 0.0 111.161 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -128.09 -69.37 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.21 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' H ' HG23 ' A' ' 32' ' ' VAL . . . -151.19 53.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 111.219 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA3' ' A' ' 30' ' ' GLY . 32.3 p -145.09 -36.05 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.254 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.87 -57.02 4.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 110.685 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -63.16 -46.8 85.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.237 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 mtp -51.3 -54.14 28.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -53.14 57.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.27 -55.21 30.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -59.38 -36.63 76.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.77 0.319 . . . . 0.0 110.673 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 5.3 mm-40 -69.88 -52.42 24.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 55' ' ' LEU . 7.7 mt -66.48 -41.51 88.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -60.09 -58.4 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -55.08 -29.74 58.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -65.73 -62.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.8 p -48.24 -36.32 13.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.363 . . . . 0.0 110.811 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -49.15 20.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.188 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -45.3 75.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.421 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.53 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -81.25 -12.53 59.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.296 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 69.33 43.99 1.0 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.783 0.325 . . . . 0.0 111.265 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 49' ' ' HIS . 6.7 mt -109.18 100.18 39.54 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.124 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.25 110.09 0.44 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.073 1.849 . . . . 0.0 111.878 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 54' ' ' GLU . 43.3 t -154.11 159.33 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.664 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -121.82 115.93 23.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.936 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 42' ' ' ILE . 27.5 tp -90.66 115.93 28.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 tt -103.64 150.84 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 26' ' ' VAL . 7.0 mt-30 -125.99 137.0 53.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.601 0.238 . . . . 0.0 110.546 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' HD11 ' A' ' 25' ' ' ILE . 1.2 m -149.45 168.75 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 111.405 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -167.11 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.042 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.25 -21.93 19.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.82 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.48 78.97 1.71 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -165.07 -32.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.064 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' A' ' 25' ' ' ILE . 22.5 pt -58.89 -37.92 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.837 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -55.95 -41.04 74.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.998 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 -39.81 33.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.63 13.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.693 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -67.9 46.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 111.479 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.49 -44.65 85.09 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.746 0.307 . . . . 0.0 111.039 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.88 60.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.584 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 67' ' ' MET . 21.1 m -88.33 130.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.985 0.421 . . . . 0.0 110.853 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.8 t-80 -91.18 -19.83 22.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.228 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.64 ' C ' HD13 ' A' ' 73' ' ' ILE . 1.2 mp -149.33 145.82 27.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -122.39 134.84 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 62.6 m -125.33 104.12 8.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.92 0.39 . . . . 0.0 110.787 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.8 m -142.32 152.02 42.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -91.17 75.27 6.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 76' ' ' THR . . . 178.17 -178.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.019 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.31 62.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.628 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.82 23.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.362 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.435 ' HB2' HD21 ' A' ' 88' ' ' LEU . 32.7 t0 -88.43 -0.3 57.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.276 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.79 -4.62 46.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.353 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -123.62 -24.81 4.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.219 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.822 ' CD2' HD13 ' A' ' 86' ' ' ILE . 8.3 m-85 -76.14 -45.72 32.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.259 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.01 0.52 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.581 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 6.4 t0 -144.33 18.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.991 HG13 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -50.64 104.52 0.43 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 38.5 Cg_endo -65.45 66.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.779 2.319 . . . . 0.0 112.956 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -98.31 161.59 13.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.153 0.501 . . . . 0.0 111.897 -179.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.17 150.41 24.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -85.43 147.24 26.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.18 29.58 9.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.287 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.527 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 tpt -55.91 -51.13 82.95 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.403 0.144 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 92' ' ' MET . 81.9 Cg_endo -76.87 -15.55 16.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.961 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -37.55 31.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.332 . . . . 0.0 110.578 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.37 -21.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -53.55 -25.59 17.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.683 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.764 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 74.83 1.83 63.34 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.178 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.01 -23.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.908 0.354 . . . . 0.0 111.853 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -97.0 10.59 65.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.844 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.764 HD11 ' HA2' ' A' ' 97' ' ' GLY . 1.9 mt -70.56 -48.6 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.414 . . . . 0.0 110.564 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -52.01 -57.21 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.159 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.47 -46.83 88.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.174 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 5.1 tp -62.52 -39.78 94.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.726 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.2 tp60 -58.69 -56.96 15.39 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -54.21 -43.4 70.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.693 ' O ' HG13 ' A' ' 110' ' ' ILE . 3.7 tttm -69.12 -43.66 73.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 104' ' ' GLN . 7.9 tp -68.14 -34.85 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' A' ' 45' ' ' LEU . 1.1 mt -71.27 -42.12 69.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 49.8 m -62.6 -36.39 82.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 106' ' ' LYS . 8.3 mt -86.39 -41.51 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.515 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 7.3 mt -57.9 -35.19 70.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 110.638 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.57 -31.92 36.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.32 -1.267 . . . . 0.0 112.438 179.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.92 108.71 0.27 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.564 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -63.96 128.74 37.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 0.0 111.02 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -132.31 -67.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.45 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -28.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.303 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -164.67 97.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.84 -178.74 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.01 154.01 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.57 146.15 40.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.065 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -170.35 1.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -158.05 53.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -104.31 -179.89 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.41 151.76 46.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -123.59 151.78 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.814 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -88.03 92.63 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.991 0.424 . . . . 0.0 110.966 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -78.68 179.59 7.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.979 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -141.93 -77.8 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -177.35 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 0.0 110.718 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 52' ' ' PRO . . . 177.99 -64.1 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.4 73.52 0.36 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.634 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -149.66 -88.54 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.26 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 3.2 ptp85 -113.86 148.74 36.17 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.829 ' HB3' HD11 ' A' ' 56' ' ' ILE . 21.9 mtmt -140.06 133.83 30.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.418 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.4 mt -104.74 150.17 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.911 HG21 HG12 ' A' ' 63' ' ' ILE . 2.3 mp -118.03 144.78 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 26' ' ' VAL . 14.8 p -129.25 118.4 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.597 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.67 124.45 52.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.5 m 48.58 -166.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.75 9.52 46.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.422 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.67 88.07 1.93 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.283 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HA ' ' HB2' ' A' ' 35' ' ' SER . . . -116.02 42.22 2.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.643 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.45 -40.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.635 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.18 -36.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.29 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.658 HG21 HG13 ' A' ' 95' ' ' VAL . 7.8 m -85.09 -20.22 30.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.176 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.87 ' HB2' ' HA ' ' A' ' 31' ' ' ALA . 1.8 t -49.74 -45.02 48.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.158 0.504 . . . . 0.0 111.292 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -32.75 74.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.805 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 30.8 mmt -58.92 -54.2 49.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.225 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -66.68 -58.64 4.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.07 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -43.18 -59.65 1.98 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.457 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.99 -35.19 79.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.074 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 37' ' ' MET . 1.9 mm-40 -65.84 -51.92 54.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 55' ' ' LEU . 24.0 mm -66.29 -36.56 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.918 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -66.96 -56.19 11.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.002 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -53.89 -33.95 58.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.795 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 108' ' ' LEU . 8.2 tt -65.7 -59.19 4.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.009 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.6 p -49.9 -37.27 30.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.84 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -35.29 45.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.373 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.4 -45.19 65.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 51' ' ' ILE . 1.6 m-70 -104.16 6.52 35.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.197 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 m-80 57.78 44.75 19.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.742 0.306 . . . . 0.0 110.864 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 53' ' ' VAL . 39.6 mt -93.82 105.99 19.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 50.1 Cg_exo -55.25 97.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.587 2.191 . . . . 0.0 112.652 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 51' ' ' ILE . 11.5 t -146.69 149.26 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -124.87 123.53 40.14 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.976 0.417 . . . . 0.0 110.353 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 42' ' ' ILE . 1.2 tp -94.99 119.99 34.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.311 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -103.79 151.1 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.79 126.76 45.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.477 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.508 ' HB2' ' OH ' ' A' ' 66' ' ' TYR . 7.2 m -162.17 167.52 24.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.449 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.568 ' O ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -64.52 -161.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.613 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 75' ' ' THR . 13.8 t -94.35 -4.65 10.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.432 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.42 63.08 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.053 0.454 . . . . 0.0 110.943 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -162.36 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.911 HG12 HG21 ' A' ' 25' ' ' ILE . 1.4 mp -52.33 -34.73 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.005 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HA ' ' HG2' ' A' ' 67' ' ' MET . 0.3 OUTLIER -71.99 -30.57 65.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 -179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.07 -44.04 20.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.301 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.624 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.7 p90 -92.37 12.88 21.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.685 ' HB3' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.5 51.06 0.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -33.5 68.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.05 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.86 65.64 0.19 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.627 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 25' ' ' ILE . 11.0 p -87.49 130.61 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 111.223 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -93.71 -24.81 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.7 mp -156.64 145.91 20.48 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.01 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -132.95 144.34 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 111.317 179.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 24.9 m -127.48 105.09 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -124.82 146.59 49.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.676 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.81 51.12 2.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 78' ' ' ARG . . . -105.44 -106.2 0.31 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 14.4 mmm-85 -157.15 40.3 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.52 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 80' ' ' ASP . 3.2 t -67.74 168.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.54 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.0 t0 -99.09 -22.32 15.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.693 0.282 . . . . 0.0 111.367 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HG3' HD11 ' A' ' 88' ' ' LEU . 6.0 ttt-85 57.42 37.32 27.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.942 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.58 15.92 7.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 27.7 p90 -110.07 109.11 19.54 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.0 -115.82 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.44 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 11.5 p-10 -160.28 27.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 86' ' ' ILE . 2.3 tt -52.86 105.41 0.52 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.082 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 39.9 Cg_endo -67.09 69.59 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.294 1.996 . . . . 0.0 112.416 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.8 HD11 ' HG3' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -98.47 161.4 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.139 0.495 . . . . 0.0 111.43 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 90' ' ' HIS . 30.9 t -147.89 158.55 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.053 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -82.61 146.79 28.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -102.88 10.6 55.78 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.586 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -54.59 -43.79 98.46 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HB2' HD13 ' A' ' 103' ' ' LEU . 71.4 Cg_endo -74.77 -14.74 21.64 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.018 1.812 . . . . 0.0 112.721 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -86.32 -37.1 18.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.747 0.308 . . . . 0.0 110.99 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.658 HG13 HG21 ' A' ' 34' ' ' THR . 46.1 t -71.52 -22.88 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.56 -35.26 29.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.514 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.623 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 72.9 7.23 69.74 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.428 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.0 -30.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.91 13.09 67.77 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.191 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.623 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.3 mt -72.65 -38.11 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.795 0.298 . . . . 0.0 111.448 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.93 -48.81 21.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 111.024 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 106' ' ' LYS . . . -78.56 -43.99 25.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 93' ' ' PRO . 2.8 tp -58.22 -56.34 23.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.568 ' HA ' HG12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -51.94 -49.77 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.097 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 109' ' ' THR . 1.9 m-80 -58.22 -51.88 67.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.067 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 102' ' ' ALA . 16.3 mttt -60.96 -44.21 97.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.645 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 104' ' ' GLN . 2.0 pt -67.17 -33.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.636 0.255 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.872 HD21 HD21 ' A' ' 45' ' ' LEU . 13.8 mt -75.22 -42.72 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 110.679 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 105' ' ' ASN . 22.5 p -55.16 -39.91 70.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.775 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.3 mt -73.85 -37.98 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.7 mt -66.91 -28.88 68.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.15 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -28.17 25.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.002 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.514 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.52 -10.0 0.42 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.196 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 3.1 m -136.94 158.0 45.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.954 0.377 . . . . 0.0 110.816 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 68.02 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 3' ' ' SER . 1.5 p-80 -129.78 44.35 2.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 -79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 18.36 8.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -147.8 170.64 17.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -123.71 169.01 11.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.14 -178.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.71 -67.22 0.21 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.22 76.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -46.56 80.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.705 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 -166.24 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.2 tp 58.92 55.27 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.81 -8.8 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.724 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 17' ' ' PHE . 1.9 m-85 -110.59 30.1 7.12 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 58.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.774 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.51 175.34 53.2 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.431 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.0 p -114.84 -177.48 3.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.93 0.395 . . . . 0.0 110.561 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -147.75 -76.87 0.17 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.661 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.09 148.99 27.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.922 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.759 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -134.25 113.58 12.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.579 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.2 mt -97.82 145.28 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.678 HG12 ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -129.96 145.54 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' H ' HD12 ' A' ' 25' ' ' ILE . 16.5 m -125.17 126.78 71.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.591 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -111.47 123.99 51.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.04 0.447 . . . . 0.0 111.708 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 m -70.59 126.6 30.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.318 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.63 -12.94 0.12 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.976 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.27 -76.94 0.77 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.428 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.94 163.79 13.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.0 111.051 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.33 13.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.3 0.09 8.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.361 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -97.47 35.25 1.67 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -75.74 -58.0 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -36.43 73.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.615 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -60.55 -54.55 44.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.04 79.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 43' ' ' LYS . . . -56.99 -53.86 53.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.946 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -66.63 -43.19 85.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.722 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -56.96 -54.99 40.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 110.893 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 55' ' ' LEU . 9.4 mt -68.76 -38.44 78.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.115 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -59.67 -55.84 29.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -58.69 -33.2 69.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' SER . 1.9 tp -64.64 -58.06 7.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.383 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.422 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 39.3 m -53.37 -38.98 63.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -29.47 52.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.867 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -55.79 -45.09 78.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.908 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -99.67 14.09 31.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.32 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 10.2 m-20 53.49 49.34 19.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.865 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 mt -97.3 102.52 12.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.0 Cg_exo -53.79 107.9 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.255 1.97 . . . . 0.0 111.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 51' ' ' ILE . 8.6 p -159.77 161.06 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.765 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 53' ' ' VAL . 1.6 mt-10 -122.96 118.71 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.66 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 24' ' ' ILE . 6.2 tp -86.34 113.71 22.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.322 0.582 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.759 HD13 ' HD3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -104.6 151.78 6.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.851 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -125.76 130.76 52.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -153.55 168.69 25.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.713 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -164.19 0.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.13 0.49 . . . . 0.0 111.395 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.72 -13.1 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -136.29 69.94 1.42 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.932 0.396 . . . . 0.0 110.833 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -35.06 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.726 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 16.2 pt -57.47 -26.76 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.761 0.315 . . . . 0.0 111.603 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.52 -37.39 71.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.12 -42.83 25.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.428 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE2' ' HA ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -90.88 13.12 17.34 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -68.97 53.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.367 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.65 -43.66 75.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.99 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.14 77.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.694 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' ILE . 2.0 t -105.03 127.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 110.959 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 81.6 t60 -84.91 -24.61 28.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 73' ' ' ILE . 18.8 mt -157.21 147.09 20.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.775 HD13 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -124.63 139.75 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.947 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 44.1 t -125.98 104.47 8.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.846 0.355 . . . . 0.0 110.412 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -142.06 148.58 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -88.13 73.28 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.352 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.49 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.721 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' HA ' HD11 ' A' ' 88' ' ' LEU . 9.6 ptm180 45.75 41.28 7.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.885 0.374 . . . . 0.0 111.229 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 26.2 m -66.35 66.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.709 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' PHE . 15.3 t0 -100.3 -21.34 15.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -55.6 -35.04 65.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.956 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.15 4.46 16.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.371 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER -92.8 -49.79 5.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.899 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.2 -78.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.29 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -154.61 19.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.704 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.699 ' CG1' HG13 ' A' ' 73' ' ' ILE . 1.2 tt -50.53 105.64 0.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.62 68.29 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.162 2.575 . . . . 0.0 113.531 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -104.49 162.39 13.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 111.814 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.99 155.79 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.032 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -83.65 148.23 27.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -119.21 23.21 8.68 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.331 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.538 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -48.06 -50.36 55.09 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 111.013 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.582 ' CG ' HD13 ' A' ' 103' ' ' LEU . 61.0 Cg_endo -74.33 -27.06 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.51 2.14 . . . . 0.0 112.785 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.77 -37.1 81.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.376 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 91' ' ' GLY . 16.7 t -76.54 -22.18 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.194 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -39.36 94.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.787 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.12 -6.19 72.74 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.664 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.32 -29.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.262 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.13 85.14 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 94' ' ' PHE . 28.0 mt -64.63 -38.63 83.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.943 0.372 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -47.85 -54.8 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.94 62.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tp -59.41 -39.51 83.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.335 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -46.55 -50.5 17.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.34 -49.28 70.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -47.58 85.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 103' ' ' LEU . 24.5 mm -57.03 -47.68 83.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.726 0.298 . . . . 0.0 110.971 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HA ' HD12 ' A' ' 111' ' ' LEU . 12.4 mt -55.01 -49.5 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.829 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.49 -43.94 55.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.15 -42.82 91.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.971 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -66.8 -32.67 74.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.8 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 5.4 mt-30 -66.57 -55.89 13.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.396 -1.224 . . . . 0.0 112.473 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.718 0.294 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.46 0.81 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.32 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -71.38 124.68 25.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.636 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.16 85.59 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -67.97 -168.78 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.039 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.455 ' CD2' ' H ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -117.9 38.98 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -62.37 176.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -94.43 -70.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.006 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 10' ' ' HIS . 0.3 OUTLIER 60.26 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.427 ' CD2' ' HB3' ' A' ' 9' ' ' HIS . 9.9 m-70 -111.98 178.26 4.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -56.78 -42.37 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.988 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 64.0 177.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.91 67.64 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.13 -68.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 15' ' ' LEU . 17.0 mt 62.08 134.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 122.73 18.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -176.05 156.54 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -113.35 -58.46 2.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.49 -61.96 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -176.32 140.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 110.954 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 7.5 tptt -131.53 -73.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.889 ' HD3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -119.48 148.85 42.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 70' ' ' VAL . 5.1 mtmm -125.93 105.05 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.816 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.2 mt -102.33 150.45 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.025 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.638 HG13 HG11 ' A' ' 70' ' ' VAL . 2.6 mt -123.23 145.02 30.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.308 . . . . 0.0 110.572 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.27 116.8 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -114.74 123.32 48.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 112.038 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.8 m -147.92 178.49 8.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.472 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.86 90.75 1.18 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.786 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.33 -132.04 32.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.745 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.98 104.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.72 -69.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.86 49.23 1.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.401 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 95' ' ' VAL . 99.1 m -158.67 -38.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 m -65.47 -46.67 78.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.355 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -72.72 -33.61 66.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -54.51 45.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.372 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -61.55 -55.8 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.151 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -43.58 -53.93 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.503 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 3.9 mm-40 -60.42 -37.6 81.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 4.3 mm-40 -68.42 -50.18 54.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.189 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.532 HD11 ' CZ ' ' A' ' 94' ' ' PHE . 3.1 mm -65.32 -34.93 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -73.51 -52.65 12.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 9.5 pt-20 -51.78 -34.78 41.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.959 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -74.75 -44.75 48.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.95 -43.35 63.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -76.6 -28.69 56.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.002 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -45.38 74.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.575 ' HB2' HD11 ' A' ' 51' ' ' ILE . 1.3 m-70 -97.68 8.06 45.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.499 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 56.95 58.11 4.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 49' ' ' HIS . 2.9 mt -113.94 102.45 54.83 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.658 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 52.6 Cg_exo -52.03 112.07 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.301 2.0 . . . . 0.0 112.313 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.889 HG22 ' HD3' ' A' ' 22' ' ' ARG . 21.9 t -150.95 161.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.96 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' N ' HG12 ' A' ' 53' ' ' VAL . 15.8 mt-10 -123.52 114.27 19.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.367 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -87.16 110.49 20.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.155 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 24' ' ' ILE . 9.4 tt -114.95 149.5 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 149.31 29.35 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 60.2 m -157.92 168.42 27.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.718 ' H ' ' HG3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -87.68 -166.65 1.64 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.359 . . . . 0.0 110.579 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HB ' ' HD3' ' A' ' 78' ' ' ARG . 16.4 m -73.8 -15.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.06 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.24 63.29 1.56 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.009 0.433 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.718 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 7.8 mm-40 -137.39 -37.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 73' ' ' ILE . 3.5 mp -54.11 -37.46 35.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' OE2' ' CD2' ' A' ' 83' ' ' PHE . 5.6 mt-10 -65.32 -40.73 94.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -78.73 -42.04 29.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -88.5 13.99 10.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.651 ' CG ' HD11 ' A' ' 86' ' ' ILE . 1.1 tmm? -65.93 47.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -48.01 75.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.564 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.47 57.04 0.2 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.706 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.646 ' HA ' ' HB2' ' A' ' 23' ' ' LYS . 3.0 m -85.96 130.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 111.802 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.6 t60 -86.3 -27.27 24.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 7.4 mt -152.05 152.08 31.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 111.049 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.98 HG21 HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -138.95 146.34 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 112.272 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.2 m -127.17 105.18 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.931 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' ALA . 45.9 p -129.08 140.8 51.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.364 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.59 72.67 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.868 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.64 95.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.471 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.542 ' HD3' ' HB ' ' A' ' 60' ' ' VAL . 6.5 tpm_? -120.71 -44.47 2.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.45 -172.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.03 -24.35 13.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.797 0.332 . . . . 0.0 111.219 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -91.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 m -160.4 105.73 1.49 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.006 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 86' ' ' ILE . 32.6 p90 -71.89 42.91 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.685 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.77 -107.46 0.52 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.739 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.781 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -138.4 22.43 2.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.182 0.491 . . . . 0.0 110.23 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.651 HD11 ' CG ' ' A' ' 67' ' ' MET . 4.4 mm -67.59 99.6 0.21 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.807 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.781 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 59.3 Cg_endo -69.04 84.36 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.409 2.073 . . . . 0.0 111.818 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -109.88 157.91 18.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 90' ' ' HIS . 10.8 t -139.75 155.74 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.064 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' N ' HG12 ' A' ' 89' ' ' VAL . 15.6 m80 -84.53 151.64 24.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.769 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.01 31.64 3.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.717 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 4.4 ttm -51.3 -49.11 83.78 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.935 -0.156 . . . . 0.0 111.381 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.5 Cg_endo -74.12 -26.54 12.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.271 1.981 . . . . 0.0 112.508 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -63.93 -36.13 82.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.029 0.443 . . . . 0.0 110.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 34' ' ' THR . 48.6 t -72.95 -22.09 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.181 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -56.02 -35.29 66.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.702 0.287 . . . . 0.0 111.423 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.655 ' H ' HD11 ' A' ' 100' ' ' ILE . . . 74.12 -0.79 51.6 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.94 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.3 -42.38 8.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.258 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.72 28.85 14.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.73 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.655 HD11 ' H ' ' A' ' 97' ' ' GLY . 12.1 mm -66.56 -46.41 86.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.925 0.393 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.81 -47.59 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.32 63.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' CD2' ' CD2' ' A' ' 94' ' ' PHE . 66.2 tp -59.34 -53.39 58.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.557 ' NE2' HD13 ' A' ' 45' ' ' LEU . 4.2 tt0 -48.65 -47.49 40.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.936 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.721 ' HA ' HD21 ' A' ' 108' ' ' LEU . 63.5 t30 -50.39 -35.29 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.235 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -75.01 -40.65 60.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.301 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.13 -50.31 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.028 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.7 OUTLIER -64.73 -39.75 94.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.23 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.651 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 85.2 m -59.3 -41.21 88.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 111.106 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 106' ' ' LYS . 22.3 mm -66.71 -48.54 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.346 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 108' ' ' LEU . 3.1 pp -69.59 -19.91 63.65 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -92.52 -22.39 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.823 0.344 . . . . 0.0 110.879 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.49 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.789 0.328 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.05 138.17 9.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.29 134.14 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.324 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -108.63 -68.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 42.4 m170 59.06 80.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 6.3 m170 -168.09 116.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.64 38.6 1.68 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.22 140.39 49.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -175.22 -27.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.3 176.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.987 0.422 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -108.02 -178.03 3.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.806 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.78 113.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.774 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 63.38 47.48 3.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.527 ' HA ' HE22 ' A' ' 18' ' ' GLN . 0.2 OUTLIER 61.92 146.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -138.24 -100.53 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 15' ' ' LEU . 61.5 m-85 -163.72 82.17 0.44 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.67 0.272 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 43.5 m-85 67.71 71.74 0.33 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.186 0.517 . . . . 0.0 110.881 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.527 HE22 ' HA ' ' A' ' 14' ' ' ASN . 2.0 pt20 -105.69 -9.87 17.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.17 123.96 0.7 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.037 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.12 115.47 15.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.746 0.307 . . . . 0.0 110.73 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -137.35 -81.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.83 146.48 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 110.584 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' NZ ' ' HG3' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -130.88 118.16 20.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.794 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mt -104.56 155.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.277 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 56' ' ' ILE . 1.2 mm -123.53 144.91 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.808 0.337 . . . . 0.0 110.813 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 55' ' ' LEU . 19.2 t -127.36 119.91 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.927 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -116.37 123.11 46.79 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.901 0.382 . . . . 0.0 111.801 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -73.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.81 66.87 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.35 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.612 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.31 164.54 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.327 . . . . 0.0 111.155 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -73.81 -9.24 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.384 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.11 25.08 3.0 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.184 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.0 m -142.58 -63.73 0.42 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -55.57 -51.25 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.779 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -42.86 95.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -52.34 -54.36 32.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.59 -54.31 37.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.51 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.34 -57.13 4.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.463 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 6.3 tt0 -59.08 -38.2 78.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.85 -52.65 48.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.0 mm -63.16 -33.83 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.098 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -58.58 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 9.0 pt-20 -53.32 -35.83 60.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.018 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 49' ' ' HIS . 1.5 mm? -66.6 -49.79 65.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 97.7 m -54.71 -42.76 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.013 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.01 -46.55 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 m -53.2 -43.94 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 45' ' ' LEU . 33.7 m80 -86.8 -9.7 55.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.512 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 26.2 m120 68.69 46.83 0.9 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.425 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.87 89.48 7.97 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.244 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.4 Cg_exo -50.39 119.04 4.55 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.353 2.035 . . . . 0.0 112.496 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 22' ' ' ARG . 16.7 m -160.12 168.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG3' ' NZ ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -123.04 114.45 20.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.902 0.382 . . . . 0.0 110.919 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 5.6 tt -92.29 110.94 22.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.062 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.98 HG23 HG23 ' A' ' 25' ' ' ILE . 3.3 tt -108.58 150.83 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 148.7 39.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.283 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 m -159.67 167.79 27.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.551 0.215 . . . . 0.0 110.639 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -80.78 -165.86 0.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 110.773 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.8 -10.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -139.2 66.31 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.432 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 0.2 OUTLIER -152.08 -37.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.138 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.717 HG23 HG21 ' A' ' 25' ' ' ILE . 1.3 mp -56.1 -41.71 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.419 . . . . 0.0 111.204 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.83 -41.21 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -76.15 -36.94 58.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -87.95 12.45 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.121 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 47.24 0.4 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.429 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.88 -42.72 38.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.08 64.05 0.37 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.585 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 25' ' ' ILE . 24.9 t -103.37 130.16 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.277 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' ND1' ' HA ' ' A' ' 22' ' ' ARG . 44.1 m80 -95.37 -20.67 18.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.734 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.683 ' C ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -156.05 144.24 19.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.095 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.715 HG13 ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -127.15 139.58 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.928 0.394 . . . . 0.0 111.163 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -127.64 106.14 8.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 27' ' ' ALA . 36.6 p -133.91 146.6 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.985 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 t -126.66 48.79 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . -110.07 0.25 18.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.805 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.701 ' HA ' ' HE1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER 76.43 62.2 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.017 0.436 . . . . 0.0 111.288 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 88' ' ' LEU . 17.3 m -83.84 -174.44 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 4.7 m-20 -98.76 -22.28 15.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.586 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.624 ' CB ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 43.75 40.83 3.29 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.833 0.349 . . . . 0.0 111.552 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.4 m -130.81 5.43 4.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.22 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 25.7 p90 -96.22 114.24 25.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.71 -119.22 8.91 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.51 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -147.26 21.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.709 0.29 . . . . 0.0 110.633 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.761 HG21 ' CZ ' ' A' ' 83' ' ' PHE . 9.2 tt -51.27 102.01 0.29 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 54.5 Cg_endo -68.44 70.61 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.364 2.042 . . . . 0.0 112.336 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -99.02 157.55 16.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.6 m -141.55 154.91 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.441 . . . . 0.0 111.418 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.701 ' HE1' ' HA ' ' A' ' 78' ' ' ARG . 6.3 m-70 -95.35 152.51 18.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.397 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.87 36.59 3.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.518 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 2.3 tmm? -57.92 -48.64 96.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.434 0.159 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' HD22 ' A' ' 103' ' ' LEU . 61.3 Cg_endo -74.18 -28.83 10.37 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.357 2.038 . . . . 0.0 112.772 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.706 ' HE1' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -67.27 -35.35 79.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.019 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 91' ' ' GLY . 17.3 t -76.69 -21.71 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.462 ' OG ' HG12 ' A' ' 98' ' ' VAL . 5.1 p -63.76 -39.96 95.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.792 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' A' ' 100' ' ' ILE . . . 88.4 -13.38 62.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.775 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG12 ' OG ' ' A' ' 96' ' ' SER . 8.9 p -96.11 -8.13 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.646 0.26 . . . . 0.0 111.468 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.75 19.82 5.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.315 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.706 HG23 ' HE1' ' A' ' 94' ' ' PHE . 88.2 mt -61.03 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.827 0.346 . . . . 0.0 110.76 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.25 -53.26 60.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.365 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 106' ' ' LYS . . . -59.58 -42.89 93.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.281 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.783 HD22 ' HG2' ' A' ' 93' ' ' PRO . 16.5 tp -73.67 -35.81 65.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.711 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 tt0 -64.2 -55.36 22.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.553 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 67.4 m-20 -60.42 -32.17 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.971 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.654 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -73.33 -41.49 63.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.694 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 104' ' ' GLN . 7.9 tp -65.85 -37.58 80.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.438 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 109' ' ' THR . 2.5 pp -73.64 -43.26 59.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.503 ' N ' HD12 ' A' ' 108' ' ' LEU . 58.9 m -59.21 -44.09 92.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.704 0.288 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG12 ' O ' ' A' ' 106' ' ' LYS . 44.1 mm -68.88 -42.19 82.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.231 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 111' ' ' LEU . 13.5 mt -62.66 -43.25 99.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.974 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 1.2 mt-30 -80.83 -18.56 47.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.584 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.86 -137.54 13.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -133.1 -45.29 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.919 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.49 -175.26 0.19 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.092 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' HD2' ' H ' ' A' ' 6' ' ' HIS . 1.4 t-160 -171.32 154.39 3.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.858 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.48 ' H ' ' HD2' ' A' ' 5' ' ' HIS . 3.9 t60 62.69 47.7 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -125.25 -46.5 1.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.693 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -176.33 132.07 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 2.7 m170 -104.76 126.47 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.751 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 59.81 111.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -72.14 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.736 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.75 24.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 61.72 -175.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.075 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -93.73 -34.7 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.052 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.64 115.4 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -121.31 76.28 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.3 96.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 -66.79 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.58 154.89 11.86 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.373 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m 72.58 172.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 110.755 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -160.18 -81.52 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.607 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -114.17 146.59 40.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.032 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -132.45 111.97 11.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.872 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 55' ' ' LEU . 8.1 mt -96.85 153.18 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.852 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.751 HG12 HG13 ' A' ' 56' ' ' ILE . 4.9 mt -124.23 144.64 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 57' ' ' GLN . 1.3 m -124.8 115.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.267 178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -119.54 123.95 45.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.757 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.9 t -137.58 155.3 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.61 -58.46 13.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.98 -175.93 39.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.566 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.46 80.36 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.99 146.35 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.023 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HB1' ' HE3' ' A' ' 37' ' ' MET . . . 39.55 34.64 0.15 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.056 0.455 . . . . 0.0 111.18 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.0 m -142.99 -43.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.759 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -65.23 -56.05 14.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.7 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -47.92 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mtt -57.47 -54.81 42.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.744 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -64.97 -58.35 6.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.238 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.61 -52.69 17.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.278 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.31 -39.0 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -63.74 -54.75 30.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.794 0.331 . . . . 0.0 110.799 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 38' ' ' ALA . 14.3 mm -61.63 -30.92 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -70.41 -53.85 14.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 7.2 tt0 -51.58 -35.74 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.1 0.476 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 41' ' ' GLU . 3.5 mm? -66.07 -48.55 70.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.99 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -41.11 66.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.23 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 2.6 pt20 -74.06 -29.43 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -58.09 -45.81 86.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.931 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -107.01 8.5 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 51.68 54.56 10.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 7.8 mt -109.6 95.61 20.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.57 115.47 2.24 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.508 2.138 . . . . 0.0 112.249 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 22' ' ' ARG . 48.8 t -150.14 158.67 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.356 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -125.61 116.94 22.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 110.792 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 24' ' ' ILE . 8.1 tp -100.89 122.13 42.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.751 HG13 HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.71 150.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.723 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 4.8 mt-30 -125.6 129.42 49.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 33.9 m -152.58 168.19 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.124 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -70.15 -163.98 0.07 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 111.299 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.68 -7.11 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.45 39.62 3.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.389 . . . . 0.0 111.144 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 0.7 OUTLIER -134.06 -32.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.482 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 HG23 ' A' ' 73' ' ' ILE . 57.5 mt -51.62 -40.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.961 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.63 -38.38 80.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 p -73.46 -42.6 61.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.694 0.283 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' HD1' ' O ' ' A' ' 62' ' ' GLU . 46.0 m-85 -90.41 10.44 25.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.179 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.68 50.39 0.68 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.492 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -41.19 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.27 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -143.84 45.85 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' CG1' HG13 ' A' ' 25' ' ' ILE . 15.4 t -89.13 130.42 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 111.324 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.516 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 55.4 t60 -91.97 -28.08 17.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.309 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -150.14 140.28 22.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.251 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.657 HG23 HD13 ' A' ' 63' ' ' ILE . 2.8 mp -120.59 137.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.941 0.401 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.32 103.95 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.901 HG23 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -132.0 148.9 52.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 72.03 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' CA ' ' HD2' ' A' ' 90' ' ' HIS . . . 45.09 -137.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 76.54 -54.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.74 HG23 ' HG3' ' A' ' 81' ' ' ARG . 29.7 m -65.71 177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.015 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.73 -19.94 15.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HG3' HG23 ' A' ' 79' ' ' VAL . 2.6 mtm180 50.53 34.77 10.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.353 . . . . 0.0 110.962 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.19 26.52 2.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.811 ' CE2' HG21 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -96.67 28.08 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.762 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.35 -110.9 0.67 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.927 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p-10 -138.26 19.4 2.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.291 0.545 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.811 HG21 ' CE2' ' A' ' 83' ' ' PHE . 14.9 tt -49.27 100.1 0.23 Allowed Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.5 Cg_endo -67.93 68.45 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.068 1.845 . . . . 0.0 112.045 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HG2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -105.5 161.72 14.1 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.981 0.419 . . . . 0.0 111.706 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.0 166.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.822 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.413 ' HD2' ' CA ' ' A' ' 77' ' ' ALA . 9.1 m80 -91.48 150.37 21.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -108.31 29.08 10.5 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.435 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 11.6 tpt -56.62 -45.77 99.9 Favored Pre-proline 0 CA--C 1.531 0.229 0 O-C-N 122.943 -0.151 . . . . 0.0 111.202 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 92' ' ' MET . 65.1 Cg_endo -72.72 -32.85 8.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.293 1.995 . . . . 0.0 112.653 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.19 -36.29 71.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.789 0.328 . . . . 0.0 110.957 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 91' ' ' GLY . 66.4 t -72.29 -23.11 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.8 p -55.49 -40.26 71.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.879 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 79.99 6.73 89.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.552 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.58 -31.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.57 0.224 . . . . 0.0 111.598 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.71 20.55 38.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.979 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.879 HD11 ' HA2' ' A' ' 97' ' ' GLY . 2.1 mt -64.74 -44.65 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.371 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -42.71 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.306 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 106' ' ' LYS . . . -67.44 -47.68 69.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.992 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.704 ' O ' HG12 ' A' ' 107' ' ' ILE . 9.5 tp -70.24 -43.05 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.194 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 2.9 tp60 -48.37 -54.44 13.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -59.85 -50.29 74.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -50.73 -43.55 58.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.03 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.903 HG22 ' CD1' ' A' ' 111' ' ' LEU . 22.2 mm -62.29 -47.93 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.558 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.742 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 55.5 mt -65.16 -46.15 82.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.74 -38.79 67.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 111.223 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.2 mt -83.59 -39.52 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' CD1' HG22 ' A' ' 107' ' ' ILE . 29.5 mt -56.56 -34.15 66.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 33.0 mt-30 -83.04 -25.73 31.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.438 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.37 39.95 0.6 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -117.15 179.13 4.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.9 96.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m80 54.48 33.09 18.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.081 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 5.8 t-80 63.42 -174.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.493 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 69.4 m-70 -56.18 152.98 9.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -41.35 83.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.073 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -175.11 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 10' ' ' HIS . 4.7 p80 -115.43 -173.59 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -118.27 125.04 49.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.032 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -80.57 -77.81 0.19 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -174.65 121.24 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.805 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.02 107.93 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 59.03 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.404 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -76.34 45.37 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 53.12 94.05 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.212 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.95 112.76 25.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 32.22 47.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.73 80.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 110.727 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -139.19 -74.96 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG3' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -115.2 146.31 41.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.573 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 70' ' ' VAL . 6.4 mttp -133.81 121.96 22.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' ILE . 2.5 mp -97.06 152.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.834 HD13 HG12 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -122.96 145.23 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.409 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' VAL . 13.9 p -131.04 125.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -119.09 123.92 45.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.046 0.451 . . . . 0.0 111.696 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -135.8 177.65 7.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.101 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.8 62.21 0.59 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.508 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.99 -72.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 66.64 76.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.179 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 33' ' ' ALA . 9.0 p -136.01 -45.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 32' ' ' VAL . . . -131.61 -37.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.485 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -72.25 -22.96 61.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.262 -179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -69.94 -49.16 54.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -57.06 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.14 -53.16 13.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -59.16 -58.08 10.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.51 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.155 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.14 -43.19 99.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.644 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 1.2 tt0 -64.34 -50.87 66.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.8 mt -63.07 -30.42 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.7 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HG3' ' OE1' ' A' ' 47' ' ' GLN . 0.2 OUTLIER -65.85 -58.76 4.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.021 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.644 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -54.91 -37.5 66.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.158 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.66 -59.46 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.432 ' SG ' HG21 ' A' ' 53' ' ' VAL . 72.9 m -52.88 -37.83 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.144 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' OE1' ' HG3' ' A' ' 43' ' ' LYS . 4.6 mt-30 -78.7 -47.86 16.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -53.14 -42.32 65.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.203 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.502 ' HB3' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -84.47 -11.8 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 t30 67.19 43.24 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.871 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 49' ' ' HIS . 7.6 mt -102.86 100.92 18.07 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.466 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 50' ' ' ASN . 51.7 Cg_exo -54.11 107.72 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 112.213 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 22' ' ' ARG . 4.3 m -152.22 159.69 3.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.813 0.339 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 1.3 mt-10 -125.44 117.54 23.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 42' ' ' ILE . 16.3 tp -89.11 116.25 27.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 111.471 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 24' ' ' ILE . 8.0 tt -106.33 150.53 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -122.82 137.35 54.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.372 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -162.4 167.78 23.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.455 0.169 . . . . 0.0 110.572 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -69.68 -163.01 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.657 0.265 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.1 -8.4 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.199 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -130.96 62.95 1.6 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.183 0.516 . . . . 0.0 111.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.93 -31.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 25' ' ' ILE . 1.6 mp -52.22 -32.29 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.326 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -76.11 -29.11 57.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.427 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.88 -44.39 20.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.584 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 63' ' ' ILE . 14.1 p90 -91.93 12.93 20.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.75 0.309 . . . . 0.0 111.01 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -75.05 52.24 0.55 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.226 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -43.85 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.69 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.83 60.64 0.41 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 25' ' ' ILE . 3.6 t -96.54 130.2 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 54.2 t-80 -92.48 -25.84 18.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.016 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 1.2 mt -150.15 144.65 25.81 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.689 ' HA ' HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -128.99 141.73 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.972 0.415 . . . . 0.0 111.213 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' H ' HG13 ' A' ' 25' ' ' ILE . 53.3 m -127.11 108.89 11.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.01 139.89 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.602 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.56 62.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.54 137.93 14.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 82.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.01 -175.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.39 -22.59 18.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.778 0.323 . . . . 0.0 111.105 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.51 ' HG3' HD11 ' A' ' 88' ' ' LEU . 1.5 ttt-85 49.28 45.76 23.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -132.85 2.5 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.358 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 86' ' ' ILE . 19.0 p90 -94.79 98.37 10.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.997 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.27 -117.98 4.8 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.568 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -156.24 27.48 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 86' ' ' ILE . 1.3 tt -55.82 104.36 0.42 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.061 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 40.6 Cg_endo -67.01 75.29 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.189 1.926 . . . . 0.0 112.652 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -98.62 156.92 16.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.404 0.621 . . . . 0.0 112.229 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 m -146.0 154.87 12.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -84.26 149.03 26.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.021 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -117.36 15.46 13.09 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.58 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.586 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 6.3 mtp -54.59 -41.84 91.71 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 92' ' ' MET . 68.2 Cg_endo -73.63 -31.93 8.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.107 1.872 . . . . 0.0 112.686 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -35.42 77.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.396 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' CG2' ' A' ' 34' ' ' THR . 22.0 t -74.56 -21.18 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.76 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 4.8 m -55.52 -37.02 67.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.693 0.282 . . . . 0.0 111.228 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 82.88 -4.53 79.54 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.548 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 98' ' ' VAL . 11.5 p -129.8 -2.78 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.614 0.245 . . . . 0.0 111.656 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.59 -4.24 30.3 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.939 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD11 ' HA2' ' A' ' 97' ' ' GLY . 3.6 mp -58.24 -40.62 78.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.854 0.359 . . . . 0.0 111.505 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -48.77 -52.88 21.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.34 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.35 -44.57 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.58 -51.31 69.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 107' ' ' ILE . 6.3 tm0? -60.69 -50.07 74.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -42.71 71.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.907 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -39.89 55.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 104' ' ' GLN . 0.6 OUTLIER -63.21 -41.28 92.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.337 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.808 HD12 ' N ' ' A' ' 109' ' ' THR . 4.5 pp -69.74 -40.95 75.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.808 ' N ' HD12 ' A' ' 108' ' ' LEU . 68.9 m -56.49 -45.61 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.2 -39.83 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.674 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.5 mt -70.64 -14.92 62.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 31.6 mt-30 -97.95 -4.44 36.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.11 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.444 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.7 46.02 3.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.88 56.16 7.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.13 172.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.81 25.72 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 84.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.53 150.84 22.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 178.97 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.673 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m170 58.41 -168.06 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.756 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -70.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -157.83 -160.88 0.96 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.525 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -157.53 154.82 29.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.309 . . . . 0.0 110.268 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 168.42 26.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.706 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -144.28 128.76 18.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.033 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.89 75.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.655 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -115.41 -9.25 12.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.076 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 151.26 42.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.823 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 58.16 76.29 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.87 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.8 -77.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.64 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 t -133.09 131.52 40.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 1.8 mmmp? -137.19 -75.26 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.3 OUTLIER -126.84 155.95 42.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -129.64 117.46 20.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.417 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 2.9 mp -106.98 152.05 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 63' ' ' ILE . 2.7 pt -117.45 144.8 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.344 . . . . 0.0 110.514 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' HG3' ' A' ' 57' ' ' GLN . 58.8 t -124.89 120.94 59.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' CYS . . . -126.97 123.31 36.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -81.59 0.62 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.57 41.21 0.19 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.903 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.76 40.91 4.54 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.96 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB1' ' OG1' ' A' ' 34' ' ' THR . . . -120.08 74.99 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.05 -34.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.163 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.53 40.59 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.249 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.437 ' OG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -167.16 -36.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.017 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -48.4 72.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.838 0.352 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -66.45 -52.49 45.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.58 -54.01 12.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -65.33 -50.9 63.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.286 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.17 -53.83 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.584 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -35.41 81.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HA ' ' OE2' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -62.45 -52.76 62.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 38' ' ' ALA . 11.7 mm -62.74 -32.84 57.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -69.77 -57.6 4.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.349 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 41' ' ' GLU . 14.7 pt-20 -53.52 -38.52 63.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.122 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 108' ' ' LEU . 3.1 tp -67.53 -53.68 26.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 68.2 m -48.55 -37.27 17.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.408 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -33.14 66.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 110.507 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -45.08 94.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.471 ' HB3' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.32 -7.43 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.364 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.31 49.38 3.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.321 . . . . 0.0 111.014 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 49' ' ' HIS . 5.0 mt -115.71 92.54 34.18 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.896 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 52.0 Cg_exo -52.04 126.74 21.09 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.96 . . . . 0.0 112.131 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -157.16 167.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.661 0.267 . . . . 0.0 110.578 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -123.3 114.25 19.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.88 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 42' ' ' ILE . 15.7 tp -93.9 114.09 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.945 0.402 . . . . 0.0 110.755 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.774 ' CG2' HG22 ' A' ' 25' ' ' ILE . 5.0 tp -104.85 149.78 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.021 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' HB ' ' A' ' 26' ' ' VAL . 5.9 mp0 -118.94 135.87 54.37 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' GLU . 20.4 m -145.16 168.09 21.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.876 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 60' ' ' VAL . 3.7 mpt_? -81.9 -161.13 0.41 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' H ' ' HB3' ' A' ' 59' ' ' ARG . 13.0 m -69.43 -22.02 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -138.18 69.58 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 58' ' ' CYS . 4.7 mm-40 -144.84 -39.68 0.26 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.558 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -55.3 -36.78 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.379 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -64.73 -39.88 94.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.746 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.2 p -73.99 -41.38 61.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -88.45 12.61 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.36 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.78 47.93 0.44 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.725 0.298 . . . . 0.0 111.42 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.39 -37.77 71.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.829 0.347 . . . . 0.0 111.357 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 23' ' ' LYS . . . -159.54 67.99 0.26 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 25' ' ' ILE . 19.3 t -105.4 128.6 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.684 0.278 . . . . 0.0 110.912 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -94.94 -14.9 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.063 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 14.1 mt -155.66 151.71 27.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.933 HG21 HG12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.07 141.37 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.603 ' N ' HD12 ' A' ' 73' ' ' ILE . 72.8 m -127.35 107.14 9.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.578 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.495 HG22 HD13 ' A' ' 88' ' ' LEU . 9.7 t -118.48 144.15 46.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.07 0.462 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.25 72.81 3.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.941 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 78' ' ' ARG . . . 52.77 -154.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.129 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 34.6 mtt180 74.56 -53.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.461 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.9 p -59.29 170.55 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -101.78 -22.7 14.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.145 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER 53.1 36.47 22.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.189 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 m -133.15 14.1 4.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.416 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 38.5 p90 -105.57 115.83 30.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.893 0.378 . . . . 0.0 110.984 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.5 -119.04 6.42 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -148.56 20.03 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.494 0.187 . . . . 0.0 110.592 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.933 HG12 HG21 ' A' ' 73' ' ' ILE . 16.5 tt -55.87 101.9 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 49.9 Cg_endo -67.11 74.36 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.591 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.801 ' CA ' HG23 ' A' ' 73' ' ' ILE . 3.7 pp -98.14 160.42 14.31 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.957 0.408 . . . . 0.0 111.722 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.33 152.7 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.32 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.513 ' CD2' ' HA ' ' A' ' 77' ' ' ALA . 36.0 m80 -86.97 146.88 25.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.088 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.64 34.29 5.45 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.637 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 1.3 ttt -56.03 -51.53 79.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.461 0.172 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.562 ' CG ' HD13 ' A' ' 103' ' ' LEU . 59.8 Cg_endo -73.07 -33.66 7.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.386 2.057 . . . . 0.0 113.002 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.783 ' CD1' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -67.29 -36.81 82.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 110.54 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 92' ' ' MET . 14.6 p -75.53 -23.28 16.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 111.656 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 t -56.26 -29.19 60.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 100' ' ' ILE . . . 71.82 -3.01 21.35 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.802 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.7 t -123.42 -37.32 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.775 0.288 . . . . 0.0 111.583 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.62 13.71 61.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.036 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD11 ' HA2' ' A' ' 97' ' ' GLY . 28.2 mt -65.96 -45.37 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.912 0.356 . . . . 0.0 110.959 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -47.23 -51.15 19.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.759 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.61 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.783 HD23 ' CD1' ' A' ' 94' ' ' PHE . 12.7 tp -61.75 -47.73 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.598 ' HA ' HG22 ' A' ' 107' ' ' ILE . 1.9 tt0 -53.98 -50.36 66.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.63 -53.11 60.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.305 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' O ' HG13 ' A' ' 110' ' ' ILE . 1.2 mtpp -68.31 -43.99 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.445 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.899 ' HA ' HD12 ' A' ' 110' ' ' ILE . 1.7 tp -63.56 -43.62 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 0.0 111.256 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.663 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 31.3 mt -60.3 -46.1 91.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.5 m -59.78 -42.95 94.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.575 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 107' ' ' ILE . 12.3 mt -56.21 -49.96 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.333 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.08 -41.92 97.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.2 pt20 -92.79 25.71 3.02 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.132 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.324 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.93 74.24 0.78 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.606 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -78.46 57.63 2.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.01 35.87 20.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -132.35 26.34 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.549 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -126.59 70.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.991 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 7' ' ' HIS . 2.3 p80 -148.74 -58.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -172.32 20.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.345 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 55.59 -84.15 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.459 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.475 ' NE2' ' HG2' ' A' ' 13' ' ' GLU . 0.6 OUTLIER 177.19 155.06 0.27 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.782 0.325 . . . . 0.0 110.92 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -146.56 -31.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.46 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -132.68 128.15 36.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -126.34 60.73 1.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 110.872 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 53.78 93.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.32 118.39 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.3 t80 62.99 138.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 99.51 4.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.13 87.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.05 -167.05 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.73 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.42 ' C ' ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -113.79 148.49 36.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.309 . . . . 0.0 110.962 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -139.47 -74.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.99 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -127.58 152.44 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 0.0 111.041 -179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -129.64 112.86 14.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.79 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.669 HG12 HD12 ' A' ' 72' ' ' LEU . 16.6 mt -97.38 154.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.957 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 73' ' ' ILE . 4.9 pt -128.62 144.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 12.6 p -125.63 116.07 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.939 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -113.52 122.95 48.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.51 124.35 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.29 102.04 0.97 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.158 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.31 -49.13 0.88 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 51.22 82.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.113 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 32' ' ' VAL . 27.8 m -147.49 110.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . 72.9 -38.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.389 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 32' ' ' VAL . 43.1 p -79.55 -13.13 59.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.946 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.26 -55.99 6.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.789 0.328 . . . . 0.0 110.649 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 10.2 t -65.39 -37.99 88.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 ttt -61.08 -53.76 53.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 42' ' ' ILE . . . -66.47 -50.24 63.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.887 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.61 -51.79 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.162 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.12 -32.62 74.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.865 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 2.4 tp10 -67.49 -51.88 45.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.871 HD13 HD11 ' A' ' 55' ' ' LEU . 1.9 mt -65.22 -38.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -52.52 21.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 7.9 pt-20 -53.44 -37.49 62.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.0 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -70.97 -46.01 63.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 53' ' ' VAL . 82.4 m -51.67 -35.1 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -36.48 46.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.51 -43.95 76.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HB3' HD11 ' A' ' 51' ' ' ILE . 1.3 m80 -92.59 -2.05 56.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 54.72 54.08 9.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.92 0.39 . . . . 0.0 111.031 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 49' ' ' HIS . 19.3 mt -114.08 105.17 54.52 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.737 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -55.81 119.87 7.3 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.039 1.826 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 52' ' ' PRO . 26.4 m -160.5 167.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.366 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -128.44 119.01 24.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.678 0.275 . . . . 0.0 110.646 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.871 HD11 HD13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -92.34 115.98 28.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.932 ' CG2' HG22 ' A' ' 25' ' ' ILE . 1.3 tt -105.4 149.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -119.97 136.15 54.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.861 ' HB2' HG23 ' A' ' 63' ' ' ILE . 5.4 m -152.57 168.42 25.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.711 0.291 . . . . 0.0 110.799 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -164.61 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 60' ' ' VAL . 7.5 p -73.69 -12.27 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.635 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.59 61.1 1.33 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.332 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 11.9 tt0 -144.74 -35.88 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.861 HG23 ' HB2' ' A' ' 58' ' ' CYS . 1.7 pt -62.98 -44.45 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.37 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 83' ' ' PHE . 23.3 tt0 -51.34 -45.94 62.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.686 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -77.29 -31.32 54.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.859 0.361 . . . . 0.0 110.681 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.35 13.85 10.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.289 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.584 ' SD ' HD12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -70.89 46.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.597 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.08 -41.03 74.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 111.454 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.77 61.19 0.13 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.945 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' SD ' ' A' ' 67' ' ' MET . 11.9 m -89.36 127.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 0.0 111.509 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' ARG . 16.9 m-70 -92.54 -20.55 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.075 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -153.29 150.54 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -140.8 144.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 111.835 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -128.03 107.46 9.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.219 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.765 HG23 ' HB3' ' A' ' 27' ' ' ALA . 1.6 m -140.88 151.5 44.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.509 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p -87.2 74.61 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.36 175.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -126.06 53.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.949 0.404 . . . . 0.0 110.423 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 5.8 t -75.85 34.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -91.43 2.1 56.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.619 0.247 . . . . 0.0 110.941 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.9 ttp85 -62.36 -34.21 76.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.155 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.0 m -160.84 45.53 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.887 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -110.65 48.7 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.69 -90.43 0.04 OUTLIER Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.802 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 4.5 t0 -163.97 25.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.696 ' CG1' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.03 106.35 0.67 Allowed Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 85' ' ' ASP . 42.4 Cg_endo -67.09 81.03 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.798 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HA ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -102.41 159.22 15.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.374 0.607 . . . . 0.0 112.426 -179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.98 153.14 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.877 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.52 144.53 26.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 110.894 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -120.3 31.15 5.37 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.4 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.517 ' N ' ' HD2' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -56.42 -47.58 98.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 111.506 0.187 . . . . 0.0 111.506 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 92' ' ' MET . 80.0 Cg_endo -76.64 -24.65 10.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.219 1.946 . . . . 0.0 112.577 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' CE1' ' HG2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -69.16 -37.9 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.465 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 91' ' ' GLY . 4.4 t -77.93 -19.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.56 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -52.21 -37.2 54.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.004 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -10.02 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.485 -0.865 . . . . 0.0 112.734 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.57 -11.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.39 . . . . 0.0 111.198 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.7 -9.32 40.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.88 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.8 mt -52.22 -39.63 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.79 0.328 . . . . 0.0 111.166 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.53 -51.89 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.153 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.94 -42.15 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.58 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.41 -51.51 69.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.925 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 107' ' ' ILE . 11.0 tt0 -49.27 -48.43 45.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -55.66 -54.82 39.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -64.56 -48.4 75.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.992 -179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' GLN . 1.2 pt -62.28 -33.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.674 0.273 . . . . 0.0 111.152 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . 6.3 mt -66.41 -48.2 70.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 0.1 OUTLIER -57.18 -43.31 82.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.134 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 106' ' ' LYS . 31.7 mm -62.39 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.668 0.27 . . . . 0.0 111.2 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 107' ' ' ILE . 6.6 mt -56.36 -41.5 76.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.783 0.325 . . . . 0.0 110.956 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 109' ' ' THR . 15.1 pt20 -79.31 -26.87 42.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.405 -1.22 . . . . 0.0 112.616 -179.872 . . . . . . . . 0 0 . 1 stop_ save_